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Summary
This thesis addresses presynaptic pathology after acute brain injury. The integrity of 
presynaptic terminals after human head injury is not known and there are inconsistent 
reports regarding the sensitivity of presynaptic terminals in animal models of acute 
brain injury. Using a range of presynaptic markers, including high affinity nicotinic 
receptors and proteins specifically located within the nerve terminal, the question of 
presynaptic terminal integrity was studied in human postmortem material and compared 
to that in animal models of acute brain injury.
[3H]-Nicotine binding
Deficits in cortical cholinergic neurotransmission have been implicated in the 
neurochemical sequelae of a head injury. Low nanomolar concentrations of [3H]- 
nicotine were used to detect the density of high affinity nicotine binding sites in 3 
cortical regions in controls and head-injured patients. No significant difference in the 
level of [3H]-nicotine binding was detected in the cingulate gyrus, superior parietal 
cortex and the inferior temporal gyrus of head-injured patients compared with controls.
Presynaptic proteins after human head injury
A number of proteins, which include: synaptophysin, SNAP-25, syntaxin,
synaptotagmin and synapsin I are specifically located on either the synaptic vesicle or 
associated with the nerve terminal membrane, and have been routinely used as markers 
of presynaptic terminal density. In homogenates of cingulate gyrus and the superior 
parietal cortex of controls and head-injured patients, a number of presynaptic proteins 
were detected by Western blotting. Synaptophysin, SNAP-25 and syntaxin 
immunoreactivity were significantly reduced by 28%, 36% and 43% respectively in the 
cingulate gyrus of head-injured patients compared with controls. However, 
synaptotagmin and synapsin I were not significantly different between groups. In the 
superior parietal cortex, there was no significant difference in the level of any of the 
presynaptic proteins in head-injured patients compared with controls, although all of the 
proteins showed a trend towards a loss. The association between cortical ChAT activity 
and synaptophysin levels in both the cingulate gyrus and the superior parietal cortex of 
head-injured patients, suggests that there is a loss of at least a proportion of cortical 
cholinergic presynaptic terminals after head injury.
nbM pathology after human head injury
The cortical mantle receives a widespread cholinergic innervation from Ch4 neurons of 
the nbM in the basal forebrain. Macroscopic evidence of damage to the nbM territory 
was evident in coronal sections from head-injured patients. Histological examination 
and semi-quantitative scoring of neuronal damage in the nbM demonstrated 
morphological changes including plastic creep, ischaemic cell change and infarction, in 
the nbM of 8 out of 12 head-injured patients. In contrast, none of the controls possessed 
any evidence of neuronal damage in the nbM. Correlation of the neuronal damage score 
attributed and ChAT activity in 3 cortical regions indicated that head-injured patients 
with low ChAT activity had extensive neuronal damage in the nbM. 
Immunohistochemistry with an antibody to ChAT verified that the nbM neurons with 
morphological abnormalities after head injury were cholinergic in origin. Association of 
Ch4 neuronal damage did not correlate with levels of any of the presynaptic proteins in 
the cingulate gyrus and the superior parietal cortex from head-injured patients. These 
data indicate that loss of cortical ChAT activity after a head injury, primarily reflects 
loss of Ch4 neurons in the nbM and not cortical presynaptic terminals.
Presynaptic pathology in animal models of acute brain injury
To obtain a temporal profile of the sensitivity of presynaptic terminals to brain injury, 
the levels of synaptophysin, SNAP-25 and syntaxin were determined in brain regions 
susceptible to ischaemic damage in rodent models of cerebral ischaemia. Western blot 
analyses indicated that levels of all three presynaptic proteins were preserved in the 
ipsilateral middle cerebral artery territory and cingulate gyrus compared with the 
contralateral hemisphere after 24h permanent middle cerebral artery occlusion in the rat. 
Immunohistochemistry combined with MCID image analyses was used to assess levels 
of staining for these presynaptic proteins in the caudate and a number of presynaptic 
inputs within the hippocampal formation after bilateral common carotid artery occlusion 
in the mouse. None of the presynaptic proteins were altered by either focal or global 
ischaemia in areas where there was evidence of neuronal damage. These data suggest 
that presynaptic proteins, and therefore presynaptic terminals are resistant to acute and 
chronic phases of brain damage in these animal models of brain injury.
Postsynaptic damage after brain injury.
The integrity of presynaptic terminal proteins was compared with that of MAP-2, as a 
marker of postsynaptic structures. In both the human postmortem brains of head-injured 
patients and global ischaemia in the mouse, early changes in the pattern of MAP-2 
immunostaining were evident. Specifically, fragmentation and swelling of dendrites, 
and accumulation of MAP-2 immunoreactivity around neuronal perikarya. Moreover, 
an early loss of MAP-2 immunostaining was observed in anatomical regions displaying 
preservation of presynaptic proteins. This suggests that the major pathological changes 
following head injury and cerebral ischaemia are postsynaptic.
GGF-2 after human head injury
GGF-2 is known to promote nicotinic acetylcholine receptor subunit expression at the 
neuromuscular junction. The existence of GGF-2 in the human brain was demonstrated 
by Western blot analyses and immunohistochemistry. The level of GGF-2 was 
significantly increased in the cingulate gyrus of head-injured patients compared with 
controls. In head-injured cases, GGF-2 immunoreactivity accumulated in the neuronal 
cytoplasm of shrunken cell bodies and was prominent in glia. Although the level of 
GGF-2 was not increased in superior parietal cortex, the majority of head-injured 
patients possessed a level of GGF-2 immunoreactivity above that of the controls. 
Neuropathological evidence of presence or absence of ischaemic damage had no effect 
on the level of GGF-2 in head-injured patients, suggesting it is not the sole stimulus 
responsible for upregulation of GGF-2 after head injury. The lack of a GGF-2 response 
in the cingulate gyrus of Alzheimer’s disease and the correlation with survival time in 
head-injured patients with a left subdural haematoma, imply that the elevation in GGF-2 
is limited to acute (head injury) and not chronic brain injury (Alzheimer’s disease).
GGF-2 in animal models of acute brain injury
The observation from human postmortem studies that GGF-2 was increased after acute 
brain injury, was supported by increases in GGF-2 in animal models of acute brain 
injury. Using Western blot analysis, GGF-2 immunoreactivity was increased in the 
ipsilateral caudate nucleus compared with the contralateral hemisphere after 24h 
permanent focal ischaemia in the rat (Intraluminal thread model). Similarly, GGF-2 
immunoreactivity was significantly increased in the ipsilateral and contralateral cortex
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4h after induction of subdural haematoma in the rat. These findings suggest a role for 
GGF-2 in the pathophysiological processes associated with acute brain injury.
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CHAPTER 1: INTRODUCTION
1.1 Human Head Injury
1.1.1 Frequency and Financial Cost of Human Head injury
Head injury is an international clinical problem and remains the subject of ongoing 
research in the UK. Head injury is the leading killer in the productive periocj through age 
40, and between the ages of 5 and 34 years exceeds all other causes of mortality 
combined (Baker et al., 1984). In the UK, there are an estimated 9 deaths from head 
injury per 100,000 population, accounting for 1% of all deaths and 25% of deaths from 
trauma (Graham and Gennareiii, 1997). Fortunately, the majority of head injured patients 
make an uneventful recovery, but others sustain irreversible brain damage. The incidence 
of disabled survivors of head injury is 100-150 per annum per 100,000 of the UK 
population, accounting for one family in 300 having a member with such a disability 
(Graham and Gennareiii, 1997).
In the USA, the estimated cost of head injuries ranges from $1 billion to $25 billion per 
annum (Pope and Tailor, 1991; Kraus et al., 1994), not to mention the social and 
economic stresses posed upon affected families. In view of the cost and sheer frequency 
of incidents, head injury is highlighted in 'The Health of the Nation' government white 
paper, as an important health issue with targets set aimed at reducing the number of 
deaths resulting from a traumatic event (MRC Field Review, 1998).
1.1.2 Types of Head Injury
Brain damage resulting from a head injury commonly referred to as traumatic brain injury 
(TBI) is complex, comprising of a number of causes, types and distribution. Head injuries 
are of two types: missile and non-missile (blunt), with the mechanisms of brain damage 
different in each type (Adams and Graham, 1988). Missile head injury involves objects 
that fall or are propelled through the air, frequently with entry of the object into the 
cranial cavity. A relatively poor prognosis is associated with missile head injuries. For 
example, gunshot wounds to the head frequently cause severe brain injuries with the 
mortality rate in some series exceeding 70% (Grahm et al., 1990; Stone, et al., 1995).
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In comparison to the largely penetrative injuries associated with missile head injury, in 
blunt head injury it is the rapid acceleration/deceleration conditions existing at the 
moment of impact that initiate damage. Brain damage resulting from a blunt head injury 
accounts for the majority of brain injuries in modern society. For this reason, from this 
point onwards blunt head injury will be solely considered.
1.1.3 Causes of Human Head Injury
Based on a comprehensive neuropathological assessment of 635 fatal 'head injuries 
encountered in Glasgow over a 15 year period, the two commonest causes of head 
injuries were road traffic accidents (53%) and falls (35%), with the remainder largely 
comprised of assaults and sporting injuries (Graham and Gennareiii, 1997). Evidence of 
recent ingestion of alcohol was noted in 22% of head injured patients in Scotland (Strang 
et al., 1978).
1.2 Classification of Brain Damage
The classification of brain damage has to take into account two extremes: the patient 
who remains unconscious from the moment of injury until death; and the patient who is 
apparently normal after the initial injury but who, as a consequence of complication/s, 
lapses into fatal coma. From a neuropathological point of view, brain damage as a result 
of head injury is classified into two categories, namely primary damage which occurs at 
the moment of injury and takes the form of fracture of the skull, surface contusions and 
diftuse axonal injury; and secondary damage which is produced by complicating 
processes initiated at the mcment of injury but do not present clinically for a duration of 
time after injury - these include brain damage due to raised intracranial pressure, 
ischaemia, intracranial haematoma, infection and swelling (Graham et al, 1995). In a 
series of over 1300 fatal blunt head injuries, Adams et al., 1980a, reported the frequency 
of principal primary and secondary types of head injury (Table 1).
The primary injury is influenced by a variety of predisposing factors such as age, 
undetected diseased state and a number of exogenous drug substances, particularly 
alcohol (Zink et al., 1993). Brain damage as a direct consequence of secondary damage 
has a profound effect on outcome after head injury.
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Blunt Injury Percentage
Primary Damage
Skull fracture 75
Cerebral contusion and laceration 95
Diffuse axonal injury
(using silver impregnation) 30
(using p-APP immunohistochemistry) 90
Secondary damage
Intracranial haematoma 60
Cerebral oedema and brain swelling 53
Ischaemic brain damage 55
Infection 4
Secondary to raised intracranial 75
pressure
Table 1: Classification and frequency of the principal types of blunt head injury.
Over recent years, improved awareness and prevention of secondary damage has reduced 
the mortality from severe head injury (Andrews et al., 1990; Murray et al., 1993). 
Recovery and functional outcome of head injured patients are the products of the 
primary damage, its delayed consequences, the secondary damage and the repair and 
rehabilitation achieved.
1.2.1 Primary Brain Damage
1.2.1.1 Skull Fracture
Presence of a skull fracture indicates the impact was of considerable force, but many 
individuals with a fracture of the skull do not sustain brain damage. The occurrence of a 
skull fracture depends on the material properties of the skull, the magnitude and direction 
of the impact, the size of the impacted area, and the thickness and strength of the skull in 
various areas. Patients with a skull fracture have a much higher incidence of intracranial 
haematoma (Servadei et al., 1988; Cooper, 1993) than patients without a skull fracture. 
Impact against a flat surface will produce fissure fractures, whereas, impact against
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small, irregular objects will produce a more localised, depressed fracture (Adams and 
Graham, 1988). There are a number of additional types of fracture with varying degrees 
of severity, and both highly localised and extensive distribution over the skull surface. 
These include hinge, coup, contrecoup, linear and basal fractures.
1.2.1.2 Cerebral Contusions
Surface contusions are common and are traditionally considered to be the hallmark of 
brain damage due to blunt head injury. Contusions occur at the moment of injury, 
brought about by the surface of the brain coming into contact with the bony 
proturbances in the base of the skull. They characteristically occur at the crests of gyri, 
but may also extend to deeper layers of the cortex, with or without involvement of 
subcortical white matter. Initially contusions present as groups of punctate 
haemorrhages, or streaks of haemorrhage perpendicular to the cortical surface (Graham 
and Gennarelli, 1997). Thereafter, the haemorrhage becomes more extensive, permeating 
into adjacent white matter. Irrespective of the site of injury contusions present a 
characteristic distribution in the brain, namely, the frontal lobes, the temporal poles, the 
lateral and inferior surfaces of the temporal lobes and the cortex above and below the 
Sylvian fissures (Graham and Gennarelli, 1997). Various identities have been ascribed to 
surface contusions: coup, contrecoup and gliding contusions to name a few. In an 
attempt to quantify both the number and distribution of cerebral contusions, the 
contusion index (Adams et al., 1980b, 1985) and the sector scoring method (Ryan et al.,
1994) have been developed.
1.2.1.3 Diffuse Axonal Injury (DAI)
Although currently recognised as DAI, historically this injury has been defined by a host 
of descriptive terms including shearing injury (Peerless and Rewcastle, 1967), diffuse 
damage of immediate impact type (Adams et al., 1977) and diffuse white matter shearing 
injury (Zimmerman et al., 1978). It occurs particularly in patients who have been 
involved in road traffic accidents or as a result of falls from a considerable height (Adams 
et al., 1984) and may lead to a brief period of concussion or prolonged coma and 
ultimately an incomplete recovery (Graham and Gennarelli, 1997). The principal 
mechanical loading associated with induction of DAI is angular and rotational 
acceleration of the brain resulting from unrestricted head movement in the instant after
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injury (Gennarelli et al., 1982a; Thibault et al., 1990). This inertial loading to the brain 
induces shear, tensile and comprehensive strains leading to dynamic tissue deformation 
(Smith et al., 1997). Critical factors in the amount of axonal damage are the magnitude, 
duration and onset rate of the angular acceleration, as well as the direction of head 
motion: DAI is produced by long acceleration loading in the range of 20-25ms (Graham 
and Gennarelli, 1997).
In a review of 122 head-injured cases, Adams et al., 1989, devised a grading system for 
DAI. In grade 1 DAI, abnormalities are limited to histological evidence of axonal 
damage throughout white matter, without evidence of lesions in the corpus callosum or 
brain stem. Grade 2 DAI accounts for widely distributed axonal injury, along with focal 
lesions in the corpus callosum. Grade 3 DAI represents the most severe end of the 
spectrum and takes the form of widespread axonal damage, and focal lesions in the 
rostral brain stem in addition to the corpus callosum. The majority of blunt head injury 
cases sustain Grade 3 DAI (Adams et al., 1989).
Detection of diffuse injury to axons can only be determined microscopically. Historically, 
conventional histological techniques of haematoxylin and eosin, and silver impregnation 
were used. Using these techniques a survival after injury of 18-24 hours is required for 
the incontrovertible identification of axonal damage, i.e. axonal bulbs (Graham et al,
1995). However, adoption of more sensitive immunohistochemical techniques has 
allowed a diagnosis of DAI in patients who survive for only a short time after injury. A 
number of axonally transported proteins have been suggested as possible markers of 
axonal damage. In a comparative study using antibodies to a number of these proteins, 
immunostaining for p-amyloid precursor protein (P-APP) produced the most sensitive 
and reliable staining of axonal damage (Sherriff et al., 1994). The same group reported 
that axonal P-APP immunoreactivity was present in all patients who survived 3 hours or 
more. Consequently, P-APP is regarded as an excellent general marker of axonal 
disruption (Gentleman et al., 1993). Confirmation of the reliability of P-APP staining for 
detecting axonal injury has been provided by the reanalysis of twenty-five cases in which 
DAI had been diagnosed in eight using silver impregnation (Gentleman et al., 1995). The 
results generated indicated that the frequency of axonal injury had been grossly
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underestimated using conventional silver protocols and that axonal injury may in fact be 
a universal consequence of fatal head injury. In addition to staining techniques, computer 
tomography and magnetic resonance imaging are now being used to investigate DAI 
after head injury (Parizel et al., 1998).
1.2.2 Secondary Brain Damage
1.2.2.1 Intracranial Haematoma
Intracranial haematoma is a frequent complication of blunt head injury and represents the 
commonest cause of deterioration and death in patients who experienced a lucid interval 
after their injury. Although classified as a form of secondary damage, the haemorrhage is 
believed to begin at the time of injury - i.e. a primary event-, but the diagnosis of 
complications reflects an interval between the onset of the haemorrhage and appearance 
of clinical features of the expanding lesion. Multiple forms of intracranial haematomas 
exist, and these result in bleeding into the extradural, subdural or subarachnoid spaces of 
the brain, or into the ventricles. Extradural, subdural and intracerebral haemorrhages are 
the usual causes of expanding intracranial lesions after head injury.
1.2.2.2 Extradural Haematoma (EDI!)
EDH occurs in approximately 2% of all types of head injury (Jamieson and Yelland, 
1968; Lindenberg, 1971) and was present in 8% of cases in the Glasgow database 
(Graham and Gentleman, 1997). A fracture of the skull exists in the majority of patients 
presenting with an EDH. The artery most often damaged is the middle meningeal artery 
at the point where it runs across the squamous part or the temporal bone (Adams and 
Graham, 1988). As the haematoma enlarges it strips the dura from the skull to form a 
circumscribed ovoid mass which indents the adjacent brain tissue (Graham and 
Gentleman, 1997). Over a period of several weeks, the EDH may increase in size by up 
to 50%, thereafter becoming smaller, and completely resolved by 4-6 weeks after the 
injury (Graham and Gentleman, 1997).
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1.2.2.3 Subdural Haematoma (SDH)
SDHs are present as thin smears of blood in the subdural space, which, unlike the 
localised nature of the EDH, spreads diffusely over the entirety of the affected 
hemisphere. A working classification defines SDH as acute when the haematoma is 
composed of blood, subacute when there is a mixture of clotted and fluid blood and 
chronic when the haematoma is fluid (Jennett and Teasdale, 1981). The majority of SDH 
arise as a result of rupture of the parasaggital bridging veins, although some have their 
origin from a cortical artery (Bullock and Teasdale, 1990). If the haematoma is not 
evacuated it may become encapsulated in a membrane and slowly increase in size, 
possibly due to repeated small haemorrhages into it (Markwalder, 1981). In these 
untreated cases, death is usually attributable to brain damage secondary to raised 
intracranial pressure and subsequent compression of the brain stem.
1.2.2.4 Intracerebral Haematoma (ICH)
ICHs generally occur in association with contusion and therefore exist particularly in the 
frontal and temporal lobes (Graham et al., 1995). Occasionally they are found in 
cerebellum and basal ganglia. Their precise pathogenesis is unclear, but it seems likely 
that they are caused by direct rupture of intrinsic cerebral blood vessels.
1.2.2.5 Cerebral Oedema and Brain Swelling
Three main types of brain swelling exist. Firstly swelling adjacent to contusions and 
ICHs. Common in white matter, a zone of damaged blood vessels exist where there is 
increased permeability at capillary level, resulting in loss of normal physiological 
regulation (Dietrich et al, 1994). Tornheim and McLaurin, 1978, reported an increase in 
water content of brain tissue around cerebral contusions, an observation later coined 
vasogenic oedema (Klatzo, 1979). Secondly, diffuse swelling of one cerebral hemisphere. 
There is a close association between diffuse swelling of this type and an ipsilateral SDH 
(Adams et al., 1980a). If during treatment the haematoma is evacuated, the brain 
expands to fill the empty volume created (Graham and Gentleman, 1997). Finally, diffuse 
swelling of the entire brain is normally seen in adolescents and children (Graham et al., 
1989a). If one or more of these types of brain swelling persist, ultimately breakdown of 
the blood brain banier will occur leading to cerebral oedema.
7
1.2.2.6 Infection
Although rare, infection exists in a small proportion of blunt head injury cases. In 
comparison, infection is relatively common in missile head injury as a consequence of 
infected material being carried directly into the cranial cavity. Nevertheless, meningitis is 
a well-recognised complication of a blunt head injury, due to spread of microorganisms 
through an open fracture of the skull (Adams and Graham, 1995). In a small number of 
head injuries a brain abscess may develop. Other complications include subdural 
empyema and cranial osteomyelitis (Graham and Gennarelli, 1997). >
1.2.2.7 Raised Intracranial Pressure (ICP)
This is recognised as the most common cause of death and neurologic disability in 
patients with severe head injuries (Miller et al., 1977). Specifically, ICPs of 20-25mmHg 
are associated with a significant increase in morbidity and mortality (Miller, 1982; 
Marmarou, 1992). The usual causes are haematomas, contusions and associated brain 
swelling. As the mass lesion expands, further structural changes occur within the already 
injured brain. Generally, the surface of the brain becomes dry and flattened, there is a 
shift of the midline structures, the cingulate gyrus herniates under the free edge of the 
falx to produce selective displacement of the pericallosal arteries away from the midline 
(a supracallosal hernia) (Miller and Ironside, 1997), the parahippocampal gyrus is 
displaced through the tentorial incisura (a tentorial hernia) and there is compression of 
the brain stem (Graham et al, 1995) (See Figure 1). Despite increasing awareness of 
management and treatment of raised ICP, brain damage secondary to this is present in 
75% of cases (Graham et al., 1987) and remains a common cause of deterioration and 
coma in patients who die within weeks of a severe head injury.
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D u r aS k u ll
Figure 1. Diagrammatic representation of (A) normal intracranial compartments and (B) 
the effects of an expanding lesion within a cerebral hemisphere after head injury, showing 
anatomical distortion and shift of the midline structures. The locations of (1) subfalcine 
(cingulate gyrus), (2) transtentorial and (3) foramen magnum hemiae are shown 
(Modified from Graham and Gennarelli, 1997).
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1.2.2.8 Ischaemic Brain Damage
Of all the pathologic mechanisms that may operate in severely head-injured patients, 
ischaemic brain damage is a pervasive finding. Ischaemic brain damage is estimated to be 
present in approximately 90% of head-injured patients (Graham et al., 1978) and remains 
an important determinant of mortality and morbidity (Graham et al., 1989b). Cerebral 
ischaemia frequently occurs at the depths of sulci as a result of vascular compression 
between swelling gyri or between swollen hemispheres and adjacent structures 
(Rosenblum, 1989). Anatomically, cerebral ischaemia is most frequent in the 
hippocampus, basal ganglia, cerebral cortex and in the cerebellum (Graham and 
Gennarelli, 1997). Global insults such a hypoxia and hypotension, and focal events such 
as haemorrhage and raised ICP are believed to contribute to the structural evidence of 
ischaemic brain damage present after head injury (MRC Field review, 1998).
1.3 Experimentally-induced brain damage
1.3.1 Animal Models
Experimental models are crucial, not only for testing therapeutic agents, but for 
elucidating the mechanisms of brain damage and identification of novel agents (MRC 
Field review, 1998). The variability in the biochemical events present in human head 
injury has contributed to ihe wide variety of animal models used to study this 
phenomenon (Hayes and Ellison, 1989). The same authors emphasise the need for animal 
models to allow f o r  the imposition of secondary insults given that human head injury 
involves insults of multiple aetiology. Animal models of head injury generally fall into 3 
categories, namely percussion, acceleration and injection models. Percussion models are 
subdivided into 2 categories, fluid and rigid percussion models. The fluid model involves 
injection of fluid using an impacted fluid column or by rapid pump infusion (Lindgren & 
Rinder, 1969). The rigid percussion model (cortical impact) involves use of a solid 
indenter, applied to the dura at various velocities and depths of indentation. In the rat, 
Dixon et al., 1991, demonstrated this could produce a variable sized contusion in the 
parasagittal cortex beneath the impacts and coma of variable duration. Depending on 
conditions, acceleration models can produce relatively pure SDH (Gennarelli et al., 
1982a), brief disturbances of consciousness or prolonged coma and DAI (Gennarelli et
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al., 1982b). The injection of blood or other fluids intracranially has been used to study 
various types of haematoma. Injection of blood into the subdural space mimics acute 
SDH (Miller et al., 1990; Bullock et al., 1991), and there are characteristically large 
areas of ischaemic necrosis underlying the SDH, of the type frequently seen in man. 
Neuropathological evidence of ischaemic brain damage is reported to be present in the 
majority of head-injured patients (Graham et al., 1978). Ischaemia per se has been 
studied using a number of permanent and transient models of focal (intraluminal thread, 
diathermy, microclips and endothelin) and global models (bilateral common carotid 
artery occlusion) of cerebral ischaemia in rodents (for review see Macrae, 1992). These 
rodent models provide a controlled environment to study the temporal profile and 
mechanisms involved in ischaemic brain damage. More recently, the pathological fluxes 
of a number of ions in ischaemic brain have been modelled in vitro using cultured 
neurons and hippocampal slices deprived of oxygen and glucose (Strasser and Fischer, 
1995a,b).
Application of these animal models allows the routine use of histopathological, 
electrophysiological and biochemical techniques to study individual mechanisms of brain 
injury. However, clinically human head injury is rarely as pure as generated in these 
experimental models (Graham and Gennarelli, 1997). From a clinical series, solitary 
lesions in human brain occurs in 26% of cases, while two, three or more than three types 
of lesions occurs in 26%, 21% and 27% respectively (Gennarelli et al, 1983). As injury 
severity worsens, the multiplicity of different types of lesions increases and, except for 
very acute deaths, the incidence of single lesions in an autopsy series of head injured 
patients will be almost zero. The extrapolation to humans of data on head injury derived 
from animals must proceed cautiously (Hayes and Ellison, 1989), given the concern that 
some models may be studying traumatic phenomena rather than traumatic disease 
(Graham and Gennarelli, 1997). Associated with use of animal models is the assumption 
that species difference can be ignored, a concept difficult to accept given the anatomical, 
physiological and genomic differences existing between species (Graham and Gennarelli, 
1997). These uncertainties emphasise the need for research on human tissues wherever 
possible.
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Despite the complexity of animal models, they remain a key tool for the development of 
neuroprotective agents, providing an essential test-bed on which to determine efficacy, 
dose, safety and tolerability and hence therapeutic potential. Combined use of human 
head injury tissue and tissue generated using animal models has helped to understand the 
pathophysiology of head injury, resulting in the identification of key processes and a 
possible cascade of events that is likely to contribute to brain damage after blunt head 
injury.
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1.3.2 Mechanisms of Traumatic Brain Damage
The physiological response to brain injury is extremely complex and involves the 
activation of an overlapping network of humoral, tissue and cellular pathways. The 
primary injury triggers a cascade of events that can lead to tissue and cellular death 
(Figure 2). These cellular changes may include alteration in neurotransmitter 
systems/receptor uptake, calcium-mediated damage, free radical effects and inflammatory 
events.
1.3.2.1 Neurochemical Changes
The excitatory amino acid neurotransmitters glutamate and aspartate produce irreversible 
damage in both neurons and glia in vitro, effects now termed excitotoxic (Rothman and 
Olney, 1986). Studies of mechanisms underlying selective neuronal vulnerability 
implicate the neurotoxic action of glutamate through activation of N-methyl-D-aspartate 
(NMDA) receptors and blockade of this receptor is associated with neuroprotection 
(Shohami et al., 1997). Using the subdural haematoma models in the rat, Bullock and 
colleagues, 1991, reported a correlation between the amount of glutamate released and 
the volume of ischaemic damage. Increases in cerebrospinal fluid (Baker et al., 1993) and 
brain (Zainer and Bullock, 1995) glutamate have been reported up to 4 days in head 
injured patients with focal brain injury. Competitive NMDA receptor blockade and 
modulation have been addressed in a variety of models as a strategy for treatment of 
head injury (for review see McIntosh et al., 1997). For several decades it has been 
known that there is an increase in the amount of acetylcholine in the brain and CSF of 
patients after head injuiy (Graham and Gennarelli, 1997). Moreover, in animal models of 
traumatic brain injury there is altered (Jiang et al., 1994) or attenuated numbers of M2 
muscarinic receptors (Ciallella et al., 1998). However, in human postmortem tissue,
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Figure 2. The cascade of events leading to cell death after blunt head injury.
Dewar and Graham, 1996, reported no change in M2 muscarinic receptor binding after 
head injury.
Changes in other neurotransmitter systems have been reported in the brain after head 
injury. Regional alterations in the tissue concentrations of a number of monoamine and 
catecholamine neurotransmitters have been reported following experimental fluid 
percussion (McIntosh et al., 1994) and cortical impact injury (Prasad et al., 1992). In 
addition, Gennarelli, 1994, described changes in dopamine receptor densities after
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traumatic brain injury in man. Inhibitory neurotransmitter systems are also affected after 
trauma, given that there is a loss of GABAergic terminals in the cat lateral vestibular 
nucleus after head injury (Povlishok and Coburn, 1989).
1.3.2.2 Calcium-Mediated Damage
It has been suggested that alterations in Ca2+ homeostasis plays a major role in neuronal 
degeneration following trauma, and several recent studies have documented alterations in 
regional brain Ca2+ concentrations following head injury (McIntosh et al., 1997). 
Following a traumatic episode, Ca2+ can enter cells by mechanoporation, receptor- 
mediated or voltage-dependent mechanisms. Elevated total brain Ca2+ concentrations 
have been reported in injured areas following both fluid percussion injury (Shapira et al., 
1989) and cortical contusion (Nilsson et al., 1993).
If Ca2f concentrations remain increased within the cell, this will trigger a series of 
potentially deleterious events. Calpain, a cysteine protease is activated when Ca2f 
concentrations exceed threshold levels (Saido et al., 1994). A number of cytoskeletal 
proteins are substrates of calpain and activation of calpain produces irreversible 
structural and functional alterations contributing to post-traumatic loss of cytoskeletal 
proteins such as spectrin (Kampfl et al., 1996), microtubule associated protein-2 (Taft et 
al., 1992), and neurofilament proteins (Postmantur et al., 1994). Dendritic damage is 
believed to occur more slowly or is causally linked to axonal disconnection (Folkerts et 
al., 1998). The progressive dissolution of these proteins causes blocks in axoplasmic 
transport within the cell, accumulation of axonal materials and ultimately delayed axonal 
disruption or secondary axotomy (Graham and Gennarelli, 1997).
1.3.2.3 Free Radical-Mediated Damage
Free radicals and oxidative stress-induced neuronal cell death have been implicated in a 
variety of neurological disorders. For almost two decades reactive oxygen species have 
been the focus of interest as possible candidates for the elicitation of various pathological 
responses after cerebral ischaemia or trauma. The brain uses approximately 20% of 
inspired oxygen (Ames, 1983). Although the majority of the oxygen is consumed for 
production of energy, a small proportion (approximately 5%) is used in alternative 
pathways, leading to the production of reactive oxygen species (ROS). The central
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nervous system (CNS) is particularly vulnerable to injury from ROS because of the 
relative lack of endogenous antioxidant defences, the abundance of stored iron (Zaleska 
and Floyd, 1985) and polyunsaturated lipids (Watson and Ginsberg, 1988). These highly 
reactive free radicals cause peroxidation of membrane phospholipids and nucleic acids, 
and can attack both neuronal membranes as well as the cerebrovasculature (McIntosh et 
al., 1997).
Despite free radical production being difficult to show in human brain, ’a number of 
animal models have shown that brain injury results in free radical production (Duckrow 
et al., 1986; O’Regan et al., 1994; Shohami et al., 1997; Doppenberg et al., 1998; Fabian 
et al., 1998). Multiple mechanisms are likely to induce production of free radicals after 
head injury. Likely candidates include activation of arachidonic acid release (Kcntos and 
Povlishok, 1986), elevated intracellular calcium (Young, 1985) and endogenous 
kininogen and kinins (Heizer et al., 1988). The formation of these highly destructive 
species has been associated with a wide variety of pathologies and contributes to a 
worsened outcome in models of brain injury (Patel et al., 1992; Shohami et al., 1997).
1.3.2.4 Inflammation
Alterations in circulating immunocompetent cells have been reported in plasma obtained 
from head-injured patients (Piek et al., 1992; Quattrocchi et al., 1992). Disruption of the 
blood brain barrier following head injury typically allows entry of blood-borne 
constituents into the CNS. Specifically, the cytokines tumour necrosis factor (Goodman 
et al., 1990) and interleukins (IL)-l and 6 (McClain et al. 1991; Woodroofe et al., 1991) 
are increased after head injury. Moreover, Yan and colleagues, 1992, reported elevated 
levels of IL-1 and IL-6 mRNA and receptors following mechanical brain injury, 
suggesting that CNS-derived cytokines may play a role in the pathophysiology of 
traumatic brain injury (Mocchetti and Wrathall, 1995).
Experimental identification of these injury mechanisms and elucidation of the timing of 
the pathologic neurochemical cascade initiated following head injury may provide 
enhanced opportunities for treatment with neuroprotective strategies designed to modify 
the synthesis, release, physiologic activity, or expression of pathogenic factors involved 
in these neurochemical cascades (McIntosh et al., 1997).
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1.4 The Cholinergic System
1.4.1 Cholinergic Innervation of the Central Nervous System
Magnocellular neurons of the basal forebrain provide a massive and widespread 
cholinergic input to a number of targets within the telencephalon (Mesulam et al., 
1983a). The neuroanatomy, cytochemistry, connectional topography and cortical 
distribution of cholinergic pathways originating in the basal forebrain have been
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investigated in considerable detail in the macaque monkey with the help of axonally 
transported tracer enzyme assays and immunohistochemistry (Mesulam et al., 1983a; 
Satoh and Fibiger, 1985; Kordower et al., 1989). Axonal tracing experiments in normal 
human brain (Selden et al., 1998) and analysis of patients with Alzheimer’s disease 
(Mesulam and Guela, 1988) suggest projections to the human cerebral cortex is similar 
to that characterised in monkey.
Mesulam and colleagues (1983b) devised a nomenclature to classify bands of cholinergic 
neurons based on their efferent projections. The projections originate from four 
overlapping Chl-Ch4 cell groups of the basal forebrain. Cholinergic neurons of the 
medial septal nucleus (Chi) and the vertical limb nucleus of the diagonal band (Ch2) 
provide the major cholinergic input of the hippocampus; cholinergic neurons of the 
horizontal limb of the nucleus of the diagonal band (Ch3) provide the major cholinergic 
input of the olfactory bulb; cholinergic neurons of the nucleus basalis of Meynert (nbM- 
Ch4) provide the principal cholinergic input of the remaining cerebral cortex and 
amygdala (Mesulam et al., 1983b; Everitt et al., 1988) (see Figure 3). In addition, Ch5 
and Ch6 neuronal groups provide the cholinergic input to multiple sites within the brain 
stem and especially the thalamus (Mesulam et al., 1983b; Woolf and Butcher, 1986),
All sectors of the human cerebral cortex receive dense cholinergic input. The origin of 
this projection is located in the Ch4 cell groups of the nbM (Selden et al., 1998). The 
Ch4 group provides the single major source of cholinergic innervation for the entire 
cortical surface, with an estimated 90% of nbM neurons cholinergic in origin (Mesulam 
et al., 1983b). An anatomical study by Eckenstein and colleagues (1988) illustrated the. 
density of cholinergic innervation was uniform in all cortical areas, with the exception of
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Figure 3 Schematic representation o f the widespread innervation o f the cortical mantle 
by Ch4 neurons o f the nucleus basalis o f Meynert The two divisions o f the lateral 
pathway, namely the capsular division (red) and perisylvian division (orange) are shown. 
The medial cholinergic pathway is represented in green and the cholinergic Ch4 neurons 
are shown in blue. Abbreviations: ac = anterior commissure; Am = amygdala; C =
caudate; CIS= cingulate sulcus; GP = globus pallidus; P = putamen. (Modified from 
Selden et al., 1998).
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entorhinal and olfactory cortex which show a marked increase in the number of stained 
terminals. Within the extensive Ch4 cell group of the nbM, two highly organised and 
discrete bundles of cholinergic fibres extend from the nucleus basalis to the cerebral 
cortex and amygdala; designated as medial and lateral cholinergic pathways. Selden and 
colleagues (1998) reported that the medial pathway joined the white matter of the gyrus 
rectus, curved around the rostrum of the corpus callosum to enter the cingulum. It 
supplied the paraolfactory, cingulate and retrosplenial cortices. The lateral pathway was 
subdivided into capsular and perisylvian divisions. Branches of the perisylvian division 
supply the frontoparietal operculum, insula and superior temporal gyrus, whereas the 
capsular division innervates the remaining parts of the frontal, parietal and temporal 
neocortex (Selden et al., 1998).
Although the majority of cholinergic innervation throughout the cortical mantle is 
provided by Ch4 neurons in the nbM, a proportion of cortical cholinergic innervation is 
obtained through intrinsic cortical cholinergic neurons (Eckenstein and Thoenen, 1983). 
In a subsequent study, Johnston and co-workers (1981) reported that these intrinsic 
neurons displayed no laminar pattern and that terminals of these cells represent a 
proportion of cholinergic terminals, possibly as much as one third of total cortical 
cholinergic terminals. However, more recently, Kasashima and co-workers (1999) found 
human cortical cholinergic neurons possessing both regional and laminal variations, 
particularly predominant in layers III and V.
1.4.2 Cholinergic Markers
Considerable experimental and pharmacological evidence has accumulated over the last 
two decades that associates a number of specific neurochemical systems in the brain with 
injury and loss of function. The main suspect is dysfunction of cholinergic 
neurotransmission, instigated through use of a host of histochemical, biochemical and 
immunohistochemical markers that allow for charting of the progress of cholinergic 
neuron status. Cholinergic neurotransmission requires biosynthesis of the acetylcholine 
(ACh), accumulation of ACh in synaptic vesicles, release of ACh, followed by 
degradation of excess ACh. A cholinergic marker protein exists for each of these cellular 
events.
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1.4.2.1 Choline Acetyltransferase (ChAT)
ChAT is the biosynthetic enzyme for ACh, catalysing the conversion of choline and 
acetyl coenzymeA to ACh and coenzymeA in cholinergic neurons (Tucek, 1985). 
Transfer of choline, by high-affinity choline transport, is considered to be the rate- 
determining step (Vogelsberg et al., 1997), since the axoplasm of cholinergic neurons 
contains only a small supply of choline. ChAT exists in 2 isoforms, namely a cytosolic 
form and a membrane-bound isoform, with cytosolic ChAT accounting for the majority 
of the enzyme in nerve terminals. Immunohistochemistry using antibodies directed 
against ChAT has been used to delineate the anatomical distribution of prcsynaptic 
cholinergic elements in the CNS (Armstrong et al., 1983; Houser et al., 1983; Nagai et 
al., 1983).
1.4.2.2 Vesicular Acetylcholine Transporter (VAChT)
Cloned in 1994, VAChT was identified based on its similarity to the Caellorhabditis 
elegans putative ACh transporter unc-17 and the Torpedo vesamicol binding protein 
(Alfonso et al., 1993; Roghani et al., 1994; Varoqui et al., 1994). VAChT has since been 
shown to be an excellent presynaptic marker for terminal fields of the cholinergic 
nervous system (Schafer et al., 1995; Gilmor et al., 1996). In several species, Usdin and 
colleagues (1995) reported that the gene for VAChT is located within the first intron of 
the ChAT gene. Colocalisation of these two proteins within cholinergic neurons may 
suggest a common regulatory mechanism (Ciallella et al., 1998).
1.4.2.3 Choline Transport Inhibitor
Hemicholinium-3 is a very specific and potent inhibitor of the high affinity choline 
transport system (Guyenet et al., 1973; Simon et al., 1975). Autoradiographic 
distribution of [3H]-hemicholinium-3 binding sites closely correlates with the localisation 
of presynaptic markers of the cholinergic system (Vickroy et al., 1985). Consequently, 
[3H]-hemicholinium-3 is considered a specific marker of presynaptic cholinergic terminals 
(Happe and Murrin, 1992).
1.4.2.4 Acetylcholinesterase (AChE)
AChE is the destructive enzyme of the cholinergic system, responsible for hydrolysis of 
ACh. Although AChE is enriched in cholinergic neurons, it is also present in some nerve
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cells which do not utilise ACh; for this reason, AChE is not considered a marker specific 
for cholinergic neurons (Butcher et al., 1975). Eckenstein and Sofroniew (1983) 
reported AChE staining in additional neurotransmitter systems, particularly 
monaminergic systems in the brain.
1.5 Cholinergic Receptors
Within the central nervous system, cholinergic receptors are subdivided into either 
muscarinic or nicotinic, depending on agonist/antagonist profile, receptor subtypes and 
pre/postsynaptic distribution. In the CNS, muscarinic receptors are present as both 
heteroreceptors and autoreceptors regulating neurotransmitter release and regulation of 
higher cognitive functions (Raiteri et al., 1984). In this thesis however, the nicotinic 
receptor will be the subject of study in brain injury.
1.5.1 Nicotinic Acetylcholine Receptors
Neuronal nicotinic acetylcholine receptors (nAChR) are part of a gene family which 
include acetylcholine receptors from skeletal muscle and part of a gene superfamily 
which includes glycine receptors, GABAa receptors and 5HT-3 receptors (Ortells and 
Lunt, 1995), but not functionally related purine and glutamate receptors. Neuronal 
nAChRs are a family of ligand-gated cation channels that allow the passage of calcium 
ions. The nAChR complexes expressed in various brain regions differ from muscle 
nAChRs in composition, agonist and antagonist pharmacology, and biophysical profile 
(Role and Berg, 1996). Receptors in this superfamily are pentameric oligomers, 
composed of five subunits orientated around a central ion channel like barrel staves 
(Lindstrom et al., 1996), the staves comprising either a  or p receptor subtypes (Cooper 
et al., 1991; Lukas and Bencherif, 1992). Application of recombinant DNA technology 
has revealed a rich spectrum of acetylcholine receptor subunit genes expressed by 
neurons (Sargent, 1993; Decker et al., 1995 and Albuquerque et al., 1997). To date, 
eight neuronal a  (a2-a9) and three p (p2-P4) subunits have been cloned in chick and 
rodents (McGehee and Role, 1995) and also in human brain tissue (Anand and 
Lindstrom, 1990; Peng et al., 1994; Monteggia, 1995). The vast number of subunit 
permutations generates enormous heterogeneity of nAChR receptors (Wonnacott et al.,
1996). Indeed, Alkondon and colleagues (1993 and 1994) reported that neuronal nAChR
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subtypes differ in their cation selectivities and permeabilities, in their activation and 
inactivation kinetics, and in their affinity for acetylcholine.
Of the a  subunits, a8 and a9 possess somewhat different characteristics to other a  
subtypes. The a8 subtype has been cloned only from chicken (Schoepfer et al., 1990) 
and not from mammalian brain tissue. In the rat, the a9 subtype has a very restricted 
distribution, being localised in the pituitary and cochlear hair cells and is thought to be 
involved primarily in cholinergic efferent innervation of cochlear hair cells (Elgoyhen et 
al., 1994).
Studies of binding (Marks et al., 1986), functional neurochemistry (Wonnacott et al, 
1989), electrophysiology (McGehee et al., 1995) and molecular biology (Galzi and 
Changeux, 1995) have shown that nAChRs and their subtypes are widely distributed in 
the central nervous system. nAChR are functionally subdivided into two principal classes, 
based on their affinity for nicotine or the snake toxin a-bungarotoxin with the anatomical 
distribution of a-bungarotoxin binding sites and nicotine binding sites being highly 
distinct in the brain. (Clarke et al., 1985).
1.5.1.1 a-Bungarotoxin Nicotinic Acetylcholine Receptor
This subset of nAChR possesses low affinity for nicotine but high affinity for a- 
bungarotoxin (Alkondon and Albuquerque, 1993). Unlike other nAChR, a-bungarotoxin 
nAChR do not consist of a plethora of subunits. In a Western blot study, Chen and 
Patrick, 1997, showed that a3, a5, a6, (52, P3 and p4 were not detected in the a- 
bungarotoxin binding nAChR purified from rat brains. When expressed in Xenopus 
oocytes only a7 and a9 form homo-oligomeric nAChRs and activation of these receptors 
can be blocked by a-bungarotoxin (Seguela et al., 1993). In view of the restricted 
distribution of a9 to hair cells, Seguela and co-workers (1993) reported that in rat brain 
at least, the a7 subtype is the main component of neuronal a-bungarotoxin binding 
nAChR. In rat brain, the distribution of a l  mRNA is similar to that of [,25I]-a- 
bungarotoxin binding sites (Clarke et al., 1985). Moreover, binding studies using [125I]- 
a-bungarotoxin suggested that high affinity [125I]-a-bungarotoxin binding sites in human 
brain are likely to be principally composed of a l  receptor subtypes (Breese et al., 1997).
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The a-bungarotoxin nAChR is believed to be a homo-oligomer of five a7 subunits (See 
Figure 4B) which when expressed in various cell lines form functional homomeric ion 
channels that flux Ca2+ efficiently and desensitise rapidly (Vijayaraghavan et al., 1992; 
Puchacz et al., 1994).
Although the exact role of a7 nAChR in the central nervous system is unclear, there is a 
growing body of evidence suggesting that it is capable of diverse functions, including 
presynaptic modulation of transmitter release (McGehee et al., 1995; Gray’et al., 1996), 
filtering of auditory stimuli (Rollins et al., 1993) and a possible involvement in the 
pathogenesis of schizophrenia (Freedman et al., 1994, 1997). In addition to a presynaptic 
role, Pugh and Berg (1994), proposed an extrasynaptic localisation and possible role in 
synaptic formation and stability.
1.5.1.2 High AfTinity Nicotinic Acetylcholine Receptors
Numerous groups have used low nanomolar concentrations of [3H]-nicotine to 
predominantly detect these high affinity nicotine binding sites. The principal receptor 
subunit combination that composes the high affinity [3H]-nicotine binding site in both 
mammals and chickens consists of subunits a4 and p2 (Anand et al., 1991; Whiting et 
al., 1991). In immunoprecipitation studies greater than 90% of high affinity nicotinic 
agonist binding in the rat brain corresponds to a receptor composed of a4 and P2 
subunits (Flores el al., 1992). Moreover, the distribution of a4p2 subunit combination 
has been reported to coincide with the distribution of high affinity [3H]-nicotine binding 
sites in the rat brain (Wada et al., 1989). Marks and colleagues, 1992, found that a4 and 
p2 mRNAs predominate in the cortex and midbrain of mice, and a4 mRNA has been 
widely detected throughout the human cerebral cortex (Wevers et al., 1994). Although 
not as prevalent as a4 or P2, several studies suggest additional subunits, namely a2, and 
P4 may contribute to brain nicotinic cholinergic activity (Luetje and Patrick, 1991; 
Connolly et al., 1992). Nevertheless, nicotine has nearly 50-fold higher affinity for the 
brain a4p2 subtype than for non-a4P2 subtypes found in the adrenal gland (Flores et al.,
1997).
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Figure 4: Pentameric models of high affinity nicotinic receptor, comprising both a  and (3 
subunits (A) and the a-bungarotoxin nicotinic receptor, comprising a7 subunits only (B). 
Shaded area denotes agonist binding site.
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The subunit stoichiometry of a4(32 nAChR expressed in Xenopus laevis oocytes has 
been deduced to be a4p2 = 2:3 (Anand et al., 1991; Cooper et al., 1991), with the 
subunits arranged around the central ion channel pore in order papap (Anand et al., 
1991). (See Figure 4A). Contrary to this, Zwart and Vijierberg (1998) in a recent study 
reported that in Xenopus laevis oocytes combination of a4 and P2 subunits in subunit 
stoichiometry other than (a4)2(p2)3 results in four additional forms of functional 
heteromeric nAChR.
i
Biochemical and molecular approaches have shown that the a4 subunit contains the 
agonist recognition site. The p2 subunit is a non-agonist binding subunit, which in 
combination with the a4 subunit increases agonist affinity and forms a functional nAChR 
(Sargent, 1993). Formation of an a4P2 subunit containing nAChR produces two agonist 
binding sites at the a/p subunit interfaces (Bertrand and Changeux, 1995).
1.5.1.3 Localisation of Nicotinic Acetylcholine Receptors
The exact cellular location of nicotinic cholinergic receptors in the brain, and particularly 
in the cortex is not yet known. Studies in humans and rodents indicate a presynaptic 
localisation for a proportion of nicotinic receptors (Wonnacott, 1997). However, other 
groups have reported the proportion of nicotinic receptors located presynaptically is 
small and that the majority of these high affinity nicotine binding sites are located 
postsynaptically (Court and Perry, 1994; Toghi et al., 1998). A hint at the cellular 
distribution of these receptors may be obtained by considering the function of these 
receptors. nAChRs are widely expressed in the nervous system, but their functions 
remain poorly understood. One hypothesis is that the receptors act presynaptically to 
modulate, rather than mediate, fast synaptic transmission in the brain (McGehee and 
Role, 1995). This feedback loop serves to introduce terminal regulation into the neural 
secretory event, representing a mechanism of fine-tuning the amplitude of chemical 
signals originating from the nerve ending (Langer, 1997). Considerable evidence has 
accumulated in favour of presynaptic nAChR that can stimulate the release of a variety of 
neurotransmitters in diverse brain regions (Wonnacott et al., 1990). Neurotransmitter 
systems affected include glutamate (Guo et al., 1998; Radcliffe and Dani, 1998), gamma- 
aminobutyric acid (Alkondon et al., 1997; Guo et al., 1998) dopamine (Marshall et al.,
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1997), serotonin and adrenaline (Li et al., 1998). Several electrophysiological studies 
have provided strong evidence for presynaptic nAChR by showing that nicotine applied 
to slice preparation increased spontaneous postsynaptic events in a manner consistent 
with transmitter release from nerve terminals (Lena et al, 1993; Bordey et al, 1996).
1.6 Cholinergic System in Brain Injury and Disease
1.6.1 Acute brain injury
One of the most debilitating consequences of head injury is an enduring impairment of 
memory and cognitive function. Oddy and co-workers, 1985, reported memory 
disturbances as the most frequent complaint by patients and relatives seven years 
posttrauma. Similarly, spatial learning impairment persists one year post-injury in rats 
(Pierce et al., 1998). Considerable evidence has accumulated that associates a number of 
specific neurochemical deficits with disrupted brain function. The importance of central 
cholinergic function in learning and memory was first postulated by Deutsch (1971). The 
body of evidence accumulated by biochemical, pharmacological and behavioural studies 
in the intervening years has supported the view that central cholinergic systems play a 
pivotal role in cognitive and mnemonic function (Bartus et al., 1982; Perry, 1986). In 
addition, nAChRs have been implicated in a variety of central processes, particularly 
learning and memory (Levin, 1992; Newhouse et al., 1994).
Dysfunction of cholinergic neurotransmission has been hypothesised as being centrally 
involved in memory impairment after head injury on the basis of evidence from 
experimental studies of TBI in rodents (Lyeth et al., 1990; Smith et al., 1991; Leonard et 
al., 1994). Microdialysis measurement of extracellular ACh levels have been used as a 
sensitive marker of cholinergic function within specific brain regions (Dixon et al., 1996). 
For example, Gorman et al., 1989, reported immediate release of ACh after head injury 
in rats. This is believed to be a transient event, in view of the reduced ability to release 
ACh from hippocampal cholinergic terminals from one to fourteen days after ischaemia 
in gerbils (Ishimaru et al., 1994).
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The most compelling evidence in support of cholinergic dysfunction following head 
injury in human subjects comes from reports that pharmacological enhancement of 
cholinergic neurotransmission ameliorated memory impairment in some head-injured 
patients (Levin et al., 1986, Cardenas et al., 1994). Moreover, novel cholinomimetic 
therapeutics have been demonstrated to improve cognitive outcome following TBI in 
rats (Pike and Hamm, 1995; Chen et al., 1998a, 1998b). Injury-induced changes in 
proteins known to be involved in cholinergic neurotransmission underscores the 
importance of this system as a target for therapeutic intervention. 1
Specifically, TBI produces a time-dependent loss of ChAT activity (Gorman et al., 1996) 
and ChAT immunohistochemical staining (Leonard et al., 1994; Schmidt and Grady, 
1995; Sinson et al., 1995). Using the global ischaemia model in gerbils, Ishimaru and 
colleagues, 1995, reported disappearance of ChAT immunoreactivity in the hippocampus 
four days after insult. Widespread loss of cortical ChAT activity has been reported in 
postmortem brain tissue (see Figure 5 from Murdoch et al., 1998) from patients who 
died following a blunt head injury. In accordance with this, high affinity [3H]-choline 
uptake, but not available choline levels have been found to be impaired two weeks 
following TBI in rats (Dixon et al., 1994). The same group reported augmenting ACh 
synthesis, by increasing the availability of choline using CDP-choline treatment 
attenuated post-traumatic spatial memory performance deficits (Dixon et al., 1997a)
In addition to presumed abnormalities of presynaptic cholinergic input, alterations in 
cholinergic receptors following TBI in rats have been reported (Delahunty et al., 1994; 
Tanaka et al, 1994). In particular, altered (Jiang et al., 1994) or a time-dependent 
attenuation of the number of M2 muscarinic receptors (DeAngelis et al., 1994; Ciallella et 
al., 1998) have been reported in experimental animal models. However, in human 
postmortem tissue, Dewar and Graham, 1996, reported no change in either Mi and M2 
muscarinic binding following head injury. Integrity of nicotinic receptors following head 
injury may have importance in terms of cholinergic enhancement strategies given that 
ACh release can be modulated by nicotinic receptor activation (Marchi and Raiteri, 1996; 
McGehee et al., 1997).
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Figure 5: ChAT activity in the inferior temporal gyrus (A); cingulate gyrus (B); superior 
parietal cortex (C), in both the left (LHS) and right (RHS) hemispheres. Data for 
controls (n=8) are shown by open bars and for head-injured patients (n=16) by hatched 
bars. Data are mean + SEM, with *p<0.05, compared to controls by unpaired two-tailed 
Student’s t test. From Murdoch et al., 1998.
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1.6.2 Alzheimer's disease
Abnormalities of cholinergic neurotransmission are the most consistent postmortem 
neurochemical finding in Alzheimer's disease (AD), in which memory deficits are central 
to the symptomatology (Perry, 1986). Reduced ChAT activity is the predominant 
neurotransmitter deficit, equivalent to a 60-90% reduction in the hippocampus and 
cortex of AD patients compared with age-matched controls (Bowen et al., 1976; Perry et 
al., 1978; Davies, 1979). Degeneration of Ch4 neurons have been reported with 
considerable variation in AD, ranging from an insignificant 18% reductioil (Pearson et 
al., 1983) to an extensive 90% depletion (Whitehouse et al., 1981). Moreover, Pearson 
and co-workers (1983), using an antibody directed against ChAT, reported shrinkage 
rather than loss of Ch4 neurons. In addition, subsequent studies found no direct 
correlation between the ChAT deficit in cerebral cortex and extent of disappearance of 
cholinergic soma in the basal forebrain (Perry et al., 1982; Allen et al., 1990).
In conjunction with the ChAT deficits, nicotinic receptors have been shown to be 
reduced, by approximately 50% in neocortex (Whitehouse et al., 1986) and hippocampus 
(Perry et al., 1987) of AD brains compared to controls, with evidence emerging that 
specific nAChR subtypes may be involved, particularly (*402 (Perry et al, 1995; 
Warpman and Nordberg, 1995; Martin-Ruiz et al., 1999). These pathological reductions 
in nicotine binding are believed to reflect changes in receptor numbers (pmax) and not 
affinity (Perry et al., 1990). Evidence of nicotinic receptor dysfunction has extended to 
additional neurological diseases including: Parkinson’s, Senile Dementia of the Lewy 
Body type and Down's Syndrome (Perry et al., 1990).
In contrast, cortical muscarinic acetylcholine receptor binding have generally been found 
not to be decreased in AD (Nordberg, 1992). Nevertheless, there have been infrequent 
reports of the loss of putatively presynaptic M2 receptors in AD (Mash et al., 1985; 
Aubert et al., 1992), and upregulation of postsynaptic Mi receptors in Parkinson's 
disease (Perry et al., 1986). Similarly, it remains less certain whether binding to a- 
bungarotoxin nAChRs is reduced in the brains of AD patients, although a reduction of a- 
bungarotoxin binding has been reported in the thalamus of patients with dementia of the 
Lewy Body type (Court et al., 1999). Therefore, it appears it is the high-affinity nAChR
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rather than muscarinic or a-bungarotoxin receptors that demonstrate most variability 
during ageing and disease.
1.6.3 Overlap in Pathology of Head Injury and Alzheimer’s Disease
There is increasing appreciation that the postmortem pathological correlates of a head 
injury share some similarities with those of AD. For example, AD-like pathology occurs 
in the brains of boxers (dementia pugilistica) suggesting that these two disorders share 
some common etiological and pathogenic mechanisms (Tokuda et al., 1991). As well as 
cholinergic dysfunction, additional landmark pathological features of AD are evident 
after head injury.
A panel of antisera that specifically stained the tangles of AD, also stained tangles in 
cases of dementia pugilistica (Roberts, 1988), with these tangles assumed to be the result 
of repetitive head injury. Extracellular deposition of amyloid P-protein (Ap) plays a 
central role in the pathogenesis of AD (Hardy and Allsop, 1991; Selkoe, 1994). 
Furthermore, deposition of Ap in the brain occurs in approximately one third of 
individuals who die shortly after a severe head injury (Roberts et al., 1994). Moreover, in 
brains from a small series of short-term survivors of head injury, Gentleman and co- 
workers (1997), found immunostaining for Ap-42 in all parenchymal deposits, similar to 
the early Ap-42 parenchymal deposits seen in AD.
Apolipoprotein E (ApoE) genotype is the most important genetic determinant of 
susceptibility to AD. The ApoE locus is associated with variations in the age of onset 
and risk of both familial (Strittmatter et al., 1993) and sporadic AD (Saunders et al., 
1993). Inheritance of specific ApoE alleles accounts for more than two decades 
difference in the rate of disease expression (Strittmatter and Roses, 1995). Specifically, 
acquisition of one or two ApoE e4 alleles increased the rate of AD by 3-fold for each e4 
allele inherited (Roses and Saunders, 1994). Using human postmortem material, Nicoll et 
al. (1995) reported the allele frequency of ApoE s4 in head-injured patients with A-p 
deposition to be higher than in most studies of sporadic AD. In human head injury, 
Teasdale and colleagues (1997), reported an association of ApoE polymorphism with 
outcome after head injury. In particular, patients possessing ApoE e4 were more than
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twice as likely as those without ApoE s4 to have an unfavourable outcome six months 
after head injury. Similarly, in boxers suffering from dementia pugilistica, inheritance of 
an £4 allele was associated with neurological impairment (Jordan et al., 1997).
1.6.3.1 Synaptic Pathology in Alzheimer's Disease
During the last ten years, increasing attention has been focused on synaptic pathology in 
AD, with loss of synapses now regarded as the major structural correlate of dementia in 
AD (Masliah, 1995). Loss or impairment of synaptic connections of the brain may 
produce important neurological deficits, including those of memory, cognition and 
behavioural functions (Hamos et al., 1989).
Several studies have shown that synaptic vesicles contain specific presynaptic proteins 
not enriched in other subcellular compartments (DeCamilli et al., 1983; Jahn et al., 
1985). Immunodetection techniques used to identify synaptic proteins have been found 
to exhibit sufficient specificity for accurate quantitation of synapses (Leclerc et al., 1989; 
Lahtinen et al., 1993). As such, presynaptic proteins have proved valuable indexes of 
synaptic density and their concentrations have correlated markedly with synaptic loss 
(Gabriel et al., 1997).
Using an array of techniques, including direct counting at the ultrastructural level (Scheff 
et al., 1989; Masliah et al., 1992) and immunohistochemistry (Hamos et al., 1989; 
Masliah et al., 1989) or immunoblotting (Davidsson and Blennow, 1998), numerous 
studies exist providing evidence of synaptic degeneration in the hippocampus (Hamos et 
al., 1989; Davidsson and Blennow, 1998) and cortex (DeKosky and Scheff, 1990; Terry 
et al., 1991; Honer et al., 1992; Davidsson and Blennow, 1998). Whether these changes 
reflect degeneration and loss of whole synaptic elements in AD and not specific 
disturbances remains to be elucidated. Early indications suggest an element of differential 
involvement of the synaptic vesicle and presynaptic plasma membrane proteins in the 
pathogenesis of AD (Shimohama et al., 1997). Such findings highlight the importance of 
both the cholinergic system and adequacy of synaptic density in consideration of 
treatment of AD. It remains to be determined if the same combination of guidelines 
applies to the treatment of head injury.
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In view of the pathological correlates of head injury and Alzheimer’s disease, it seems 
possible that a presynaptic component may be involved in the pathogenesis of brain 
damage after head injury. It remains to be determined whether there is differential 
involvement of synaptic vesicle and presynaptic plasma membrane proteins in this 
process.
1.7 The Presynaptic Locus and its Associated Proteins
In the past few years, there has been major advances in understanding the mdlecular basis 
of synaptic vesicle exocytosis. The purification of vesicle-associated proteins and the 
isolation of their cognate genes (Jahn and Sudhof, 1994) have been facilitated by the 
abundance of synaptic vesicles in the brain. In 1995, Sudhof reported the identification of 
more than 10 presynaptic proteins (see Figure 6A). Subsequently they have been 
characterised and their role in synaptic transmission, through a complex array of protein- 
protein interactions have been elucidated (See Figure 6B).
1.7.1 Synaptophysin
Synaptophysin is the most abundant integral membrane protein of synaptic vesicles, 
constituting approximately 6-8% of the synaptic vesicle membrane proteins. 
Synaptophysin is believed to be present in most, if not all synapses of the brain 
(Wiedenmann and Franke, 1985), and estimated to be present in more than 95% of 
cortical presynaptic terminals (Navone et al., 1986). As a consequence synaptophysin is 
considered a representative marker protein of presynaptic terminals and has been 
routinely used as a reliable measure of synaptic density in postmortem brain (Hamos et 
al., 1989; Ince et al., 1995; Honer et al., 1997). Although synaptophysin was the first 
synaptic protein to be characterised in molecular terms, its function has remained unclear 
for a long time. The roles suggested are diverse, ranging from that of a vesicular Ca2 
sensor to a function in synaptic vesicle biogenesis (McMahon et al., 1995). Alternatively, 
synaptophysin has been proposed to be involved in the formation of a pore between the 
vesicle membrane and the presynaptic membrane during exocytosis (Thomas et al., 
1988). Recent in vitro chemical cross-linking studies have suggested that synaptophysin 
may function as a molecular switch, controlling the association of synaptobrevin with 
other components of the neurotransmitter release machinery (Edelmann et al., 1995).
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Figure 6: Schematic diagram of the major proteins located on synaptic vesicles (A), 
(Modified from Sudhof, 1995). Potential protein-protein interactions of proteins located 
on synaptic vesicles and presynaptic nerve terminal membrane (B), (Modified from 
Linial, 1997).
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In contrast to these observations, synaptophysin knockout mice were viable and fertile, 
with mutant brains normal in structure and protein composition, and no detectable 
changes in probability of release (McMahon et al., 1995). These findings have led to the 
suggestion that this major synaptic vesicle protein is not essential for synaptic 
transmission, but merely represents an evolutionary remnant void of function (McMahon 
et al., 1995).
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1.7.2 Syntaxin
The syntaxins comprise a growing gene family, with syntaxin 1 (syntaxin), consisting of 
syntaxin 1A and IB, neuron specific, whereas others display a broader specificity 
(Bennett et al., 1993; Bock et al., 1996). Syntaxin is an integral membrane protein with a 
distribution in the CNS very similar to that of synaptosomal associated protein of 25kDa 
(SNAP-25) (Li et al., 1996). Syntaxin functions as a central component in regulated 
neurotransmitter release through interaction with proteins on the vesicle and 
plasmalemmal membrane. The interaction between syntaxin and other protein elements is 
believed to generate a core complex that forms the anchor for a cascade of protein- 
protein interactions leading to fusion and ultimately synaptic transmission. Moreover, via 
a direct association with N-type Ca2+ channels, syntaxin 1 is intimately involved in the 
structural and functional coupling of the action potential to neurotransmitter release 
(Sheng et al., 1994, 1998). Evidence that syntaxin participates in neurotransmitter 
release includes the reduction of secretion of PC 12 cell generated by microinjection of a 
syntaxin antibody or protein fragments (Bennett et al., 1993) and selected cleavage of 
syntaxin by botulinum neurotoxin C (Blasi et al., 1993).
1.7.3 SNAP-25
Synaptosomal associated protein of 25kDa (SNAP-25) was first described by Wilson and 
colleagues as a neuron-specific protein, differentially expressed in the rat brain and 
localised primarily in axons and nerve terminals (Oyler et al., 1989). Two isoforms of 
SNAP-25 are generated by alternative splicing (Bark, 1993), namely SNAP-25a and 
SNAP-25b, predominant in embryonic and adult tissue respectively (Bark et al., 1995). 
Oyler and colleagues (1989) reported the primary structure of SNAP-25 is 
predominantly hydrophilic, with no apparent membrane binding domains. However,
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SNAP-25 is subject to covalent addition of fatty acids, particularly linkage of palmitate 
by thioester bonds to cysteine residues (Hess et al., 1992). Immunofluoresence and 
subcellular fractionation studies have shown that SNAP-25 is an integral membrane 
protein associated with the presynaptic plasma membrane (Oyler et al., 1989). 
Functionally, SNAP-25 serves as a key player firstly in axonal elongation and synapse 
formation (Catsicas et al., 1991; Osen-Sand et al., 1993) and secondly in membrane 
fiision events (Sollner et al., 1993b). In neurotransmitter release, SNAP-25 is an essential 
member of the release machinery, present as a tight complex with syntaxin responsible 
for specific trafficking of synaptic vesicles to the active zone of the presynaptic 
membrane (Chapman et al., 1994; McMahon and Sudhof, 1993). Moreover a number of 
studies have demonstrated interaction of SNAP-25 with a la  (Kim and Catterall, 1997) 
and a lb  (Vance et al., 1999) subunits of Ca2+ channels located on the nerve terminals.
1.7.4 Synaptotagmin
Synaptotagmin 1 (Synaptotagmin) is an abundant synaptic vesicle protein and one of the 
first integral membrane proteins of the synaptic vesicle identified (Matthew et al., 1981). 
The brain expresses at least 8 synaptotagmins (Li et al, 1995), with different 
synaptotagmins differentially expressed in neurons (Sudhof, 1995). Synaptotagmin is 
regarded the putative Ca2+ sensor for neurotransmitter release, with evidence for such a 
role supported by a large number of genetic and microinjection studies (Littleton et al., 
1994; Mikoshiba et al., 1995). In the presence of Ca24, synaptotagmin undergoes a 
conformational change, thereby releasing its ‘fusion clamp’ over neurotransmitter release 
(Shupliakov et al., 1996). In addition, Ca2+ coreceptors may cooperate with 
synaptotagmin in the control of the release process (DeBello et al., 1993; Sutton et al., 
1995). Synaptotagmin is involved in docking of the synaptic vesicle to the presynaptic 
plasma membrane and exocytosis into the synaptic cleft (Brose et al., 1992). Therefore, 
synaptotagmin plays a dual role, as a specialised synaptic vesicle protein on the one hand 
and as a Ca2+ sensor on the other, thereby linking the signal for neurotransmitter release 
to the vesicle fusion machinery (Sollner and Rothman, 1996).
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1.7.5 Synapsins
The synapsins consist of a family of 4 closely related proteins (synapsin la, lb, I la and 
lib) (Sudhof et al., 1989), possessing extensive sequence homology in the N-terminal but 
divergence in the C-terminal (Benfenati et al., 1989). Accounting for approximately 6% 
of vesicle protein (Huttner et al., 1983), synapsin I is the most abundant of a!! neural 
phosphoproteins and is enriched on the cytoplasmic surface of synaptic vesicles. 
Synapsin I represents a major target for multiple protein kinases (Nicol et al., 1997). In 
particular, synaptic vesicle associated calcium calmoduiin protein kinase II (CaMKII) 
seems to be the major enzyme responsible for phosphorylation of synapsin I at specific 
sites, resulting in changes in its structure and biological properties (Stefani et al., 1997). 
One major feature of synapsin I is its ability to simultaneously interact with synaptic 
vesicles and cytoskeletal elements, in a phosphorylation-dependent manner (Greengard et 
al., 1993). In in vitro reconstruction experiments Hirokawa and colleagues (1989) 
demonstrated synapsin I forms cross-bridges among synaptic vesicles and the 
cytoskeleton. Binding of synapsin I to synaptic vesicles and its regulation by 
phosphorylation is postulated to play a crucial role in the biological activity of synapsin I 
(Llinas et al., 1985). Phosphorylation of synapsin I by CaMKII reduces its affinity for 
synaptic vesicles 5-10 fold (Benfenati et al., 1992), therefore removing constraints on the 
availability for exocytosis. Synapsin I binds to multiple cytoskeletal elements, although, 
actin represents the main cytoskeletal substrate within the presynaptic terminal (Thiel,
1993) and synapsin I is believed to alter actin dynamics by binding laterally along actin 
filaments and cross-linking them into bundles (Ceccaldi et al., 1993; Baines et al., 1995). 
Interaction of synapsin I with actin is dramatically inhibited or virtually abolished by 
CaMKII regulated phosphorylation of synapsin I (Stefani et al., 1997). In this way, 
synapsin I may mediate reversible cytoskeletal anchoring of synaptic vesicles of the 
reserve pool to a cytoskeletal meshwork, preventing their direct contact with the 
presynaptic active zone.
Generally, synapsin I is assumed to have a central role in short-term regulation of 
neurotransmitter release and in the maturation of synaptic contacts during synaptogenesis 
(for review see DeCamilli et al., 1990a). Specifically synapsin I is part of a mechanism 
by which the nerve terminal can finely tune the efficiency of the neurotransmitter release 
machinery, accelerating synaptic vesicle trafficking during repeated stimulation (Rosahl
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et al., 1995). A role for synapsin I in synaptogenesis is demonstrated by injection of 
synapsin I into Xenopus blastomeres accelerating synapse formation (Schaeffer et al.,
1994). In addition Chin and co-workers, 1995, showed that hippocampal cultures 
derived from synapsin I deficient mice exhibited a marked reduction in axonal elongation 
and rate of synapse formation. Although the identification and isolation of the core 
machinery mediating the release process has advanced during the past few years, it is 
unlikely that the entire plethora of molecular components have been identified and that 
the current picture will no doubt be refined. Indeed, in the last year a new generation of 
proteins implicated in synaptic transmission have emerged: endobrevin (Wong et al.,
1998), SNAPIN (Uardi et al., 1999), tomosyn (Fujita et al., 1998) and Vam7p 
(Ungermann and Winkner, 1998) to name a few.
1.7.6 Neurotransmitter Release: The SNARE Hypothesis
Neurotransmitter release requires the repeated release of neurotransmitter at high 
frequency at the nerve terminal. The locus of vesicular exocytosis has been 
ultrastructurally defined and consists of pre- and postsynaptic membrane specialisations 
and numerous synaptic vesicles in the nerve terminal (Tong and Jahr, 1994). Although 
neurotransmitter release shares a variety of properties with generalised secretion 
(DeCamilli and Jahn, 1990b; Bennett and Scheller, 1993), synaptic vesicle exocytosis is 
distinguished by unique temporal properties fundamental to its function in mediating fast, 
intermittent synaptic transmission.
A convergence of biochemical, genetic and cell-free studies have allowed the formulation 
of a model of docking and fusion: The SNARE hypothesis (Sollner et al, 1993a). Freeze- 
fracture studies suggest that this release apparatus is a highly structured entity (Heuser et 
al., 1979) ensuring the spatial specificity and short delay requirements of efficient 
neurotransmitter release. The SNARE hypothesis predicts that a key step in the sequence 
of events that leads to docking and fusion of a vesicle with the target membrane is the 
interaction of proteins localised on the cytosolic surface of the vesicle (v-SNAREs) with 
proteins localised on the cytosolic surface of the target membrane (t-SNAREs), see 
Figure 7. The v-SNARE is synaptobrevin and the t-SNAREs are syntaxin and SNAP-25 
(Bauerfiend et al., 1996). Formation of the SNARE complex (7s complex) is followed by 
recruitment of the cytosolic factors a-soluble-NSF-attachment protein and N-
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ethylmaleimide -sensitive factor to form the 20s complex. Finally the 20s complex 
disassembles in a reaction requiring ATP hydrolysis (Sollner et al., 1993b). As 
understanding of basic neurotransmitter release improves, attention will undoubtedly 
shift to how these molecules and events are modified to produce changes in synaptic 
efficacy (Sudhof, 1995).
sy n ap to p h y s in  synap to tngm in <tSNAP
VAMP
SNAP-25
lyntixin
ADP+P| ATP
20S
Figure 7: The SNARE hypothesis: Proposed model of molecular events involved in 
synaptic vesicle docking and fusion (Modified from Bennett, 1994).
1.7.7 Presynaptic Proteins in Acute Brain Injury
Release of neurotransmitter is the primary mode of communication and changes in 
efficacy of this process is thought to be at the basis of nervous system plasticity (Sudhof,
1995). Plasticity is believed to establish the restoration of function by changes in 
electrophysiological, anatomic and biochemical parameters (Stroemer et al., 1995). 
Synaptic plasticity has been extensively studied in the mammalian brain hippocampal 
formation, but the existence of CNS plasticity in the neocortex after trauma remains a
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controversial issue (Cotman and Nieto-Sampedro, 1982).
Focal cerebral ischaemia produces an area of infarction surrounded by neurons that may 
respond to nearby damage. The nerve cell is the most vulnerable to ischaemic damage in 
the central nervous system, although various subcellular components of neurons are 
thought to possess differential vulnerability (von Lubitz and Diemer, 1982), with both 
presynaptic and postsynaptic origins involved. A number of previous studies have used 
microtubule-associated protein 2 (MAP-2) as a sensitive marker of postsynaptic dendritic 
damage after cerebral ischaemia (Kitagawa et al., 1989; Dawson and Hallenbeck, 1996; 
Martinez et al., 1997). Alternatively, probes against various synaptic proteins have been 
used for studying neuronal plastic responses following a number of different CNS injuries 
(Kitagawa et al., 1992; Korematsu et al., 1993; Yamagata et al., 1995; Iwata et al.,
1996). The study of the subtle molecular alterations of the synapses and of plasticity 
might yield important clues as to the mechanisms and pattern of damage after brain 
injury.
The issue of synaptic plasticity in the brain after injury has been studied in a vast number 
of species and experimental models, using an equally diverse range of marker proteins. 
Consequently, a divergent set of results exists, adding to the controversy of CNS 
plasticity after injury. Nevertheless, a general consensus suggests that presynaptic 
terminals may be relatively resistant to ischaemia in contrast to the higher susceptibility 
of postsynaptic sites (Kirino et al., 1990; Kitagawa et al., 1992). In contrast to the loss of 
MAP-2 immunoreactivity after cerebral ischaemia, Miyazawa and colleagues (1993), 
reported preservation of synaptophysin immunoreactivity. Similarly, Kitagawa et al., 
1992, reported unchanged synapsin-1 immunoreactivity in the degenerated CA1 two 
months after insult. Moreover, electron microscopy studies revealed intact presynaptic 
terminals, abundant in synaptic vesicles, twelve months after the ischaemic event 
(Bonnekoh et al., 1990).
However, other groups have reported synaptic changes both in the form of a loss and 
increases in the level of presynaptic proteins in several models of brain injury. 
Synaptophysin has been reported to be increased in the cortex (Stroemer et al., 1995), 
the caudate (Korematsu et al., 1993) and the stratum lacunosum molecular layer and
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stratum oriens of the CA1 sector of the hippocampus (Miyazawa et al., 1993) after 
ischaemia, with the increase proportional to the severity of ischaemic injury. In situ 
hybridisation experiments have shown elevated growth associated protein of 43kDa 
(GAP-43) mRNA expression after ischaemic lesions in humans (Ng et al., 1992). In 
addition, kainate (Boschert et al., 1996) and ischaemia-induced lesions (Maiti et al.,
1998) both resulted in upregulation of SNAP-25 in the mossy fibre layer of the 
hippocampus. Moreover, Lynch and co-workers, 1994, reported augmented expression 
of three presynaptic proteins, namely, synapsin, synaptophysin and synaptotagmin, after 
long-term potentiation, a well studied form synaptic plasticity. In contrast, site-specific 
loss of presynaptic proteins have been reported following CNS injury. For example, 
SNAP-25 immunoreactivity is transiently reduced in the inner molecular layer of the 
dentate gyrus (Marti et al., 1998) and synapsin-1 is reduced in the ipsilateral caudate 
(Kitagawa et al., 1992) after ischaemic lesions. The spectrum of plastic changes may be a 
reflection of the inherent variability associated with use of different species and 
experimental models of inducing brain injury.
It remains essential to clarify mechanisms of damage of presynaptic terminals, since nerve 
terminals occupy the majority of the neuropil and their loss leads to massive destruction 
of nervous tissue. An understanding of the progression of molecular events that provide 
the basis for remodelling in the cortex after stroke/head injury will allow development of 
exogenous therapies to improve neuroanatomical plasticity after injury (Stroemer et al.,
1995). One candidate that is thought to contribute to survival or remodelling is the 
endogenous production and supply of neurotrophic factors.
1.8 Neurotrophic Factors
Several peptide growth factors have been identified and implicated in the CNS response 
to trauma. The neurotrophin family consists of nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF) and neurotrophin-3, -4/5, -6 (NT-3; NT-4/5; NT-6) 
(Korsching, 1993). The function of neurotrophic factors is mediated by binding to 
specific tyrosine kinase receptors (Chao, 1992). Each of the neurotrophins exert specific 
actions on distinct, but overlapping populations of developing and/or mature neurons (Ip 
et al., 1993). Functional!}', the traditional view holds that neurotrophic factors are
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signaling proteins essential for neuronal survival and differentiation in the peripheral and 
CNS. The efficacy of neurotrophic factors to support cell survival has been most 
extensively studied in the cholinergic system (Hagg and Varon, 1993; Dixon et al., 
1997b). In addition, neurotrophic factors have been suggested to have a more limited 
and specific role as retrograde modulators. Indeed, retrograde transport was first 
demonstrated with injection of [,25I]-labeled NGF into the terminal fields of sympathetic 
and sensory neurons in the peripheral nervous system (PNS) (Hendry et al., 1974) or 
cholinergic neurons in the CNS (Schwab et al., 1979). Similarly, injection'of iodinated 
BDNF, NT-3 and NT-4 resulted in their retrograde transport to adult PNS and CNS 
neuron cell bodies (DiStefano et al., 1992; Sobreviela et al., 1996). Consequently, 
neurotrophic factors function as retrograde messengers, in doing so enhancing synaptic 
efficacy in targeted neuronal systems.
1.8.1 Neurotrophic Factors in Synaptic Plasticity
A novel role for the neurotrophins is their participation in the dynamic modulation of 
synaptic efficacy (Levine and Black, 1997). Neuronal impulse activity is known to 
enhance neurotrophin production and secretion (Thoenen et al, 1991), which in turn 
potentiates neuronal activity and synaptic efficacy. A number of recent studies have 
demonstrated this capacity of neurotrophic factors to enhance efficacy of synaptic 
transmission. In hippocampal slices, BDNF and NT-3 enhanced the strength of Schaffer 
collateral CA1 synapses (Kang and Schuman, 1995). Using dissociated cell culture of rat 
cortical neurons, Kim et al., (1994), reported NT-3 induced a 5-6 fold increase in the 
frequency of spontaneous action potentials. Moreover, BDNF and NT-3 potentiated 
evoked synaptic currents at the Xenopus neuromuscular junction (Lohof et al., 1993). In 
addition to these acute effects, long-term effects of neurotrophic factors on synaptic 
function, particularly plasticity have been addressed in the visual system (Gu et al., 
1994).
All of the observations are in favour of a presynaptic action of neurotrophic factors, 
possibly through potentiation of availability of loaded vesicles or in the probability of 
vesicular exocytosis (Stoop and Poo, 1996). Using cultured rat cortical neurons, Takei 
and colleagues (1997) reported BDNF and NT-3 elevated the levels of a number of both 
vesicle-associated and membrane-associated proteins of the neurotransmitter release
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machinery. In addition, neurotrophin treated Xenopus neuromuscular cultures showed an 
enhanced expression of synapsin I and synaptophysin (Wang et al., 1995). While 
different cytoplasmic transduction mechanisms are triggered by various neurotrophin 
factors, their actions are likely to converge on common effector proteins involved in 
presynaptic release, possibly protein kinases downstream of putative proteins involved in 
trafficking, docking and exocytosis of synaptic vesicles (Stoop and Poo, 1996).
1.8.2 Neurotrophic Factors and Brain Injury >
Several recent reports have suggested that neurotrophic factors are synthesised or 
released following brain injury, perhaps to facilitate neuronal repair mechanisms and re­
establish function in injured brain (Varon et al., 1991). The evidence for involvement of 
neurotrophins and other peptide growth factors in neuronal plasticity evolves from 
observations made in complex integrated neuronal systems in vivo and from detailed 
analyses in a variety of in vitro systems.
NGF is the best known and most widely studied of all the neurotrophic factors in relation 
to acute brain injury, with evidence emerging that astrocytes are an important site of 
NGF production following brain injury in rats (Goss et a l , 1998). NGF is reported to be 
acutely increased in a number of models of acute brain injury (for review see McIntosh et 
al., 1997). In humans, NGF is elevated in CSF following head injury (Patterson et al., 
1993). Like NGF, basic fibroblast growth factor (bFGF) is postulated to participate in 
the protection and repair processes of neurons following brain injury. Regional increases 
in bFGF have been shown following lesioning of the entorhinal cortex and fimbria-fornix 
transection (Gomez-Pinella et al., 1992), and after cortical trauma (Logan and Berry, 
1993). In vivo, bFGF attenuated infarct size following permanent focal cerebral 
ischaemia in the rat (Koketsu et al., 1994). Insulin-like growth factor-1 (IGF-1) has been 
evaluated as a potential therapeutic neuroprotective agent in several in vivo models. 
Sandberg-Nordqvist and colleagues (1996), reported upregulation of not only IGF-1, but 
IGF binding protein-2 and -4 mRNAs following cerebral contusion. IGF-1 has been 
found to improve both neurological and motor cognitive outcome following experimental 
brain injury (Saatman et al., 1997). Alterations in BDNF and NT-3 mRNAs have been 
demonstrated in rat hippocampus after experimental brain trauma (Hicks et al., 1997). 
Moreover, exogenous BDNF administration prevented neuronal death following global
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ischaemia in the rat (Kiprianova et al., 1999)
1.8.3 Neuregulins
One growth factor signaling system receiving recent attention is that involving the 
neuregulins. The name neuregulin reflects signaling through neu and related receptors 
and suggests involvement of these molecules in regulating neural development and 
function (Marchionni et al., 1997). The neuregulin family of growth factors, also known 
as glial growth factor (GGF) (Brockes et al., 1980), as acetylcholine receptor inducing 
activity (ARIA) (Falls et al., 1990), as neu differentiation factor (NDF) (Peles et al., 
1992) and as heregulin (HRG) (Holmes et al., 1992) are all products of a single gene 
located on the short arm of human chromosome 8 (Orr-Urteger et al., 1993). The 
neuregulins belong to the epidermal growth factor (EGF) superfamily and exhibit some 
15 membrane-attached and secreted isoforms, generated by alternative splicing and usage 
of 3 distinct promoters. The majority of the neuregulins are synthesised and released as 
biologically active, membrane-bound precursors termed pro-neuregulins which are 
subsequently processed to produce the soluble secreted forms of neuregulins (Burgess et 
al., 1995).
Neuregulins mediate their biological activities through members of the EGF receptor (or 
ErbB) superfamily, namely, ErbB2, ErbB3 and ErbB4. Experiments in cell culture 
demonstrated that neuregulin receptors can be constituted by ErbB2/ErbB3 or 
ErbB2/ErbB4 heterodimers and ErbB4/ErbB4 homodimers, but not by ErbB2/ErbB2 or 
ErbB3/ErbB3 homodimers (for review see Lemke, 1996). Following ligand binding and 
receptor dimerisation, transduction of cellular signals occurs through 
autophosphorylation of tyrosine residues. Pinkas-Kramarski and colleagues (1996) 
reported neuregulin-induced responses appeared to depend upon the erbB heterodimer 
formed and the subsequent interaction of the receptors with distinct signaling pathways.
The study of neuregulins has advanced through the generation and analysis of mutant 
mice. Disruption of the neuregulin gene (Meyer and Birchmeier, 1995), ErbB2 (Lee et 
al., 1995) and ErbB4 (Gassman et al., 1995) have shed light on the molecular 
interactions of this signaling system. Mice lacking functional neuregulin or erbB 
receptors died in utero due to aberrant cardiac and nervous system development. In
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contrast, mice heterozygous in the disrupted gene appeared healthy and fertile 
(Carraway, 1996). These observations imply the inactivated genes are essential and that 
they are not functionally or developmentally redundant.
Neuregulins are expressed by both peripheral and central neurons (Marchionni et al., 
1993; Chen et al., 1994) and are believed to be involved in numerous interactions 
between neurons and glia. In general, neuregulins are regarded as multi-functional 
regulators influencing cellular proliferation, differentiation, survival or fate- (for review 
see, Carraway and Burden, 1995). The functional properties of the neuregulin family 
have been in the main characterised in a number of in vitro systems. Consequently, the 
neuregulins are known to induce a variety of responses in cultured cells. For example, 
neuregulins have been shown to promote astrocyte survival and differentiation in cerebral 
cortical dissociated cell culture (Pinkas-Kramarski., 1994) and to enhance the 
development of oligodendrocytes from bipotential 0 2A glial progenitor cells (Vartanian 
et al., 1994). While most of the reported effects are on non-neuronal cells, evidence is 
accumulating for a direct effect of neuregulins on neurons. In particular, at least one of 
the neuregulin receptors (ErbB4) is expressed by brain neurons in many different regions 
of the brain (Lai and Lemke, 1991). Moreover, Bermingham-McDonogh (1996) 
reported that the neuregulins act directly on retinal ganglion neurons to promote neurite 
outgrowth and neuronal survival.
1.8.3.1 Neuregulins as Indirect Neurotrophins
As a consequence of the specificity of peptide growth factors for tyrosine kinase 
receptors, no single trophic factor factors is expected to rescue all neurons afflicted in 
neurological disease and injury (Marchionni et al., 1996). Several lines of evidence 
support the concept that neuregulins act as indirect neurotrophins via induction of 
neurotrophin synthesis and secretion. Verdi and co-workers, 1996, reported NT-3 
expression was upregulated 40-fold in glial cells treated with recombinant human GGF-2. 
Furthermore, conditioned media from schwann cells contained soluble neurotrophic 
activities, possibly NGF (Marchionni et al., 1997).
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1.8.3.2 Neuregulins and Plasticity
The persistent expression of both neuregulin and its cognate receptors in the postnatal 
and adult heart suggests a continuing role for neuregulins in the myocardial adaption to 
physiologic stress or injury (Zhao et al., 1998). The continued and abundant expression 
of the neuregulins in the adult CNS suggests that the neuregulins are involved in the 
response of the brain to environmental stimuli. Indeed, Eilam and co-workers (1998) 
have shown that brain neuregulin and ErbB4 are induced by 3 types of stimuli, namely: 
use of a glutamate receptor agonist, locomotion and tetanic stimulation. These 
observations strengthen the argument that the neuregulin family of ligands participates in 
activity-dependent brain processes and in neuronal plasticity. In conjunction with the 
pleiotrophic actions of the neuregulins in the nervous system, they have the potential for 
the treatment of a variety of neurological disorders, including stroke or traumatic 
brain/spinal cord injury. Whether GGF-2 exists in the human postmortem brain, and at 
what level after head injury remains to be determined.
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1.9 Aims of Thesis
The sensitivity of neurons and glial cells to brain injury has been well characterised. 
However, the question of whether presynaptic terminals are damaged after acute brain 
injury has received less attention. The integrity of presynaptic terminals after human 
head injury is not known and there are inconsistent reports regarding the sensitivity of 
presynaptic terminals in animal models of acute brain injury. Presynaptic terminals 
serve to regulate the highly orchestrated process of neurotransmitter release. Since 
neurochemical deficits have been reported in neurodegenerative disorders and after head 
injury, the status of presynaptic terminals is of importance regarding possible 
therapeutic approaches.
The main aims of the work described in this thesis were:-
(i) To determine the levels of high affinity nAChRs in the cortex after head
injury.
(ii) To determine levels of individual presynaptic marker proteins in the 
cortex after head injury.
(iii) To investigate the existence of neuronal damage in the nbM after head 
injury.
(iv) To define the integrity of presynaptic terminals after ischaemic damage
in animal models of cerebral ischaemia and contrast this with the
sensitivity of postsynaptic structures.
(v) To explore whether GGF-2 exists in the human brain and to determine
the level of GGF-2 after head injury and in animal models of acute brain 
injury.
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CHAPTER 2: MATERIALS & METHODS
2.1 Human Postmortem Studies
2.1.1 Head-Injured Brain Tissue Collection
Fresh brain tissue was obtained at autopsy from 16 patients (12 males; 4 females) who 
died following a head injury and from 8 control subjects (5 males; 3 females) who died7
from causes other than a CNS pathology. Collection of the material was approved by the 
ethics committee of the Institute of Neurological Sciences, Glasgow. At autopsy, as part 
of a standard protocol, 11 anatomically defined regions in each cerebral hemisphere were 
dissected from a lcm-thick coronal slice at the level of the lateral geniculate body. The 
tissue was transported to a dedicated human grade II containment suite where all 
subsequent analyses of unfixed material were conducted according to defined health and 
safety protocols. The dissected samples for analyses were frozen in isopentane at -40°C 
and stored at -80°C. Brain regions for analyses were grey matter from the cingulate 
gyrus, inferior temporal gyrus and superior parietal cortex from the left hemisphere only 
and subcortical white matter from the corpus callosum. The remainder of the brain was 
fixed in 10% formalin for neuropathological examination of brain damage resulting from 
head injury (Adams et al., 1980a; Graham et al., 1995) and for Alzheimer type pathology 
(Khachaturian, 1985), Case details of control and head-injured patients are summarised 
in Table 2. The survival time after injury in the head-injured group ranged from 1 to 
300h. Postmortem delay ranges were: controls = 22 to 63 and head injured = 17 to 120h. 
The mean ± SEM ages were: control = 57 ± 4 and head-injured = 45 ± 4 years. Control 
patients died from a number of non-CNS related disorders including: ischaemic heart 
disease; aspiration pneumonia and pulmonary embolism. The neuropathological features 
of the head-injured patients are detailed in Table 3. Of the 16 head-injured patients, 
numbers presenting with particular findings were: skull fracture 13; oedema 11; DAI 8; 
contusions 15; raised ICP 14; SDH 12; ischaemic brain damage 12. Oedema and SDH 
were bilateral, right and left with 7 of the head-injured patients with SDH having 
undergone surgical evacuation of the haematoma prior to death. Varying grades of DAI 
and contusions were reported in cases, and ischaemic damage was either localised to 
brain regions supplied by specific cerebral vessels or diffuse throughout the brain.
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2.2 Presynaptic Pathology after Head Injury in the Human Brain
2.2.1 [3H]-Nicotine Receptor Binding
Membrane preparations for receptor binding assays were derived from the: inferior 
temporal gyrus; cingulate gyrus and superior parietal cortex. Grey matter was dissected 
from the blocks, homogenized 1:10 in 50mM Tris HC1 pH7.4, containing 8roM CaCl2 
and centrifuged (26,000g, 15min, 4°C). The supernatant was discarded and the pellet
i ,
washed twice. The final membrane preparation was stored at -70°C until use. [ H]- 
nicotine binding was determined by resuspending membranes (30mg/ml original 
weight/ml, 50mM Tris buffer, pH7.4) and incubating for 60min at 25°C with 4nM L-(-)- 
[W-methyl 3H]-nicotine (specific activity 64.4 Ci/mmol, Dupont, NEN) in the absence or 
presence of O.lmM carbachol to detect non-specific binding. The reaction was stopped 
by placing the samples on ice for lOmin after which the membranes were filtered through 
GF/C filters pre-soaked in 0.05% polyethyleneimine using a Brandel M24R cell 
harvester. Filters were washed three times with 3 ml of cold buffer (as above) and 
radioactivity in the filters determined by liquid scintillation counting. Protein content of 
the samples was measured by the method of Lowry et al., (1951), see section 2.2.2.
2.2.2 Western blotting
Grey matter was dissected from the cingulate gyrus and superior parietal cortex of 
controls and head-injured patients. Samples were rapidly homogenized 1:10 
(weight:volume) in Hepes buffer (5mM Hepes, 0.32M sucrose, benzamidine 5mM, p- 
mercaptoethanol 2mM, EGTA 3mM, MgSC>4 0.5mM, sodium vanadate ImM, 
phenylmethyl-sulphonyl fluoride O.lmM, leupeptin 2pg/ml, pepstatin A 5pg/ml, 
aprotonin 2pg/ml, pFI8), using a glass-glass homogeniser. Samples were then centrifuged 
for 5min at 13000 rpm using a Beckman Microfuge E with the supernatant retained and 
stored at -70°C. Protein assays were performed according to Lowry et al., (1951). 
Briefly, samples were diluted 1:5 and 1:10 in homogenisation buffer, 25pl of which was 
added to 1ml of 2% sodium carbonate in 0.1M NaOH containing copper sulphate and 
potassium sodium tartrate (both 0.02% aqueous solutions). 100|j.l of Folin and 
Ciocalteu’s reagent (Sigma, UK) was then added, followed by vortexing and the reaction 
mixture was allowed to stand for 20-3Omin at room temperature. Bovine serum albumin
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(BSA) standards were prepared at concentrations of 0.2, 0.4, 0.6, 0.8 and l.Omg/ml in 
homogenisation buffer. Absorbance of standards and samples were measured at 680nm, 
using a spectrophotometer (Pharmacia LKB, Ultrospec III) for detection. A typical 
example of the standard curve obtained using the Lowry assay is shown as Figure 8. 
After calculation of protein content in brain homogenates, samples were prepared in 
Laemmli buffer (0.1M Tris-HCl pH8.0, 5M urea, 5% sodium dodecyl sulphate (SDS), 
5% dithiolthreitol and 0.1% bromophenol blue) (Laemmli, 1970) such that lpl was 
equivalent to 1 pg of protein.
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Figure 8: Representative standard curve for Lowry Protein assay.
2.2.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The SDS-PAGE gels consisted of a lower resolving and upper stacking gel contained 
within two glass plates. The resolving gel comprised of 10-12% acrylamide, 0.33% 
bisacrylamide, 0.75M Tris-base, pH8.8 and was polymerised using 0.1% ammonium 
persulphate (Sigma) and 0.04% TEMED (Sigma). A small volume of 0.1% SDS was . 
added to the upper surface of the resolving gel during polymerisation and removed on
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addition of the stacking gel. The stacking gel consisted of 4.8% acrylamide, 0.11% 
bisacrylamide, 0.25M Tris-base, pH6.8 and polymerisation achieved as for the resolving 
gel. Either a 10- or a 15-well comb was inserted into the stacking gel and a 45min 
polymerisation period was allowed before addition of samples. The cast gels were 
mounted in the electrophoresis rig and the inner and outer reservoirs filled with 
electrophoresis buffer: 0.025M Tris-base; 0.0192M glycine and 0.1% SDS. Combs were 
removed, samples boiled for 5min and spun briefly using a Beckman Microfuge E 
desktop centrifuge. lOpg aliquots were loaded using a Hamilton syringe (Hamilton 
Bonaduz, Switzerland) and proteins separated using a Mini-Protean II cell (Bio-Rad, 
Hemel Hempstead, UK). Broad range biotinylated and prestained standards (Bio-Rad) 
were diluted 1:5 in Laemmlli buffer (Laemmli, 1970) and added alongside. Samples were 
electrophoresed at 60volts through the stacking gel and 80volts thereafter, with current 
approximately 15-25mAmps throughout. Optimisation for primary antibody 
concentrations directed against all proteins was performed prior to quantification of 
protein bands.
2.2.4 Semi-Dry Blotting and Alkaline Phosphatase Detection
Gels were sandwiched between twelve pieces of filter paper and one piece of 
nitrocellulose, cut to the dimensions of the gel and presoaked in Transfer buffer (0.025M 
Tris-base, pH8.3, 0.0192M glycine and 20% methanol) and water respectively. Air- 
bubbles were removed by gentle rolling of the filter paper-gel-nitrocellulose-filter paper 
stack. Proteins were transferred to the nitrocellulose membrane (Schleicher and Schuell, 
London, UK) by semi-dry transfer for 15min at 15volts (Trans-Blot SD, Bio-Rad). To 
demonstrate equal loading of the gels, after transfer the stacking gel was removed and 
the resolving gel was stained for 2 days in 0.1% coomassie blue (Sigma) in water: 
methanol: glacial acetic acid (5:5:2 by volume). Background (non-protein) staining was 
removed by destaining the gel in a solution containing 12.5% isopropanol and 10% 
glacial acetic acid. Coomassie blue staining of protein bands were scanned and is shown 
in Figure 9. The nitrocellulose membranes were blocked in 5% defatted dry milk in 
0.065M Tris-base, 0.1% Tween-20 (Sigma) (T-TBS) buffer for lh at room temperature 
with agitation. Blots were then incubated with a primary antibody diluted in T-TBS
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0.065M Tris-base, 0.1% Tween-20 (Sigma) (T-TBS) buffer for lh  at room temperature 
with agitation. Blots were then incubated with a primary antibody diluted in T-TBS 
overnight at 4°C. Following incubation, blots were washed in T-TBS, incubated with a 
biotinylated anti-mouse or anti-rabbit secondary antibody (Vector), diluted 1:500 in T- 
TBS. After washing, blots were incubated for lh  at room temperature with streptavidin 
alkaline phosphatase conjugate (Amersham, Slough, UK) diluted in T-TBS containing 
5% defatted dried milk. Immunoreactivity was visualised following incubation with an 
alkaline phosphatase substrate kit (Bio-Rad), blots were rinsed in distilled water and 
allowed to air-dry
0mm
Figure 9: Coomassie blue stained SDS-PAGE gel showing protein loading and 
separation by Western blotting. B and P correspond to biotinylated and prestained 
molecular weight protein standards respectively.
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2.2.5 Proteins Detected
Primary antibodies directed against a number of presynaptic proteins were used to assess 
presynaptic pathology after head injury. Concentrations of primary antibodies used and 
product details are summarised in Table 4. A primary antibody to the housekeeping 
protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal 
loading control. 1 Opg of protein was added for detection of presynaptic proteins, except 
GAPDH and 5pg of protein was loaded to detect GAPDH. All of the antibodies used 
were monoclonal, with the exception of anti-ChAT, which was polyclonal.
2.2.6 Enhanced Chemiluminescnce (ECL) Detection
In some Western blotting experiments to detect nitrotyrosine residues, ECL detection 
was used instead of alkaline phosphatase. SDS-PAGE and semi-dry transfer were 
performed as described in sections (2.2.3 and 2.2.4). Blots were washed in water, 
followed by rinsing in 50mM phosphate buffered saline (PBS) (made from PBS tablets, 
Oxoid, Hampshire, UK), containing 0.1% Tween-20 (PBS-T) (Sigma). Non-specific 
binding was blocked by incubation of blots in PBS containing 5% defatted dried milk 
(PBS-M) for 30min at room temperature with constant agitation. Blots were washed 
with water and incubated with monoclonal anti-nitrotyrosine (1:50) (Upstate 
Biotechnology, USA) diluted in PBS and incubated for 1.5h at room temperature with 
agitation. Thereafter, blots were washed with water and incubated with horse anti-mouse 
secondary antibody conjugated to horseradish peroxidase (Promega, UK) (1:1000) in 
PBS-M for 1.5h at room temperature. Blots were washed with water, followed by PBS- 
T and water once again. The membrane was then incubated in equal volumes of the ECL 
(Amersham, UK) reagents (1 and 2) for lmin exactly and excess ECL reagent drained on 
blotting paper. Membranes were then placed in SaranWrap and positioned in film 
cassettes (protein side up) and exposed to hyperfilm (Fujifilm, Japan) for initially 15 
seconds, and exposure time modified thereafter to optimise signal generation. Optimum 
exposure time was lmin. Films were then developed, washed in water and allowed to air- 
dry before densitometrical analysis.
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2.2.7 Dot-Blotting
Two pieces of blotting paper and 1 piece of 0.45pm nitrocellulose (Schleicher & Schuell, 
Germany) were prewetted in TBS for lmin and loaded onto the Minifold I Spot-blot 
plate platform (Schleicher & Schuell). A pipette was rolled over the surface of the 
membrane and the stack was clamped in place. One pi of protein in 40pl of buffer was 
loaded and aspirated with a vacuum pump for 3min. The membrane was removed from 
the platform and after washing in T-TBS for 3xl0min, non-specific binding was blocked 
by incubation of the membrane in T-TBS containing 5% defatted milk (T-T^S-M) for lh 
with agitation. The blots were then washed in T-TBS and incubated with monoclonal 
anti-nitrotyrosine (Upstate, USA) diluted 1:5000 in T-TBS-M for 1.5h at room 
temperature. After washing, blots were incubated with horse radish peroxidase 
conjugated secondary antibody (Promega, UK), diluted 1:1000 for 1.5h at room 
temperature. After numerous washes in T-TBS and distilled water, immunoreactivity was 
visualised as described above for ECL detection. Optimum exposure time was 2min.
2.28 Quantification and Validation of Optical Density Analysis
Optical density of the protein signal was quantified by densitometric analysis (MCID, 
Imaging Research, Ontario, Canada) of the blots. A range (0.1-1.0 ODunits) of Kodak 
Wratten gelatin filters (Eastman Kodak Company, New York, USA) were used for 
calibration and calculation of optical density of the protein bands. Readings for 
calibration were recorded from the area exactly adjacent to the band of interest. To 
ensure accurate calibration, individual calibration curves were constructed for each band 
on a blot. To verify the linear relationship between the amount of protein loaded and the 
optical density of the signal generated, 1, 2, 5, 10, 20 and 30pg samples of protein from 
a sample of cingulate gyrus from a control patient were separated using SDS-PAGE and 
semi-dry transfer, incubated with anti-synaptophysin (1:5000) and developed using the 
alkaline phosphatase conjugate substrate. The blot and the relationship between protein 
loaded and optical density are shown in Figure 10.
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Figure 10: Validation o f use o f optical density image analysis.
Western blot (A), showing the signal generated using anti-synaptophysin (1:5000) and 
the alkaline phosphatase conjugate detection system with ascending amount o f loaded 
protein from grey matter o f the left cingulate gyrus o f a control subject. (B) Relationship 
between quantity o f protein loaded and the optical density o f the bands measured using 
image analysis.
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2.3 Immunohistochemistry
Fresh frozen, 4% paraformaldehyde-fixed left cingulate gyrus from the same group of 
controls and head-injured patients was cryostat cut (Microtome 3050, Bright, 
Huntingdon, UK) at a thickness of 30pm and mounted on to poly-L-lysine coated slides. 
Sections were dried and stored at -20°C until use. Sections were removed from the 
freezer, thawed and rinsed with two washes of PBS. Endogenous peroxidases were
blocked by incubating sections with 3% hydrogen peroxide (Sigma) in methanol for
1
30min. After rinsing firstly in running water for lOmin, followed by PBS 2x5min, 
sections were drawn round using a hydrophobic pen (Dako, Cambridge, UK). Non­
specific binding was blocked by incubation with 350pl of blocker solution containing 
0.5% bovine serum albumen (BSA) and 10% normal horse (monoclonal) or goat 
(polyclonal) serum in PBS for lh at room temperature. Sections were then incubated 
with 350pl of primary antibody overnight at 4°C, diluted in PBS containing 0.1% BSA 
and 1.5% serum (see Table 4 for dilutions). The following day, sections were washed in 
PBS and incubated with biotinylated secondary antibody (horse anti-mouse or goat anti­
rabbit) diluted 1:100 in PBS. Sections were then washed with PBS 2x5min, followed by 
incubation with a Vectastain ABC kit (Vector) (made up approximately lh before use) 
for lh at room temperature. Once again sections were washed with 2x5min PBS and 
immunoreactivity visualised by incubation of sections with the chromagen 3,3- 
diaminobenzidine. After detection, the reaction was stopped by rinsing in water, 
dehydrated through alcohols and counterstained with haematoxylin (optional) before 
mounting using DPX mountant (Raymond Lamb, Eastbourne, UK).
2.3.1 Quantification of Immunohistochemical Signal: Relative Optical Density
Sections were viewed using a Leitz DM RB light microscope (Leica, Germany). 
Immunostaining of the presynaptic proteins was restricted to the neuropil and was absent 
from the cell bodies (see Figure 11). Immunostaining was diffuse, consistent with the 
distribution of synaptic vesicles throughout the neuropil.
A B
I
Figure 11: The pattern o f immunohistochemical staining for (A) synaptophysin and (B) 
SNAP-25 staining in cingulate gyrus from a human control subject. Antibodies to both 
proteins produced diffuse and punctate pattern o f immunostaining in the neuropil, but 
absent from cell bodies (arrows).
The intensity o f the immunohistochemical signal o f the presynaptic proteins, 
synaptophysin and SNAP-25, was measured by MC1D image analysis, using a camera 
(Nikon, Japan) attached to a light microscope (Leica). Since the immunostaining for the 
presynaptic proteins was predominantly localised in the neuropil, relative optical density 
was measured at 10 points within 5 fields o f cortical grey and subcortical white matter 
(background), and calculated as the mean o f 50 grey matter readings subtract the mean 
o f 50 white matter readings.
2.4 nucleus basalis of Meynert Pathology after Head Injury
2.4.1 Ch4 Neurons in the nbM
Blocks o f  interest were removed from specimen jars containing brain material stored in 
10% formalin. Using the anterior commissure and optic tract as anatomical landmarks for 
the identification o f the nbM (see Figure 12), as described previously (Allen et al., 1988), 
a 1 cm-thick coronal slice containing the intermediate portion o f the nbM was dissected 
from blocks from the same group o f controls and head-injured patients, used previously 
to assess presynaptic pathology after head injury. Brain slices were washed, dehydrated
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and paraffin embedded and 8pm thick sections were serially cut using a microtome (Jung 
Biocut 2035, Leica, Germany). Sections were mounted onto 3-aminopropyl 
triethoxysilane-coated slides and dried in an oven overnight at 37°C.
Figure 12: M acroscopic identification o f the nbM in human postmortem brain. Scale bar 
= 1cm. The arrow indicates the anterior commissure, used as an anatomical landmark for 
macroscopic identification o f the nbM. The localisation o f the Ch4 neurons o f the NbM 
is indicated by *.
2.4.2 Histology and Semi-Quantitative Analysis
Every tenth section was stained for haematoxylin/eosin (H&E) and cresyl violet/luxyl fast 
blue (LFB/CV) (see Appendix 1). As described by Allen et al., (1988), Ch4 neurons o f 
the nbM were identified through a combination o f their size, morphology and 
hyperchromatic staining pattern (See Figure 13). Using H&E and LFB/CV stained 
sections, damage to Ch4 neurons o f the intermediate portion o f the nbM was semi- 
quantitatively assessed using the following scoring system: -
Scoring System: 0 No damage
1 0-10% damage
2 10-25% damage
3 25-50% damage
4 50-100% damage.
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with scores representing the number o f damaged Ch4 neurons as a percentage o f the 
total Ch4 neuronal population in the intermediate portion o f  the nbM. Criteria considered 
for assessment included: cell morphology (circular or irregular); hyperchromatic Nissl 
substance staining; eosinophilic and/or luxophilic neurons and presence o f incrustations.
Figure 13: Histological staining o f Ch4 neurons o f the nucleus basalis o f Meynert o f a 
control subject. Using haematoxylin/eosin (A) and luxol fast blue/cresyl violet (B) 
staining in adjacent sections, Ch4 neurons were identified as large circular neurons with 
Nissl substances densely stained with haematoxylin or cresyl violet. Nuclear membranes 
and nucleoli are clearly defined with myelin counterstain (luxol fast blue) absent from 
healthy neurons. Magnification X400.
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2.4.3 Immunohistochemistry for Choline Acetyltransferase
Adjacent sections to those used for H&E and LFB/CV staining were placed in an oven at 
65°C for half hour to melt wax. Dewaxing of the sections was completed by placing 
sections in xylene for 2x10 min, followed by dehydration in absolute alcohol for 10 and 
5min. Retrieval of antigen binding sites was achieved by microwaving sections at high 
power for 2x5min in lOmM citric acid and allowed to cool for 30min thereafter. The 
remainder of the immunohistochemistry protocol was similar to that described in section 
2.3. Normal donkey serum was used in the blocking solution and sections were incubated 
overnight at 4°C with a polyclonal primary antibody to choline acetyltransferase (clone 
AB144p, Chemicon; donated by Dr D. Maxwell, Institute of Biomedical and Life 
Sciences, University of Glasgow), diluted 1:1000 in PBS containing 1.5% normal donkey 
serum and 0.1% BSA. The following day the standard protocol was used (see section 
2.3), except that an ABC elite kit was used and 3,3-diaminobenzidine was used as 
chromagen with nickel enhancement.
2.5 Animal Models of Acute Brain Injury
A number of rodent models of cerebral ischaemia were used to assess presynaptic 
terminal integrity after acute brain injury.
2.5.1 Focal Cerebral Ischaemia in the Rat: Permanent Middle Cerebral Artery 
Occlusion: Intraluminal Thread Model
Surgery was performed by Louise Marks as detailed in Appendix 2. After a recovery 
period of 24h, the animals were reanaesthetised, decapitated and the brain rapidly 
removed. The area of cortex supplied by the middle cerebral artery was dissected from 
both the ipsilateral and contralateral hemispheres and snap-frozen in liquid nitrogen. The 
area supplied by the unaffected anterior carotid artery, including the cingulate gyrus was 
dissected from both hemispheres and processed as described above.
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2.5.2 Focal Cerebral Ischaemia in the Rat: Permanent Middle Cerebral Artery 
Occlusion: Diathermy model.
Surgery was performed by Dr Rammy Gill, Roche, Switzerland using the method of 
Tamura et al., 1981. Animals were allowed to survive for 24h before being transcardially 
perfused with 4% parafomaldehyde.
2.5.3 Western blotting and Image Analysis
Membrane homogenate preparation and Western blotting were performed as described in 
section 2.2.2-2.2.4. Optical densities of the immunoreactive signals generated for a 
number of presynaptic proteins, namely, synaptophysin, SNAP-25, syntaxin and were 
determined by MCID image analysis as described in section 2.2.8.
2.5.4 Global Cerebral Ischaemia in the Mouse: Transient Bilateral Common 
Carotid Artery Occlusion
Surgery was performed by Stephen Kelly as described in Appendix 3.
2.5.5 Tissue Processing and Staining
Fixed brains were cut into 3mm blocks and processed for paraffin embedding. 
Specifically, blocks were dehydrated in cassettes for 30min in two volumes of 70%, 90% 
and 100% alcohols and for lh in xylene. Thereafter blocks were wax-embedded via 
overnight incubation in paraffin wax at 65°C. 6pm thick sections were cut at the level of 
the caudate and dorsal hippocampus using a microtome (Leica RM2135, Germany) and 
mounted on to poly-L-lysine coated slides and air-dried. Paraffin embedded brain tissue 
was dewaxed in histoclear and dehydrated in alcohol solutions prior to H&E (see 
Appendix 1) and immunohistochemical staining. Immunohistochemistry and relative 
optical density measurements on mouse tissue was performed as described for human 
brain tissue in sections 2.3 -  2.3.1. Primary antibody concentrations used were: anti- 
synaptophysin, 1:10000; anti-SNAP-25, 1:5000; anti-syntaxin, 1:2000 and anti-MAP-2, 
1:750.
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2.5.6 Assessment of Neuronal Damage
The extent of neuronal damage was determined in the caudate and a number of layers 
within the hippocampus (CA1, CA2, CA3, hilus and dentate gyrus) of both hemispheres. 
The amount of neuronal damage was expressed as a percentage of the overall neuronal 
population within the specific brain regions, with low scores equivalent to minimal 
damage and high scores equivalent to considerable damage.
Scoring system: 0 no damage
1 0-10% damage
2 10-25% damage
3 25-50% damage
4 50-100% damage
2.6 GGF-2 in Acute Brain Injury
The response of GGF-2 to acute brain injury was assessed in human postmortem brain 
tissue from controls and head-injured patients and in a number of animal models of acute 
brain injury.
2.6.1 GGF-2 and Human Head Injury
Using the same group of controls and head-injured patients detailed in section 2.11, and 
Tables 2 and 3, GGF-2 levels were assessed using both Western blot analyses for the 
cingulate gyrus and the superior parietal cortex (see sections 2.2.2-2.2 4), and 
immunohistochemistry (for the cingulate gyrus (see section 2.3). In Western blotting a 
panel of primary antibodies was used against GGF-2, each directed against different 
recognition sequences of the GGF-2 protein (see Figure 14). All of these antibodies 
were provided by Dr Mark Marchionni, Cambridge NeuroScience and used at dilution of 
1:500 in T-TBS for Western blotting. Antibody CN16 was used at a dilution of 1:500 for 
immunohistochemistry, as described in section 2.3.
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Figure 14: Primary antibodies directed against GGF-2.
Five primary antibodies, namely CN16, 11366, 19937, 51210 and 51211, recognise 
specific epitopes on the GGF-2 protein. The coding introns are indicated in numbers (1- 
13) and various domains of the proteins are shown: Ig, immunoglobulin; CHO, 
carbohydrate; TM, transmembrane domains and EGF-L, epidermal growth factor-like 
domain.
2.6.2 Subdural Haematoma in the Rat
Surgery was performed by Dr Michael Fitzpatrick (see Appendix 4) and after a 4h 
survival period, rats were reanaesthetised, decapitated and the brain rapidly removed. 
The area of cortex underlying the haematoma and the corresponding area on the 
contralateral hemisphere were dissected on ice and snap-frozen in liquid nitrogen. Levels 
of GGF-2 immunoreactivity were determined by separation of 10pg of protein on 10% 
acrylamide gels by Western blotting and SDS-PAGE, as described in sections 2.2.2- 
2.2.4. The primary antibody, 51210, was used to detect GGF-2 immunoreactivity.
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2.6.3 Focal Cerebral Ischaemia in the Rat: Permanent Middle Cerebal Artery 
Occlusion - Diathermy Model
Surgery was performed by Dr Marc Soriano using the method of Tamura et al., 1981. 
The brain was rapidly removed and tissue from the cortical and striatal MCA territory 
was dissected on ice from both the ipsilateral and contralateral hemispheres and snap- 
frozen in liquid nitrogen. Membrane homogenates were prepared as described in sections 
2.2.2. Western blot analysis of GGF-2 levels was performed using the primary antibody 
CN16 diluted 1:500 as detailed in section 2.2.2-2.2.4. '
2.6.4 Alzheimer’s Disease Brain Tissue Collection
Fresh brain tissue was obtained at autopsy from 8 patients (3 males; 5 females) 
diagnosed with Alzheimer’s disease and 9 control subjects (5 males; 4 females) with no 
evidence of Alzheimer’s disease symptomatology. Tissue collection and processing was 
as described previously (Dewar et al., 1990). Brain tissue was dissected from the left 
cingulate gyrus only. Case details of the Alzheimer’s disease and control subjects are 
summarised in Table 5. Postmortem delay ranges were: control = 3 to 6h and 
Alzheimer’s disease = 2.5 to 14.2h. The mean ± SEM ages were: Alzheimer’s disease = 
81 ± 2 years and controls 82 ± 3 years. Membrane homogenates preparation and 
Western blotting were performed as described in section 2.2.2.-2.2.4. GGF-2 was 
detected using CN16 (1:500) and optical density measured using the protocol in section 
2 2^ .8 .
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Case Age Sex PM Delay (h)
AD 1 78 F 2.5
AD 2 82 M 10
AD 3 81 F 6
AD 4 81 M 5
AD 5 85 F J
AD 6 69 M 6
AD 7 82 F 14.2
AD 3 94 F 3.5
C 1 86 M 6
C 2 74 M 5
C 3 96 F
C 4 75 M 4
C 5 83 F 6
C 6 86 M 5.5
C 7 76 F 5
C 8 73 M 6
C 9 79 F 6
Table 5: Case Details o f  Alzheimer’s Disease and Control Patients
P ostm ortem  delay is the number o f  hours between death and freezing <>| 
the tissue. F; female; M  male.
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CHAPTER 3: RESULTS
3.1 Presynaptic pathology: Human postmortem brain studies
Mechanisms involved in human head injury have been studied in both rodent trauma 
models and use of human postmortem brain material. Involvement of various cellular 
compartments and pathophysiological mechanisms have been shown to contribute to the 
behavioural and neurochemical deficits existing after a head injury. However, whether
t
there is damage or dysfunction of the presynaptic terminals after a head injury is not 
known. Therefore, this study was designed to address this issue using human 
postmortem brain tissue from the cortex of controls and head-injured patients. Deficits 
in cortical choline acetyltransferase activity are present in the human brain after head 
injury (Murdoch et al., 1998). However, whether this is due to a loss of cholinergic 
innervation or presynaptic terminals in not known. The levels of a number of 
presynaptic markers were assessed by receptor binding, Western blot analyses and 
immunohistochemistry in a group of controls and head-injured patients.
3.1.1 Nicotinic receptor binding
Mnemonic and cognitive deficits are debilitating consequences of human head injury 
(Oddy et al., 1985). The cholinergic system, including nAChRs have been implicated in 
the processes of learning and memory (Newhouse et al., 1994). Low nanomolar 
concentrations of [3H]-nicotine were used to detect high affinity nAChRs in 
homogenates from 3 cortical regions; cingulate gyrus, superior parietal cortex and 
inferior temporal gyrus. A proportion of these nAChRs are believed to be present on 
presynaptic terminals (Wonnacott, 1997), thereby providing a measure of cortical 
presynaptic terminal integrity. 4nM [3H]-nicotine binding used in this study did not 
detect any change in the number of nAChRs in the cingulate gyrus, the superior parietal 
cortex or the inferior temporal gyrus of controls and head-injured patients (Figure 15).
3.1.2 Western blotting
Western blotting analyses was performed for a number of presynaptic proteins in 
homogenates from the cingulate gyrus and the superior parietal cortex of controls and 
head-injured patients. In the cingulate gyrus, levels of synaptophysin, SNAP-25 and 
syntaxin immunoreactivity were reduced by 28%, 36% and 43% respectively in head-
67
B00G
*3
g
<t>g'■Goo
.2'3
oWhCX
00
i,K &
00_c
*3
G
ffi
G
’5+->
2ex
oo
2
o
eg*+H
Cingulate
Control Head-Injured
Parietal
Control Head-Injured 
Temporal
Control Head-Injured
Figure 15
[3H]-nicotine binding in the cingulate gyrus (A), superior parietal cortex (B) and inferior 
temporal gyrus (C) of controls (open bars) and head-injured patients (filled bars). Data 
represent the mean + SEM. Unpaired two-tailed Student's t tests revealed there was no 
difference in the level of [3H]-nicotine binding in any of the cortical regions examined in 
head-injured patients (n= 16) compared with controls (n=8).
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injured patients compared to controls (Figures 16, 17, 18). Synaptotagmin and synapsin 
I were detected at the predicted molecular weights, but optical densities of these 
proteins were not statistically different between controls and head-injured patients. 
Synaptotagmin immunoreactivity was reduced by 18% (Figure 19) and synapsin la and 
I b were increased by 12 and 20% respectively in head-injured patients compared with 
controls (Figure 20), but these differences did not reach statistical significance. The 
housekeeping protein GAPDH is routinely used as an internal loading control for 
blotting techniques (Zhong and Simons, 1999). The levels of GAPDH immunoreactivity 
were not different between head-injured patients and controls (Figure 21), indicating 
equivalent amounts of protein had been loaded in the gel lanes.
In the superior parietal cortex from the same group of controls and head-injured patients 
as used for the cingulate gyrus analyses, none of the presynaptic proteins were 
significantly reduced in the head-injured group compared to controls. The mean levels 
of synaptophysin (Figure 22), SNAP-25 (Figure 23), syntaxin (Figure 24) and 
synaptotagmin (Figure 25) were reduced by 18, 26, 14 and 17% respectively in the 
head-injured group compared to controls, although none of these changes reached 
statistical significance. Similarly, the levels of both synapsin la and lb (Figure 26) were 
no different in the superior parietal cortex of head-injured patients compared to controls. 
The level of GAPDH immunoreactivity was unchanged in the head-injured patients 
compared to control subjects (Figure 27). An overview of the presynaptic protein 
measurements in the cingulate gyrus and the superior parietal cortex are summarised in 
Table 6.
3.1.3 Immunohistochemistry for presynaptic proteins
Immunohistochemistry for synaptophysin in fresh-frozen, 4%-paraformaldehyde fixed 
cingulate gyrus from blocks adjacent to those used for Western blot analyses was 
performed for the same group of controls and head-injured patients. Synaptophysin 
immunostaining was predominantly present in the neuropil as a punctate pattern 
attributable to synaptophysin’s localisation on synaptic vesicles (Navone et al., 1986). 
Minimal synaptophysin immunostaining was detected within cell bodies in either the 
controls or head-injured patients (Figure 28). The distribution of synaptophysin 
immunostaining in the neuropil permitted determination of relative optical density
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Figure 16
Synaptophysin immunoreactivity is reduced in the cingulate gyrus o f head-injured 
patients compared with controls. A: Western blots o f synaptophysin immunoreactivity in 
8 controls (C) and 16 head-injured patients (H), with detection o f synaptophysin at the 
predicted molecular weight o f 38kDa One control case and one head-injured case were 
loaded onto both gels accounting for 26 bands detected per experiment. B: Quantitative 
data o f the immunoblots in A. The mean value (bar) o f synaptophysin immunoreactivity 
in the head-injured patients (closed circles) was reduced by 28%, *p<0.05, compared to 
controls (open circles). Unpaired two-tailed Student's / test was used for statistical 
analysis.
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Figure 17
SNAP-25 immunoreactivity is reduced in the cingulate gyrus o f head-injured patients 
compared with controls. A: Western blots of SNAP-25 immunoreactivity in 8 controls 
(C) and 16 head-injured patients (H), with detection o f SNAP-25 immunoreactivity at the 
correct molecular weight o f 25kDa. B: Quantitative data o f the immunoblots in A. 
Unpaired two-tailed Student's / test showed the level o f SNAP-25 immunoreactivity was 
significantly reduced by 36%, *p<0.05, in head-injured patients (closed circles) compared 
with controls (open circles). Bars represent the group means.
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Figure 18
Syntaxin immunoreactivity is reduced in the cingulate gyrus o f head-injured patients 
compared with controls. A: Western blots o f syntaxin immunoreactivity in 8 controls (C) 
and 16 head-injured patients (H), with detection o f syntaxin immunoreactivity at the 
correct molecular weight o f 35kDa. B: Quantitative data o f the immunoblots in A. 
Unpaired two-tailed Student's t  test showed the level o f syntaxin immunoreactivity was 
significantly reduced by 43%, *p<0.01, in head-injured patients (closed circles) compared 
with controls (open circles). Bars represent the group means.
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Figure 19
Synaptotagmin immunoreactivity in the cingulate gyrus o f head-injured patients 
compared with controls. A: Western blots o f synaptotagmin immunoreactivity in 8 
controls (C) and 16 head-injured patients (H), with detection o f synaptotagmin at the 
correct molecular weight o f 65kDa. B: Optical density values o f the immunoblots in 
panel A. Bars represent the group means. Levels o f synaptotagmin immunoreactivity 
were not different between controls (open circles) and head-injured patients (closed 
circles).
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Synapsin I immunoreactivity in the cingulate gyrus o f head-injured patients compared 
with controls. A: Western blots o f synapsin I immunoreactivity in 8 controls (C) and 16 
head-injured patients (H), with detection of the synapsin I doublet at the correct 
molecular weights of 86kDa and 80kDa for synapsin la and lb respectively. B, C: 
Quantitative data for the Western blots in A. Bars represent the group means. Unpaired 
two-tailed Student's / tests revealed there was no difference in the levels o f both synapsin 
la and synapsin lb in head-injured patients (closed circles) compared with controls (open 
circles).
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Figure 21
GAPDH immunoreactivity in the cingulate gyrus o f head-injured patients compared with 
controls. A: Western blots o f GAPDH immunoreactivity in 8 controls (C) and 16 head- 
injured patients (H), with detection o f GAPDH immunoreactivity at the correct molecular 
weight o f 36kDa. B: Optical density values for the western blots in A. Bars represent the 
group means. Levels o f GAPDH immunoreactivity were unchanged in controls (open 
circles) compared with head-injured patients (closed circles), using the Unpaired two- 
tailed Student’s 1 test.
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Figure 22
Synaptophysin immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A: Western blots o f synaptophysin immunoreactivity in 8 
controls (C) and 16 head-injured patients (H), with detection o f synaptophysin at the 
predicted molecular weight o f 38kDa. B: Quantitative data o f the immunoblots in A. The 
mean value (bar) o f synaptophysin immunoreactivity in the head-injured patients (closed 
circles) was no different to controls (open circles), using an unpaired two-tailed Student's 
/ test for statistical analysis.
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Figure 23
SNAP-25 immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A: Western blots of SNAP-25 immunoreactivity in 8 controls 
(C) and 16 head-injured patients (H), with detection o f SNAP-25 immunoreactivity at the 
correct molecular weight o f 25kDa. B: Quantitative data o f the immunoblots in A. 
Unpaired two-tailed Student's / test revealed that the level o f SNAP-25 immunoreactivity 
was no different in head-injured patients (closed circles) compared with controls (open 
circles). Bars represent the group means.
77
A Syntaxin
H H C H H H C H C H H H H
35kDa
35kDa
C H C H H C C H H C H C H
G0)
"c5o
K.o
B
0.50
0.25-
o°
o
00
Control
• • •
Head-Injured
Figure 24
Syntaxin immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A: Western blots o f syntaxin immunoreactivity in 8 controls (C) 
and 16 head-injured patients (H), with detection o f syntaxin immunoreactivity at the 
correct molecular weight o f 35kDa. B: Quantitative data o f the immunoblots in A. 
Unpaired two-tailed Student's t  test revealed that the level o f syntaxin immunoreactivity 
was unchanged in head-injured patients (closed circles) compared with controls (open 
circles). Bars represent the group means.
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Figure 25
Synaptotagmin immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A: Western blots o f synaptotagmin immunoreactivity in 8 
controls (C) and 16 head-injured patients (H), with detection o f synaptotagmin at the 
correct molecular weight o f 65kDa. B: Optical density values o f the immunoblots in 
panel A. Bars represent the group means. Levels o f synaptotagmin immunoreactivity 
were not different between controls (open circles) and head-injured patients (closed 
circles), using unpaired two-tailed Student's 1 test for statistical analysis.
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Figure 26
Synapsin I immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A: Western blots of synapsin I immunoreactivity in 8 controls 
(C) and 16 head-injured patients (H), with detection o f the synapsin I doublet at the 
correct molecular weights o f 86kDa and 80kDa for synapsin la and lb respectively. B, C: 
Quantitative data for the Western blots in A. Bars represent the group means. Unpaired 
two-tailed Student's t  test revealed there was no difference in the levels o f both synapsin 
la and synapsin lb in head-injured patients (closed circles) compared with controls (open 
circles).
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Figure 27
GAPDH immunoreactivity in the superior parietal cortex o f head-injured patients 
compared with controls. A. Western blots o f GAPDH immunoreactivity in 8 controls (C) 
and 16 head-injured patients (H), with detection o f GAPDH immunoreactivity at the 
correct molecular weight o f 36kDa. B: Optical density values for the western blots in A. 
Bars represent the group means. Unpaired two-tailed Students t  tests revealed that levels 
o f GAPDH immunoreactivity were unchanged in controls (open circles) compared with 
head-injured patients (closed circles).
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Synaptophysin
Figure 28
Representative synaptophysin immunostaining in the cingulate gyrus from a control (A) 
and a head-injured patient (B). Immunostaining was diffuse and punctate in pattern in the 
neuropil, but minimal in cell bodies (arrows). Relative optical density values were 
measured from areas o f synaptophysin immunostaining in the neuropil. Ten 
measurements were made per case and the means calculated. Magnification X400.
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Table 6: Summary of Cortical Presynaptic Protein Pathology after Human
Head Injury
Cingulate Parietal
Synaptophysin -28% * -18%
SNAP-25 -36% * -26%
Syntaxin -43%** -14%
Synaptotagmin -18% -17%
Synapsin la +12% -8.1%
Synapsin lb +20% -10.8%
GAPDH +1.3% + 4.7%
Data represents the percentage difference in the mean optical density for each group of 
head-injured patients (n=16) compared with controls (n=8). Values represent either an 
increase (+) or a reduction (-) in optical density. *p<0.05 and **p<0.01 by unpaired 
two-tailed Student’s t tests
measurements of the immunoreactive signal. In accordance with the Western blot 
analysis (Figure 16), synaptophysin immunostaining was reduced in the cingulate gyrus 
of head-injured patients compared with controls, equivalent to a 30% reduction (Figure 
29). In contrast, SNAP-25 immunoreactivity was no different in the head-injured 
patients compared to controls.
3.1.4 Correlation of ChAT activity with synaptophysin immunoreactivity
Widespread cortical deficits of ChAT activity have been demonstrated previously for 
the same group of controls and head-injured patients used in the current study (Murdoch 
et al., 1998). Correlation of ChAT activity in the cingulate gyrus and the superior 
parietal cortex with synaptophysin levels (detected by Western blot analyses) for the 
head-injured group indicated that patients with low levels of ChAT activity tended to 
have low levels of synaptophysin immunoreactivity whereas those with higher ChAT
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Figure 29
Relative optical densities of synaptophysin (A) and SNAP-25 (B) immunoreactivities in 
the cingulate gyrus of controls (open circles) and head-injured patients (closed circles). 
Data represent mean + SEM and individual data points correspond to individual patients 
values. Unpaired two-tailed Student's t test revealed that the level of synaptophysin 
immunoreactivity was reduced by 30%, *p<0.05, in head-injured patients compared with 
controls. The level of SNAP-25 immunoreactivity was no different between controls and 
head-injured patients.
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activity tended to have higher levels of synaptophysin immunoreactivity (Figure 30). 
Correlation coefficients for linear regression analyses (Pearson’s product moment) were 
r2=0.260 and 1^=0.461 for the cingulate gyrus and the superior parietal cortex 
respectively, with *p< 0.05 for the superior parietal cortex.
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Figure 30
Relationship between synaptophysin immunoreactivity detected by Western blot analysis 
and ChAT activity in the cingulate gyrus (A) and the superior parietal cortex (B) of head- 
injured patients. The linear coefficient value is stated for both cortical regions. Linear 
regression analysis indicated that *p<0.05 for the parietal, but p>0.05 for the cingulate 
gyrus.
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3.1.5 Postsynaptic changes after head injury
To contrast the presynaptic changes observed after head injury, MAP-2, a protein 
routinely used as a marker of postsynaptic elements after brain injury (Kitagawa et al., 
1989; Folkerts et al., 1998), was detected by immunohistochcmistry in the cingulate 
gyrus from the same group of controls and head-injured patients as those used to assess 
presynaptic pathology. In controls, MAP-2 immunostaining was faint and limited to 
narrow dendritic processes. The dendrites were not fragmented and no pinching or 
swelling of MAP-2 staining was seen along the length of the dendrites (Figure 31). In 
head-injured patients, MAP-2 immunostaining accumulated in dendrites and shrunken 
cell bodies. In a patient who survived 3 days after a head injury, MAP-2 was localised 
to swollen, fragmented dendrites, indicating a disruption of dendritic processes after 
head injury. In a patient who survived 4 days after head injury, MAP-2 staining was 
intense not only in the dendritic processes but also in shrunken neuronal perikarya.
3.1.6 Nitrotyrosine formation after head injury
Free radical-mediated neuronal cell death is implicated in the pathogenesis of brain 
damage (Coyle and Puttfarcken, 1993; Berlett and Stadtman, 1997). The potent oxidant 
peroxynitrite is implicated in diverse pathological conditions (Miller et al., 1995; 
Shigenaga et al., 1997). To investigate whether free radical-mediated damage was 
involved in the presynaptic dysfunction in the cingulate gyrus after head injury, the 
level of the peroxynitrite-radical byproduct, nitrotyrosine (Kooy et al., 1995; Smith et 
al., 1997) was detected by Western and dot blot analyses in homogenates from grey 
matter from the cingulate gyrus of control and head-injured patients. Using Western blot 
analyses, specific binding of the anti-nitrotyrosine antibody to several epitopes was 
detected in both controls and head-injured patients (Figure 32), although the signal was 
unsuitable for quantification. Dot-blot analyses produced an easily quantifiable signal, 
with nitrotyrosine immunoreactivity no different between control and head-injured 
patients. Nevertheless, there was a trend towards an increase in the head-injured group, 
with only 5 of the head-injured patients having a nitrotyrosine relative optical density 
lower than the mean of the controls (Figure 33).
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Figure 31
Representative MAP-2 immunostaining in the cingulate gyrus o f controls (A) and head- 
injured patients (B, C). MAP-2 immunostaining was localised to thin, continuous dendrites 
in controls (A). In a head-injured patient who survived 3 days (B) MAP-2 immunostaining 
was located in swollen, fragmented dendrites (arrows). In a patient who survived 4 days 
after a head injury (C), MAP-2 immunostaining was present in dendrites, but also 
accumulated in cell bodies (arrowheads). Magnification X400.
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Figure 32
Western blot of nitrotyrosine immunoreactivity in the cingulate gyrus of controls (C) and 
head-injured patients (H). A number of bands (arrows) were detected in both controls and 
head-injured patients, indicating binding of the primary antibody to epitopes on proteins 
of various molecular weights. These results indicate that nitrotyrosine residues are present 
in proteins in both controls and head-injured patients.
3.2 nbM pathology after human head injury
The nbM provides a cholinergic input to the entire cortical mantle through the Ch4 
subpopulation o f neurons (Mesulam et al., 1983b). To elucidate whether the deficits in 
cortical ChAT activity after head injury reflects a loss o f cortical cholinergic 
presynaptic terminals or alternatively loss o f cholinergic input from the basal forebrain, 
the integrity o f the Ch4 neurons in the nbM was determined in the same group o f 
controls and head-injured patients. The coronal sections o f 10%-formal saline fixed 
brain containing the intermediate portion o f the nbM were macroscopically identified 
using the anterior commissure and optic tract as anatomical landmarks (Allen et al., 
1988). In a head-injured case, macroscopic evidence o f damage within the nbM territory
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Figure 33
Quantification o f nitrotyrosine immunoreactivity in the cingulate gyrus of controls and 
head-injured patients. A: Dot-blot o f nitrotyrosine immunoreactivity for the 8 controls 
and 16 head-injured patients. B: Quantitative data for nitrotyrosine immunoreactivity in 
the cingulate gyrus o f controls (open circles) and head-injured patients (closed circles). 
Individual data points correspond to values for individual patients and the bars represent 
the group means. Unpaired two-tailed Student’s t  test analysis revealed no statistically 
significant difference between groups.
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was evident through presence o f a haemorrhage and a compression o f the brain 
structures due to raised intracranial pressure (Figure 34).
Photomicrograph of macroscopic identification of neuropathological findings in the 
region of the nbM of a head-injured patient. The coronal slice shown provides evidence 
of a well-defined dark core, corresponding to a brain haemorrhage (arrow), resulting in 
ischaemic brain damage, raised intracranial pressure and a midline shift (#) causing 
compression of brain structures, including the nbM (arrowhead).
3.2.1 Histological assessment
Ch4 neurons o f the nbM were identified using H&E and LFB/CV stained sections 
(Figure 35). In controls, Ch4 neurons were large (30-40jim) and circular, although often 
oval. The nucleus was eccentrically placed with a distinct nucleolus and abundant 
cytoplasm, with marginated Nissl bodies and lipofuscin granules. In tissue from head- 
injured cases a range o f morphological changes were seen in Ch4 neurons. Firstly, 
ischaemic cell change, the neurons having an intensely eosinophilic or luxophilic 
cytoplasm and in some cases incrustations (Figure 35). The nucleus was hyperchromatic 
and the nucleolus could no longer be recognised. In a few head-injured cases there was 
infarction o f part or the entire nbM nucleus (Figure 35): in several cases the margins o f 
the lesion could be demarcated by the boundary o f  cresyl violet stained and luxophilic
Figure 34
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H&E LFB/CV
Figure 35
Photomicrograph o f  histological assessment o f Ch4 neuronal damage in the nbM of 
controls (A, B) and head-injured patients (C, D, E, F) using H&E (A, C, E) and LFB/CV 
(B, D, F). In the control case, Ch4 neurons were large in diameter, densely staining for 
nissl stains, with the nucleolus clearly defined (A, B). A range o f morphological changes 
existed in head-injured patients, including partial (C, D) or total infarction o f the nbM 
nucleus (E, F). Ischaemic neurons were eosinophilic (arrows) and no longer positive for 
cresyl violet, but were luxophilic (arrowheads). Magnification X400.
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neurons (Figure 36). Evidence o f mechanical distortion resulting from compression o f 
brain tissue and development o f ‘plastic creep’ (Langfitt et al., 1964) o f neurons was 
also observed, with neurons being transformed from a round to an elongated structure.
Normal Infarcted
T
Figure 36
Photomicrograph of LFB/CV staining at the border o f a normal portion o f the nbM and a 
zone o f localised infarction. Normal Ch4 neurons were generally positive for cresyl violet 
with the nucleolus clearly defined. Within the infarcted zone, Ch4 neurons were irregular 
and luxophilic, with the nucleolus and nuclear membrane less distinct. The dotted line 
represents the border between normal and infarcted nbM territory. Magnification X200.
Damage to the Ch4 neurons o f the nbM was semi-quantitatively assessed by 2 
investigators, both blind to the identity o f the cases. None o f the control cases examined 
had any evidence o f Ch4 neuronal damage, all being attributed a score o f 0 (Table 7). 
The scores given for head-injured patients ranged from 0 through to 4, with 8 o f the 12 
head-injured patients having evidence o f neuronal damage in the nbM There was no 
association between survival time after death and postmortem delay and neuronal 
damage in the nbM o f head-injured patients (Figure 37).
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Table 7: Neuronal damage in the human nbM after head injury
Neuronal damage 
score
Controls
(n=4)
Head-Injured 
(n= 12)
0 4 4
1 0 <3
2 0 1
3 0 2
4 0 2
w. *'»
Number of controls and head-injured patients exhibiting neuronal damage 
scores of 0-4. None of the controls had evidence of Ch4 neuronal damage 
in the nbM. Two-thirds of head-injured patients examined had evidence of 
neuronal damage in the nbM.
93
A
4001
300-
ed
>
t3GO
200-
100“
0
cd
13*3
60)t;o
cn O 
P - t
B
150
100
50
1
Neuronal damage score
1 2 3
Neuronal damage score
Figure 37
Plot of neuronal damage score in the nbM of head-injured patients and survival (A) or 
postmortem delay (B). Individual data points correspond to scores attributed to individual 
head-injured patients. No relationship existed between neuronal damage in the nbM and 
either of these parameters in head-injured patients.
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3.2.2 Correlations between Ch4 neuronal damage and ChAT activity and levels of 
presynaptic proteins
To determine if damage to Ch4 neurons of the nbM was associated with ChAT 
activity/immunostaining and presynaptic protein levels in the cortex a number of 
correlations were performed. ChAT activity in the cingulate gyrus, superior parietal 
cortex and inferior temporal gyrus for the same head-injured cases and neuronal damage 
to Ch4 neurons of the nbM were related in that head-injured patients with extensive 
neuronal damage in the nbM tended to have low levels of ChAT activity, whereas those 
with no or minimal neuronal damage in the nbM had higher levels of ChAT activity 
(Figure 38). Association of Ch4 neuronal damage in the nbM did not correlate with the 
levels of the presynaptic proteins synaptophysin, SNAP-25, syntaxin and synaptotagmin 
in the cingulate gyrus (Figure 39) and the superior parietal cortex (Figure 40).
3.2.3 ChAT Immunostaining
ChAT immunostaining in controls was prominent in large, circular Ch4 neurons, and in 
dendritic processes. Immunostaining was absent from the nuclear membrane and 
nucleolus of controls. In contrast, in head-injured patients ChAT immunostaining was 
present in shrunken neurons with the nucleolus intensely positive for ChAT (Figure 41). 
The overall intensity of ChAT immunostaining was reduced in the head-injured patients 
compared to controls (Figure 41). Localisation of ChAT to shrunken neurons and a 
reduction in the intensity of staining both imply that the neuronal damage in the human 
nbM after head injury is to the cholinergic cells.
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Figure 38
Relationship between neuronal damage in the nbM and ChAT activity (from Murdoch et
al., 1998) in the cingulate gyrus (A), superior parietal cortex (B) and inferior temporal
gyrus (C) of head-injured patients. Individual data points correspond with individual
head-injured cases. In each cortical region, head-injured patients with extensive neuronal
damage in the nbM had low levels of ChAT activity, whilst patients with no or minimal
neuronal damage in the nbM had higher levels of cortical ChAT activity.
96
A0.75i
•55 0.50jG a>T3
o
'+3cxo
0.25H
0
C
0.3i
&  0 . 2 -ooC<U
T3
73o•-P
Clo
o . l -
0J
Synaptophysin
1 2  3 4
Neuronal damage score
Syntaxin
0 1 2  3 4
Neuronal damage score
B
0 .2 -i
C/5
-I o.H
73 o ’P 
CX
O
D
0.5l
£
•S 0 ^
73 o 
P  cx O
0J
SNAP-25
1 2  3 4
Neuronal damage score
Synaptotagmin
•  •
1 2  3 4
Neuronal damage score
Figure 39
Relationship between neuronal damage in the nbM and the levels of synaptophysin (A), 
SNAP-25 (B), Syntaxin (C) and Synaptotagmin (D) immunoreactivities in the cingulate 
gyrus of head-injured patients. Individual data points correspond with individual head- 
injured cases. No association existed between the extent of neuronal damage in the nbM 
and the levels of immunoreactivity for each of these presynaptic proteins in the cingulate 
gyrus of head-injured patients.
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Relationship between neuronal damage in the nbM and the levels of synaptophysin (A), 
SNAP-25 (B), Syntaxin (C) and Synaptotagmin (D) immunoreactivities in the superior 
parietal cortex of head-injured patients. Individual data points correspond with individual 
head-injured cases. No association existed between the extent of neuronal damage in the 
nbM and the levels of immunoreactivity for each of these presynaptic proteins in the 
superior parietal cortex of head-injured patients.
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Figure 41
Photomicrographs o f choline acetyltransferase immunostaining in Ch4 neurons o f the nbM 
in a control (A) and a head-injured patient (B). In the control case, ChAT immunostaining 
was intense in perikaya and dendritic processes (arrows) o f large, circular Ch4 neurons
(A). In the head-injured case, intense ChAT immunostaining was present in the nucleolus 
o f shrunken, irregular nbM neurons (arrowheads) (B). No ChAT immunostaining was 
detected in the negative control (no primary antibody) (C). Magnification X400.
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3.3 Presynaptic pathology in animal models of brain injury
The pathophysiology o f  human head injury is extremely complex involving a wide 
variety o f different mechanisms. Ischaemic damage is one o f the most common 
neuropathological features after head injury (Graham et al., 1978). In order to determine 
if  ischaemia per se, in the absence o f other pathologies, affected presynaptic proteins, 
the proteins examined in human material were studied in a number o f animal models o f 
cerebral ischaemia. Techniques used were Western blotting and immunohistochemistry 
followed by densitometric analysis.
3.3.1 Permanent middle cerebral artery occlusion in the rat: Intraluminal thread 
model
Occlusion o f the MCA by insertion o f an intraluminal thread for 24h produced an area 
o f ischaemia damage easily delineated using H&E staining (Figure 42). The area o f in 
the ipsilateral hemisphere corresponds to those brain regions supplied by the MCA. In 
the ipsilateral hemisphere, the cingulate gyrus was unaffected with staining comparable 
to the contralateral hemisphere
Intraluminal Thread Model 
Cingulate
Contra
Figure 42
Representative H&E stained coronal section at the level of the caudate nucleus after 24h 
permanent MCAo using the intraluminal thread model. The dotted line delineates the area 
of palor corresponding to the zone of ischaemic brain damage as a consequence of 
compromised blood flow. Note the H&E staining of the ipsilateral cingulate cortex is 
normal (arrow) and a zone o f tissue degradation exists as a consequence of severe 
ischaemic damage. Brain tissue was dissected from the ipsilateral cortex (area of palor) 
and the corresponding contralateral cortex. The cingulate cortex was dissected from both 
cerebral hemispheres.
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Western blotting of homogenates from the cingulate gyrus and the MCA territory from 
the contralateral and ipsilateral hemisphere was performed for synaptophysin, syntaxin 
and SNAP-25 immunoreactivity (Figure 43). For each of these presynaptic proteins, the 
level of immunoreactivity in the MCA territory and cingulate gyrus were no different in 
the ipsilateral hemisphere compared with the contralateral. This suggests that 
presynaptic proteins are not degraded after 24h permanent MCAo using the intraluminal 
thread model.
T
3.3.2 Permanent middle cerebral artery occlusion in the rat: Diathermy model
24h after permanent MCAo, the brains were removed, fixed and processed for 
immunohistochemistry. Sections were immunostained for the presynaptic proteins 
synaptophysin, SNAP-25 and syntaxin. In the contralateral cortex, immunostaining for 
each of these proteins was diffuse and restricted to the neuropil. Neuronal perikarya 
were counterstained with haematoxylin and none of the presynaptic protein 
immunostaining was localised to the large, circular cell bodies. (Figure 44). In the 
ipsilateral cortex neuronal perikarya were shrunken and triangular with vacuolation of 
the neuropil. The pattern of immunohistochemical staining in the ipsilateral cortex was 
different to the contralateral cortex for each of the presynaptic proteins. SNAP-25 and 
syntaxin immunoreactivity appeared to be reduced, although this could not be quantified 
due to severe oedema of the tissue (Figure 44). In the contralateral caudate, 
synaptophysin and syntaxin immunoreactivity were restricted to the neuropil, being 
completely absent from axon fibre tracts and healthy neuronal perikarya (Figure 45). 
SNAP-25 immunostaining was present in both the neuropil and the axonal tracts, but 
not the neuronal perikarya in the contralateral caudate. In the ipsilateral hemisphere, 
widespread neuronal damage existed after 24h permanent MCAo. Synaptophysin 
immunostaining was similar to the contralateral caudate, however, SNAP-25 and to a 
lesser extent syntaxin immunoreactivity had accumulated as intensely staining globules 
in the axon fibre tracts (Figure 45). A diffuse pattern of immunostaining for each of the 
presynaptic proteins was preserved in the neuropil.
3.3.3 Transient bilateral common carotid artery occlusion (BCCAo) in the mouse.
Presynaptic proteins were not altered in brain tissue which had been rendered 
permanently ischaemic. In head-injured patients there may be transient periods of 
ischaemia followed by reperfusion of the tissue. These events can be modeled in
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Figure 43
Quantitative data for Western blots of the presynaptic proteins synaptophysin (A), 
syntaxin (B) and SNAP-25 (C) in cingulate (Cing) cortex (circles) and middle cerebral 
artery (MCA) territory (squares) after 24h permanent MCAo using the intraluminal 
thread model in the rat (n=4). Open (contralateral) and closed (ipsilateral) shapes show 
optical densities for the presynaptic proteins in the contralateral and ipsilateral 
hemispheres respectively.
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Figure 44
Photomicrographs o f synaptophysin (A, B), SNAP-25 (C, D) and syntaxin (E, F) 
immunostaining in the contralateral (A, C, E) and ipsilateral cortex (B, D, F) after 24h 
permanent MCAo in the rat. Immunostaining for each o f the presynaptic proteins was 
restricted to and diffuse in the cortical neuropil in the contralateral hemisphere. After 
MCAo, extensive neuronal loss existed in the ipsilateral cortex and tissue damage as a 
consequence o f  oedema was observed. Immunostaining for the presynaptic proteins was 
present but difficult to quantify due to tissue damage induced by oedema.
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Figure 45
Representative photomicrographs o f synaptophysin (A, B), SNAP-25 (C, D) and syntaxin 
(E, F) immunostaining in the contralateral (A, C, E) and ipsilateral caudate (B, D, F) after 
24h permanent MCAo in the rat. Immunostaining for each o f the presynaptic proteins was 
diffuse in the neuropil in the contralateral hemisphere. Subtle SNAP-25 immunoreactivity 
was also localised in axon fibre tracts in the contralateral hemisphere. Widespread 
neuronal loss existed after MCAo, but immunostaining for the presynaptic proteins 
persisted. Accumulation o f SNAP-25 and syntaxin immunoreactivities were observed in 
the fibre tracts in the ipsilateral caudate (arrows).
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rodents: to obtain an understanding of the timescale of possible presynaptic changes 
after transient ischaemia a time-course study was performed in mice. Animals were 
allowed to survive 1, 3 or 10 days after 17min of transient bilateral common carotid 
artery occlusion. Shams had an identical surgical procedure with the exception of 
applying the clips to the carotid arteries. After the appropriate survival period animals 
were fixed and the brains processed for histology and immunohistochemistry. 
Histological and immunohistochemical assessments were performed at the level of the 
caudate and the dorsal hippocampus, regions where ischaemic damage to neuronal 
perikarya is well charcterised in this animal model.
Caudate. Histology and Immunohistochemistry
Neuronal damage was semi-quantitatively assessed in the caudate using H&E stained 
sections. In shams, neuronal perikarya were large and circular, intensely staining for 
haematoxylin and negative for eosin. The neuropil and axon fibre tracts were stained 
with eosin. (Figure 46). One day after BCCAo, neuronal perikarya were no longer 
circular, but shrunken and triangular with an intensely eosinophilic neuronal cytoplasm 
(Figure 46). At 3 and 10 days after BCCAo there was widespread neuronal loss and 
vacuolation of the neuropil. Immunohistochemistry for synaptophysin in the caudate of 
shams was restricted to the neuropil and absent from haematoxylin counterstained round 
neuronal perikarya. From 1 through to 10 days after BCCAo, extensive neuronal loss 
was evident with preservation of synaptophysin immunostaining in the neuropil (Figure 
47). Similarly, SNAP-25 immunostaining was present in the neuropil of shams and was 
preserved 1, 3 and 10 days after BCCAo in the caudate. (Figure 48). The relative optical 
density of the immunostaining for both synaptophysin and SNAP-25 in the neuropil was 
quantified for shams, 1, 3 and 10 days survival after BCCAo. No difference in the level 
of immunostaining for either synaptophysin and SNAP-25 were detected over the time- 
course examined (Figure 49).
Hippocampus: Histology
The extent of neuronal damage was semi-quantitatively assessed in the CA1, CA2, 
CA3, hilus and the dentate gyrus of shams and animals allowed to survive 1, 3 and 10 
days after BCCAo. Minimal/no neuronal damage was detected in any of the 
hippocampal layers of sham animals. At each of the survival timepoints, maximal 
neuronal damage was in the CA2 and CA1 sectors with minimal neuronal loss in the
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Figure 46
Photomicrographs o f histological assessment o f neuronal damage in the caudate o f sham 
animals (A), and lday (B), 3 days (C) and 10 days (D) after BCCAo in the mouse. In 
Sham animals neurons are large and circular, and positive for haematoxylin. 1 day after 
global ischaemia, cell bodies are shrunken and the neuronal cytoplasm eosinophilic (arrow) 
(B). Widespread neuronal loss existed at both 3 days (C) and 10 days after global 
ischaemia. Magnification X400.
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Figure 47
Photomicrographs o f synaptophysin immunostaining in the caudate o f sham animals (A) 
and Iday (B), 3 days (C) and 10 days (D) after BCCAo in the mouse. Neuronal loss in the 
caudate was observed from lday after global ischaemia (A). Synaptophysin 
immunostaining in the neuropil persisted up to 10 days after global ischaemia in the 
mouse. Magnification X400.
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Figure 48
SNAP-25 immunostaining in the caudate o f sham animals (A) and lday (B), 3 days (C) 
and 10 days (D) after BCCAo in the mouse. Neuronal damage in the caudate was 
observed from lday after global ischaemia (A). SNAP-25 immunostaining in the neuropil 
persisted at 1 ,3 , and 10 days after global ischaemia in the mouse. Magnification X400.
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Figure 49
Relative optical densities of synaptophysin (A) and SNAP-25 (B) immunoreactivities in 
the caudate of sham animals (open circles) and mice allowed to survive 1, 3 and 10 days 
after BCCAo (closed shapes). The levels of immunostaining for both synaptophysin and 
SNAP-25 were no different between shams and animals allowed to survive either 
timepoint after surgery.
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CA3 region (Figure 50). Haematoxylin and eosin staining of the CA2 region of the 
hippocampus demonstrated large, circular neurons in sham animals. CA2 neurons in the 
hippocampus of animals allowed to survive 1 and 3 days after BCCAo were shrunken 
and irregular with an eosinophilic neuronal cytoplasm (Figure 51). After 10 days 
survival, eosinophilic neuronal cytoplasms were still visible amidst a necrotic CA2 
layer. The CA1 pyramidal neurons in sham animals were large and regular, being 
positive for haematoxylin. In animals allowed to survive 1 and 3 days after BCCAo, a 
portion of the CA1 neurons were triangular and shrunken, with an intensely eosinophilic 
neuronal cytoplasm (Figure 52). The pattern of CA1 H&E staining at 10 days after 
BCCAo was similar to that observed in the CA2 10 days after BCCAo (Figure 51).
Hippocampus: Immunohistochemistry
To address the level of presynaptic protein immunostaining in the hippocampus at each 
timepoint after BCCAo, the relative optical density of presynaptic staining was 
determined in regions of the hippocampus adjacent to neuronal layers in both 
hemispheres: the stratum oriens and stratum lacunosum of the CA1, the presynaptic 
innervation of the CA3, and the outer, middle and inner molecular layers of the dentate 
gyrus. Levels of synaptophysin immunoreactivity were broadly similar between 
hemispheres and periods of survival after BCCAo in all six of the hippocampal layers 
measured, indicating that synaptophysin immunostaining is preserved up to 10 days in 
the caudate (Figure 47) and in the hippocampus (Figure 53, 54) after global ischaemia. 
SNAP-25 immunoreactivity was similar between hemispheres and there was a trend 
towards a reduction in the relative optical density of SNAP-25 immunostaining in all 
hippocampal layers from 1 through to 10 days survival compared with sham animals 
(Figure 55, 56). Levels of relative optical density of syntaxin immunostaining was 
similar in the stratum oriens, stratum lacunosum and the CA3 sector of the hippocampus 
(Figure 57). In each of the molecular layers of the dentate gyrus there was a trend 
towards a reduction in syntaxin immunostaining from 1 through to 10 days survival 
after BCCAo compared to sham animals (Figure 58).
Cortex. Immunohistochemistry
In the cortex of sham animals, synaptophysin immunostaining was diffuse in the 
neuropil and absent from neuronal perikarya. At 1, 3 and 10 days after BCCAo, 
widespread neuronal loss exists although synaptophysin immunostaining was preserved
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Figure 50
Semi-quantitative assessment of neuronal damage in anatomical layers of the 
hippocampus of sham animals (n=4) (A) and mice allowed to survive 1 (n=3) (B), 3 
(n=4) (C) or 10 days (n=l) (D) after BCCAo. Data is shown for both the left (open 
shapes) and right hemisphere (closed shapes) and represents individual animal scores. 
No or minimal neuronal damage existed in any of the hippocampal layers in sham 
animals. CA2 and CA1 layers were most vulnerable to ischaemic damage at each 
timepoint.
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Figure 51
Photomicrographs o f histological assessment o f neuronal damage in the CA2 sector o f the 
hippocampus o f sham animals (A), and lday (B), 3 days (C) and 10 days (D) after 
BCCAo in the mouse. In sham animals, CA2 neurons were large and regular, with Nissl 
substances visible (A). At lday and again at 3 days after global ischaemia, a portion o f the 
CA2 neuronal perikarya was shrunken with an intensely eosinophilic cytoplasm (arrows) 
(B, C). The majority o f neurons in the CA2 sector o f  the hippocampus were shrunken 10 
days after global ischaemia (D). Magnification X400.
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Figure 52
Photomicrographs o f histological assessment o f neuronal damage in the CA1 sector o f  the 
hippocampus o f sham animals (A), and lday (B), 3 days (C) and 10 days (D) after 
BCCAo in the mouse. At 1 and 3 days after global ischaemia, a proportion o f CA1 
neurons possessed shrunken cell bodies and eosinophilic neuronal cytoplasms (arrows) (B, 
C). Complete destruction o f CA1 neurons and disruption the overall tissue structure was 
evident 10 days after global ischaemia. Magnification X400.
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Figure 53
Relative optical density of synaptophysin immunoreactivity in the stratum oriens (A), 
stratum lacunosum (B) and CA3 (C) of sham animals (n=6) and mice allowed to survive 
1 (n=3), 3 (n=4) or 10 days (n=l) after BCCAo. Data is shown for both the left (open 
circles) and right hemisphere (closed circles). Bars represent the group means.
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Figure 54
Relative optical density of synaptophysin immunoreactivity in the outer (A), middle (B) 
and inner molecular layer (C) of sham animals (n=6) and mice allowed to survive 1 
(n=3), 3 (n=4) or 10 days (n=l) after BCCAo. Data is shown for both the left (open 
circles) and right hemisphere (closed circles). Bars represent the group means.
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Figure 55
Relative optical density of SNAP-25 immunoreactivity in the stratum oriens (A), stratum 
lacunosum (B) and CA3 (C) of sham animals (n=6) and mice allowed to survive 1 (n^3), 
3 (n=4) or 10 days (n=l) after BCCAo. Data is shown for both the left (open circles) and 
right hemisphere (closed circles). Bars represent the group means.
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Figure 56
Relative optical density of SNAP-25 immunoreactivity in the outer (A), middle (B) and 
inner molecular layer (C) of sham animals (n=6) and mice allowed to survive 1 (n=3), 3 
(n=4) or 10 days (n=l) afler BCCAo. Data is shown for both the left (open circles) and 
right hemisphere (closed circles). Bars represent the group means.
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Figure 57
Relative optical density of syntaxin immunoreactivity in the stratum oriens (A), stratum 
lacunosum (B) and CA3 (C) of sham animals (n=6) and mice allowed to survive 1 (n=3), 
3 (n=4) or 10 days (n=l) after BCCAo. Data is shown for both the left (open circles) and 
right hemisphere (closed circles). Bars represent the group means.
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Figure 58
Relative optical density of syntaxin immunoreactivity in the outer (A), middle (B) and 
inner molecular layer (C) of sham animals (n=6) and mice allowed to survive 1 (n=3), 3 
(n=4) or 10 days (=1) after BCCAo. Data is shown for both the left (open circles) and 
right hemisphere (closed circles). Bars represent the group means.
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in the neuropil (Figure 59). Similarly, an identical pattern of neuronal loss but 
preservation of neuropil immunostaining was observed with SNAP-25 (Figure 60). 
These data imply that although there might be subtle changes in the level of these 
presynaptic proteins in specific brain regions, these alterations are small and presynaptic 
proteins are preserved in a number of animal models of acute brain injury.
3.3.4 MAP-2 immunostaining after transient bilateral common carotid artery in 
the mouse
To compare the sensitivity of presynaptic proteins with that of postsynaptic markers, 
MAP-2 immunostaining was performed in sections of the caudate and hippocampus 
after BCCAo in the mouse. In sham animals, MAr-2 immunostaining was diffuse 
labeling dendritic processes in both the caudate and hippocampus. At 3 and 10 days 
after BCCAo, low power pictures demonstrated a loss of MAP-2 in the caudate and in 
the CA2 and CA1 sectors of the hippocampus (Figure 61). High power magnification of 
MAP-2 immunostaining in the CA1 shows labeling of dendritic processes and around 
pyramidal neuron cell bodies. In contrast, after BCCAo MAP-2 immunostaining was 
absent from dendritic processes and shrunken CA1 neurons, with residual MAP-2 
immunostaining associated with a few remaining morphologically normal neurons 
(Figure 62). Likewise, in the caudate of sham animals MAP-2 immunostaining was 
diffuse in the neuropil, but r.ot accumulated around cell bodies. One day after BCCAo, 
MAP-2 immunostaining accumulated around a few cell bodies but was reduced in the 
neuropil. By 3 days, widespread depletion of MAP-2 in the caudate was observed 
(Figure 63). In the cortex of sham animals, MAP-2 immunostaining was present in 
parallel strands of dendritic process but absent from cell bodies. One day after BCCAo, 
MAP-2 immunostaining was redistributed from dendritic processes and accumulated 
around neuronal perikarya. At 3 days after BCCAo, MAP-2 immunostaining was 
reduced from the neuropil and dendritic processes, but remained around cell bodies 
(Figure 64). In each of the anatomical brain regions examined, MAP-2 
immunoreactivity was disrupted at the early survival times after BCCAo. In contrast, 
immunostaining for each of the presynaptic proteins was preserved in all of the brain 
regions assessed up to 10 days after BCCAo. These morphological findings suggest that 
the major pathological changes following brain injury are postsynaptic.
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Figure 59
Representative photomicrographs o f synaptophysin immunostaining in the cortex o f sham 
animals (A) and 1 day (B), 3 days (C) and 10 days (D) after BCCAo in the mouse. Despite 
neuronal damage in the cortex 1 day after global ischaemia (B), synaptophysin 
immunoreactivity persisted in the cortex at 3 and 10 days after global ischaemia in the 
mouse. Magnification X400.
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Figure 60
Photomicrographs o f  SNAP-25 immunostaining in the cortex o f sham animals (A) and 
lday (B), 3 days (C) and 10 days (D) after BCCAo in the mouse. Despite extensive 
neuronal damage in the cortex lday after global ischaemia (B), SNAP-25 
immunoreactivity persisted in the cortex at 1, 3 and 10 days after global ischaemia in the 
mouse. Magnification X400.
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Figure 61
Photomicrograph o f loss o f MAP-2 immunostaining in coronal sections o f the caudate (A, 
C, E) and hippocampus (B, D, F) in shams (A, B) and lday (C, D) and 3days (E, F) after 
BCCAo in the mouse. Widespread loss o f MAP-2 immunostaining was evident in the 
caudate at both 3 and 10 days after global ischaemia. Disappearance o f  MAP-2 
immunostaining was restricted to the CA2 sector (arrows) o f the hippocampus at 3 days 
after global ischaemia, and absent from the CA2 (arrows) and CA1 (arrowheads) neuronal 
layers o f the hippocampus 10 days after global ischaemia. Magnification X400.
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Figure 62
Photomicrograph showing MAP-2 immunostaining in the CA1 sector o f the hippocampus 
in sham animals (A) and lday after BCCAo in the mouse (B). In shams intense MAP-2 
immunostaining was localised to dendrites and around the neuronal cell bodies. 
Widespread loss o f dendritic and neuronal staining was evident at 1 day after global 
ischaemia, although preservation o f MAP-2 immunostaining was restricted to a few 
morphologically normal CA1 neurons (arrows). Magnification X400.
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Figure 63
Photomicrographs o f  MAP-2 immunostaining in the caudate in sham animals (A) and lday
(B) and 3days (C) after BCCAo in the mouse. The diffuse pattern o f MAP-2 
immunostaining in the caudate o f shams was replaced by a gradual (B) and almost 
complete loss o f  MAP-2 immunostaining (C) lday and 3days after global ischaemia in the 
mouse. Magnification X400.
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Figure 64
Photomicrographs o f disrupted MAP-2 immunostaining in the cortex in sham animals (A) 
and lday (B) and 3 days (C) after BCCAo in the mouse. An even pattern o f dendritic 
staining in the shams (arrows) was replaced by redistribution and accumulation o f MAP-2 
immunostaining around neurons (arrowheads) and loss o f dendritic MAP-2 
immunostaining lday and 3days after global ischaemia. Magnification X400.
126
3.4 GGF-2 after acute brain injury
A number o f growth factor systems have been proposed to influence outcome after 
ischaemic and traumatic brain injury. One growth factor signaling system receiving 
recent attention is that involving the neuregulins. The neuregulins have multiple actions 
in the nervous system, including cell survival, proliferation and differentiation. 
(Carraway and Burden, 1995). The neuregulin, GGF-2 is involved in a spectrum o f 
neurobiological processes (Marchionni et al., 1997). The aim o f the study was to 
elucidate if GGF-2 exists in adult human postmortem brain and to determine both the 
level and distribution o f GGF-2 in the cerebral cortex by Western blotting and 
immunohistochemistry o f patients who had sustained a fatal head injury. The level o f 
GGF-2 was also investigated by W estern blotting in homogenates o f brain tissue from 
animal models o f acute brain injury.
3.4.1 GGF-2 and human head injury
Five primary antibodies to GGF-2 (51210, 13366, 19937, CN16 and 51211), each 
directed against a distinct epitope on the protein detected a single band on the 
immunoblot for both the control and head-injured patient. (Figure 65). The band 
detected by each antibody ran at the predicted molecular weight o f 55kDa, and this 
pattern was repeated using an additional 2 controls and 2 head-injured patients in an 
identical experimental design
GGF-2
13366 19937 CN16
55kDa
Figure 65
Western blots showing GGF-2 immunoreactivity in homogenates from a control (C) and 
a head-injured (H) case (A). The immmunoreactive bands detected by 5 primary 
antibodies to GGF-2 are shown. Similar protein bands were detected using additional 
controls (n=3) and head-injured cases (n=3) examined with the panel of 5 primary 
antibodies. 127
In the cingulate gyrus, the levels of GGF-2 immunoreactivity detected with CN16 were 
significantly increased in the head-injured group compared to controls (*p<0.05), 
equivalent to a 60% increase in the head-injured group over controls (Figure 66). There 
was considerable heterogeneity in the level of GGF-2 immunoreactivity in the cingulate 
gyrus of head-injured patients, with 9 out of the 16 head-injured patients having a GGF- 
2 immunoreactivity higher than the maximum value in the control group. 
Immunohistochemical staining using CN16 revealed minimal labeling of GGF-2 in the 
neuronal perikarya and neuropil in the cingulate gyrus of controls. In sections from this 
brain area in the head-injured patients, increased GGF-2 immunostaining was observed 
(Figure 67). Staining was localised to the neuronal cytoplasm of shrunken perikarya. 
GGF-2 immunostaining was also prominent in glia of head-injured patients.
In the superior parietal cortex there was no difference in the level of GGF-2 in head- 
injured patients compared with controls (Figure 68). There was no association between 
the level of GGF-2 immunoreactivity in the cingulate gyrus of the superior parietal 
cortex of head-injured patients (Figure 69). The heterogeneity in the GGF-2 response 
was not associated with the presence or absence of ischaemic brain damage in either the 
cingulate gyrus or the superior parietal cortex (Figure 70). There was no correlation of 
GGF-2 immunoreactivity in the cingulate gyrus and neuropathological evidence of a 
SDH in head-injured compared with those head-injured patients with no SDH (Figure 
71). Association of GGF-2 immunoreactivity in head-injured patients with a left SDH 
with survival time after injury suggested that the GGF-2 response is maximal over the 
first 24 h after brain injury (acute), followed by a reduction to lower levels of GGF-2 
immunoreactivity over longer periods (chronic) of survival after head injury (Figure 
71).
3.4.2 GGF-2 immunoreactivity in white matter and Alzheimer’s disease
GGF-2 is known to not only to regulate glial cell survival, but has also been implicated 
in neuronal-glial interaction via an indirect trophic support loop. GGF-2 
immunoreactivity was no different in subcortical white matter from the corpus callosum 
of the same group of controls and head-injured patients (Figure 72). To further confirm 
that the increase in GGF-2 immunoreactivity detected is an acute pathophysiological 
response, the level of GGF-2 immunoreactivity was determined in the cingulate gyrus
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Figure 66
GGF-2 immunoreactivity in the cingulate gyrus is increased in head-injured patients 
compared to controls. A: Western blots showing the level o f CN16 immunoreactivity in 8 
controls (C) and 16 head-injured patients (H). A control and a head-injured case were 
loaded on both gels accounting for 26 bands detected. B: Optical density values of the 
55kDa band in immunoblot (A). The mean value o f GGF-2 immunoreactivity for the 
head-injured group was 60% higher than the mean o f the controls, with *p<0.05, by 
unpaired two-tailed Student’s t test.
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Figure 67
Representative GGF-2 immunostaining in the cingulate gyrus of controls (A) and head- 
injured patients (B). There was minimal GGF-2 immunostaining within the cytoplasm of 
neurons in controls (*) and faint GGF-2 immunostaining was present in the neuropil.
In head-injured cases, GGF-2 immunoreactivity accumulated in the neuronal cytoplasm 
o f shrunken neuronal cell bodies (arrows) and was prominent in glia (arrowheads). 
Magnification X400.
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Figure 68
GGF-2 immunoreactivity in the superior parietal cortex o f controls and head-injured 
patients. A: Western blots showing the level o f CN16 immunoreactivity in 8 controls (C) 
and 16 head-injured patients (H). B: Optical density values o f the GGF-2 immunoreactive 
bands in (A). No statistically significant difference existed in the level of GGF-2 
immunoreactivity between head-injured patients and controls.
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Figure 69
Relationship between the optical density of GGF-2 immunoreactivity in the cingulate 
gyrus (A) and the superior parietal cortex (B) and the survival time prior to death of head- 
injured patients. Individual data points represent individual head-injured patients.
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Figure 70
Relationship between GGF-2 immunoreactivity in the cingulate gyrus (A) and the 
superior parietal cortex (B) and the presence (open circles) or absence (closed circles) of 
ischaemic brain damage histologically assessed in blocks adjacent to those used for 
Western blotting. The bars represent the group means.
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Figure 71
A: Relationship between GGF-2 immunoreactivity in the cingulate gyrus and 
neuropathological identification of a left (LSDH) or right/bilateral (R/bi SDH), or no 
subdural haematoma (no SDH). Bars represent the group means. B: Relationship 
between GGF-2 immunoreactivity in the cingulate gyrus of head-injured patients with a 
left subdural haematoma and survival time after injuiy prior to death.
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Figure 72
Quantitative data for GGF-2 immunoreactivity detected in the subcortical white matter of 
the corpus callosum in controls (open circles) and head-injured patients (closed circles). 
Bars represent the group means. Unpaired two-tailed Student’s 1 test revealed there was 
no difference in the level of GGF-2 immunoreactivity between groups.
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from a small cohort of Alzheimer’s disease patients and age-matched controls (Figure 
73). No difference in the level of GGF-2 immunoreactivity existed between groups.
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Figure 73
Quantitative data for GGF-2 immunoreactivity in homogenates from the cingulate gyrus 
of controls (open circles) and Alzheimer’s disease patients (closed circles). There was no 
difference in the level of GGF-2 immunoreactivity in Alzheimer’s disease patients 
compared with aged-matched controls.
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3.4.3 GGF-2 in animal models of acute brain injury
Ischaemic brain damage and presence of a subdural haematoma are common 
neuropathological findings after head injury. To determine whether these components of 
brain damage contribute to the elevated levels of GGF-2, these features were examined 
in animal models of acute brain injury. After 24h permanent MCAo in the rat, the 
55kDa band of GGF-2 immunoreactivity accumulated primarily in the ipsilateral 
caudate. In comparison, in both sham animals and the contralateral hemisphere of 
experimental animals a low level the 55kDa band of GGF-2 immunoreactivity was 
detected (Figure 74). The level of GGF-2 was determined in the cortex underlying a 
SDH 4h after surgery in the rat. In Western blots of rat brain homogenates, two bands of 
GGF-2 immunoreactivity were detected: an 80kDa band and the previously observed 
55kDa band. In a Western blot, the 80 kDa band was predominantly present in sham 
animals, but after SDH it was reduced and replaced by an accumulation of the 55kDa 
band in the cortex both ipsilateral and contralateral to the SDH (Figure 75).
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Figure 74
GGF-2 immunoreactivity in brain homogenates after 24h permanent MCAo in the rat. A: 
Representative Western blot o f GGF-2 immunoreactivity in the contralateral (contra) and 
ipsilateral (ipsi) cortex and caudate and 24h after MCAo in the rat (n=2). B: Quantitative 
data for GGF-2 immunoreactivity detected by Western blotting. Immunoreactivity for the 
55kDa band was increased in the ipsilateral and caudate after MCAo compared with the 
contralateral hemisphere.
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Figure 75
GGF-2 immunoreactivity in cortical homogenates 4h after subdural haematoma (SDH) in 
the rat. A: Representative Western blot showing detection o f a 80kDa and 55kDa bands 
o f GGF-2 immunoreactivity in the ipsilateral (ip) and contralateral (con) cortex in sham 
animals and after 4h SDH. B: Quantitative data for GGF-2 immunoreactivity detected in 
W estern blots. GGF-2 immunoreactivity o f the 55kDa band was significantly increased, 
*p<0.05, in both the ipsilateral and contralateral cortex after SDH (filled bars) compared 
to SHAM animals (open bars). The 80kDa band o f GGF-2 immunoreactivity was 
significantly reduced, *p<0.05, in the ipsilateral cortex after subdural haematoma 
compared to sham animals.
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CHAPTER 4: DISCUSSION
4.1 Human Postmortem Studies
4.1.1 Nicotinic receptor binding
Mnemonic and cognitive deficits existing after head injury are attributable to deficits in 
the central cholinergic system, on the basis of TBI in experimental animals (Leonard et 
al., 1994) and improvement with cholinomimetic therapeutic strategies in both rodents 
(Pike et al., 1997; Chen et al., 1998a, 1998b) and man (Levin et al., 1986; Cardenas et 
al., 1994). Abnormalities of cholinergic neurotransmission in human head injury could 
occur either by changes in receptors or a loss of presynaptic inputs. The aim of this initial 
study was to determine the integrity of high affinity nAChRs after human head injury.
The status of brain nAChRs after head injury is related to the question of potential 
cholinergic therapy. A proportion of high affinity nAChRs are postulated to have a 
presynaptic distribution (Abdulla et al., 1995) and function to modulate synaptic 
transmission (for review see Langer, 1997). Using brain homogenates, the density of 
high affinity nAChRs was found to be unaltered in each of the cortical areas examined 
from head-injured patients compared with controls. In addition, autoradiographic 
analyses of [3H]-nicotine and [,25I]-bungarotoxin binding were no different in the 
cingulate gyrus from the same group of head-injured patients and controls (Murdoch et 
al., 1998). No relationship existed between age or postmortem delay and the density of 
cortical nicotine binding sites. The latter observation is not surprising given that previous 
studies in models of the human autopsy process, have indicated that the binding 
components of receptors arc relatively stable postmortem (Whitehouse et ai., 1984). 
[3H]-Nicotine, at the concentration used in the present study, predominantly binds to the 
high affinity (X4P2 nAChR, whereas [125I]-a-bungarotoxin binds to nAChRs containing 
the a l  subunit. The results therefore indicate that neither binding site is reduced in the 
cortex after head injury.
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The preservation of cortical nAChRs contrasts with the widespread deficits in cortical 
ChAT activity reported in head-injured patients (Dewar and Graham, 1996; Murdoch et 
al., 1998). Similarly, experimental brain injury in rats produced a time-dependent loss of 
both ChAT activity (Gorman et al, 1996) and ChAT immunohistochemical staining 
(Leonard et al, 1994; Sinson et al, 1995). Moreover, lesioning of the nbM using either 
high frequency electrical lesioning (Smith et al, 1989) or the cholinergic specific 
immunotoxin 192IgG-saporin (Bednar et al, 1998) produced no apparent changes in 
cortical nAChR density despite extensive reductions in ChAT activity. This implies that 
ChAT activity and nAChRs in the cortex are differentially affected in acute brain injury. 
This view is supported by Court and Perry, 1991, who speculated that even where 
nAChRs and ChAT share locations, it is unlikely that they will be modulated by the same 
control mechanisms. In addition to investigations of nAChRs, alterations in muscarinic 
cholinergic receptors have been assessed after experimentally-induced brain injury in 
animals. Selective labeling of Mi and M2 muscarinic receptor subtypes revealed a 
differential response, in that M2 sites were reduced at 24h but not 3h after injury, while 
Mi sites were unaltered at both timepoints compared to controls (DeAngelis et al,
1994). The M2 receptor subtype is believed to be expressed on presynaptic cholinergic 
neurons (Rouse et al, 1997). Controlled cortical impact injury in rats resulted in a loss of 
M2 receptors in the hippocampus 2-4weeks post-injury (Ciallella et al, 1998; Shao et al, 
1999). Likewise, Jiang and colleagues, 1994, reported alterations in muscarinic receptor 
binding sites in the neocortex 15 days after TBI. However, in human postmortem 
material neither Mi or M2 muscarinic receptor binding were altered in the temporal 
cortex of head-injured patients compared to controls (Dewar and Graham, 1996), 
indicating a difference between man and animals and a need for further characterisation 
of cholinergic receptor status after brain injury.
There is increasing appreciation that the postmortem pathological correlates of a head 
injury share some similarities with those of AD. In AD, loss of cortical ChAT activity is 
paralleled by an approximate 50% reduction in cortical (Whitehouse et al, 1986) and 
hippocampal nAChRs (Perry, 1986) compared with aged-matched controls. In contrast 
to the loss of nAChRs in AD, no or only modest changes in binding to muscarinic and a- 
bungarotoxin cholinergic receptors has been reported in the neocortex of AD patients
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(Davies and Feisullin, 1981; Sugaya et al., 1990; Nordberg, 1992). The preservation of 
nAChRs and a-bungarotoxin receptors after head injury, may reflect a consequence of 
the pathophysiological processes associated with acute brain injury rather than the 
chronic degeneration of AD in elderly patients.
Although use of tritiated agonists has the advantage of recognising only fully assembled 
receptors (Whiteaker et al., 1998), binding studies using homogenates do not distinguish 
between pre- and postsynaptic nAChRs (Miyai et al., 1990). The printipal receptor 
subunit combination that comprises the high affinity [3H]-nicotine binding site consists of 
the subunits ct4 and p2 (Whiting et al., 1991; Flores et al., 1992). Nicotine has 
approximately 50-fold higher affinity for the oup2 subtype found in the brain than non- 
a.4p2 subtypes found in the adrenal gland (Flores et al., 1997). The precise cellular 
location of the subunit comprised nAChRs in the neocortex is unclear. The parallel 
reduction in nicotine binding sites and ChAT activity in AD suggests that these receptors 
are presynaptic (Whitehouse et al., 1986). Nevertheless, the extent to which high affinity 
nAChRs reside presynaptically on cholinergic terminals remains controversial with the 
possibility that a major portion of nAChRs are located either postsynaptically or on non- 
cholinergic terminals (Wonnacott, 1997; Bednar et al., 1998). The initial conclusion that 
cholinergic presynaptic terminals are preserved after head injury, by way of measurement 
of high affinity nAChRs, might be incorrect given that this method may not solely detect 
presynaptic nAChRs, since high-affinity nAChRs may have been detected 
postsynaptically and/or non-cholinergic terminals in addition to presynaptic sites.
One environmental factor that may have confounded the nAChR data in the head-injured 
patients and controls is chronic nicotine intake via tobacco smoking. Administration of 
nicotine to rodents either in their drinking water or by direct infusion into the brain 
(Kellar et al., 1989; Marks et al., 1992; Collins et al., 1996) increased the binding of 
[3H]-nicotine by as much as threefold. More importantly, studies using human 
postmortem brain tissue demonstrated a significant increase in the density of [?H]- 
nicotine binding in cerebral cortex, hippocampus and midbrain obtained from cigarette 
smokers compared with that in non-smoking controls (Benwell et al., 1988; Perry et al., 
1996). Moreover, in the brains of mice subjected to chronic nicotine administration, the
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most significant increase in [3H]-nicotine binding was detected in the cortex (Pietela et 
al., 1998), and this increase was considered to be due mainly to an upregulation in cufo 
nAChR number (Peng et al., 1994b) but not affinity for the ligand. Details of smoking 
habits were not available for either the head-injured patients or controls in this study. 
However, if a significant number of the head-injured patients were heavy smokers, the 
concurrent upregulation of the (X4P2 subtype comprising nAChR would mask any change 
in [3H]-nicotine binding in this group compared with controls.
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4.1.2. Presynaptic pathology after head injury
Over recent years identification and biochemical characterisation of numerous synaptic 
vesicle and presynaptic plasma membrane proteins has provided fundamental insight into 
the molecular mechanisms underlying neurotransmitter release (for review see Bennett 
and Scheller, 1994). A plethora of protein interactions have been identified that could 
function in the different steps of neurotransmitter release (see Figure 6B). This 
potentially provides a number of potential protein interactions that could be interrupted 
or dysfunctional in acute brain injury. As understanding of the brain mechanisms of 
neurotransmitter release has advanced, attention has shifted to how these proteins are 
modified to produce changes in synaptic efficacy (Bajjalieh and Scheller, 1995).
Using a range of methods, a number of synaptic proteins have been routinely employed 
as reliable measures of synaptic density in human postmortem brain tissue (Hamos et al., 
1989; Alford et al., 1994; Akulinin et al., 1998). To obtain a better understanding of the 
individual molecular alterations in synapses after head injury, a number of distinct 
presynaptic proteins were examined in the cortex after head injury. Levels of 
synaptophysin, SNAP-25 and syntaxin, as detected by Western blotting analyses, were 
significantly reduced in the cingulate gyrus of head-injured patients compared with 
controls. Synaptophysin is the major integral membrane protein of synaptic vesicles, 
accounting for approximately 7% of total vesicle protein (Wiedenmann and Franke, 
1985), and is estimated to be present in more than 95% of cortical presynaptic terminals 
(Navone et al., 1986). This observation was supported by immunohistochemical staining 
of sections with an antibody to synaptophysin. Synaptophysin immunoreactivity was 
significantly reduced by 30% in head-injured patients compared with controls, consistent
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with a loss of cortical presynaptic terminals in the neuropil after head injury. This is in 
line with Akulinin and co-workers, 1998, who reported that synaptophysin 
immunoreactivity was reduced by 35% in the neocortex Iweek after cardiac arrest, 
presumably resulting in an episode/s of transient cerebral ischaemia comparable to head 
injury.
SNAP-25 and syntaxin are localised to the membrane of the presynaptic nerve terminal 
(Li et al., 1996) and share homology not only in their distribution but also their function 
as t-SNAREs (Bauerfiend et al., 1996). In addition to the plasmalemmal localisation, 
significant pools of both proteins are also present on the membrane of synaptic vesicles 
and other synaptic trafficking organelles (Walch-Solimena et al., 1995). These findings 
suggest proteins located on both the synaptic vesicle and the nerve terminal membranes 
are reduced after head injury, implying there is an overall loss of presynaptic terminals 
rather than site or protein-specific changes. The abundance of synaptophysin on synaptic 
vesicles and the localisation of SNAP-25 and syntaxin on multiple sites might contribute 
to their loss, whilst other piesynaptic marker proteins are preserved after head injury. 
Synaptophysin, SNAP-25 and syntaxin have a common link in that they are all believed 
to interact with the synaptic vesicle protein synaptobrevin (VAMP), see figure 6A 
(McMahon and Sudhof, 1995). Although the level of synaptobrevin was not examined in 
the present study, it seems possible that if synaptobrevin or its function is particularly 
susceptible to trauma, this would contribute to the loss of these particular presynaptic 
proteins after head injury.
Lipid modification, attachment of palmitic acid, is responsible for anchoring the 
intrinsically hydrophilic protein SNAP-25 to the nerve terminal membrane (Oyler et al.. 
1989; Hess et al., 1992). Free radical production is implicated in brain injury on the basis 
of a number of studies in experimental animals (Wems and Luccechi, 1990; Doppenberg 
et al., 1998). There is mounting evidence that oxygen radical-induced lipid peroxidation 
plays a pathological role in acute brain injury (Braughler and Hall, 1989; Siesjo et al., 
1989; Lewen and Hillered, 1998). SNAP-25 is known to be rapidly palmitoylated and 
depalmitoylated, a process which has a role in establishing, maintaining and strengthening 
synaptic connection (Lane and Yiu, 1997). Deregulation of this process as a consequence 
of head injury, could explain the loss of SNAP-25 immunoreactivity after head injury.
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Similarly, syntaxin present complexed to SNAP-25 would be lost as a result of this 
process.
The results obtained for Western blotting analysis of SNAP-25 were not supported by 
immunohistochemical staining of sections of cingulate gyrus for SNAP-25. This may be a 
reflection of the methodology used to quantify SNAP-25 immunoreactivity. Relative 
optical density measurements were calculated as the mean grey matter reading minus the 
mean white matter reading taken from the subcortical white matter 6f the corpus 
callosum. Thus a confounding factor may have been the presence of SNAP-25 
immunostaining in the white matter tracts of the corpus callosum. By contrast, minimal 
synaptophysin immunostaining was detected in the corpus callosum of either group. 
SNAP-25 is conveyed to the presynaptic terminals by fast anterograde axonal transport 
(Hess et al., 1992; Li et al., 1996). Relative optical density measurement in white matter 
potentially could have masked deficits in SNAP-25 immunoreactivity in grey matter from 
the cingulate gyrus of head-injured patients.
Although three of the synaptic proteins examined in the cingulate gyrus were 
significantly reduced after head injury, there were only modest changes in the levels of 
the synaptic vesicle proteins synaptotagmin and synapsin I, suggesting a differential 
involvement of synaptic proteins in head injury. Levels of synaptotagmin immuoreactivity 
were decreased by 18%, whereas synapsin la and lb immunoreactivities were increased 
by 12 and 20% respectively. This differential response may be a consequence of the 
properties of the presynaptic proteins. Synaptotagmin is the putative Ca2f sensor for 
neurotransmitter release (Littleton et al., 1994). Although levels of synaptotagmin have 
been reported to be reduced in AD (Davidsson and Blennow, 1998), there is no evidence 
of loss of synaptotagmin after acute brain injury. Synapsin I is the most abundant of all 
neuronal phosphoproteins (Thiel, 1993), and unlike the other presynaptic proteins is 
enriched on the cytoplasmic surface of synaptic vesicles (Huttner et al., 1983). In animal 
models of plasticity, phosphorylation-state specific alterations in synapsin I have been 
detected, without changes in the levels of total synapsin I (Yamagata et al., 1995). 
Specifically, reactivity at phospho-site 3 and to a lesser extent phospho-site 1 antibodies 
were increased in the hippocampus and neocortex of kindled animals (Yamagata et al.,
1995). The antibody used to detect synapsin I in the present study recognised all
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phosphorylation states of the protein, therefore we were unable to examine possible 
phosphorylation-state specific changes in synapsin I in the cortex after head injury.
Despite selective loss of several synaptic proteins in the cingulate gyrus, no significant 
reductions in any of the synaptic proteins was detected in the superior parietal cortex 
from the same group of head-injured patients and controls (see Table 6). Anatomical and 
inter-patient heterogeneity in the level of presynaptic proteins in the head-injured patients 
may be a reflection of the multiple types and severity of neuropathological features 
present after head injury (Graham et al., 1978). Peculiarities in findings in the parietal 
cortex have been noted previously. Although ChAT activity has been found to be 
reduced throughout the cortex after head injury, downregulation of ChAT activity was of 
a smaller magnitude in the parietal cortex than other cortical regions (Murdoch et al.,
1998). Similarly, fluid percussion injury in the rat reduced ChAT activity in the frontal 
and temporal cortices, but increased ChAT activity in the parietal cortex (Gorman et al., 
1996). Excitotoxic lesions of the rat nbM resulted in a significant loss of [3H]-cytisine 
binding to nAChRs in the parietal cortex only (Bednar et al., 1998). The present data add 
to the catalogue of inconsistencies observed in the parietal cortex compared with other 
anatomical brain regions after experimental brain damage and human head injury.
This investigation into the integrity of presynaptic terminals after head injury clearly 
illustrates protein and anatomically specific changes. Evidence of synaptic pathology in 
both the cortex (DeKosky and Scheff, 1990; Terry et al., 1991) and hippocampus 
(Hamos et al., 1989; Davidsson and Blennow, 1998) has been frequently reported in 
postmortem brain tissue from AD patients. Moreover, Shimohama and colleagues, 1997, 
provided evidence of differential involvement of presynaptic proteins in AD, in that 
synaptophysin and synaptotagmin only were significantly reduced in the temporal cortex 
of AD patients compared with aged-matched controls. SNAP-25, syntaxin and 
synaptotagmin were only modestly different between groups. This suggests that synaptic 
protein loss is another pathological correlate of AD and head injury. Therefore, the 
findings in the present study imply that there is a differential involvement of presynaptic 
proteins, and that there is loss of presynaptic terminals after head injury. The positive 
association of ChAT activity and synaptophysin immunoreactivity (detected by Western 
blot analyses) in both the cingulate gyrus and to a greater extent in the superior parietal
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cortex, suggests that the loss of ChAT activity is associated to some extent with physical 
destruction of presynaptic terminals.
4.1.3 Postsynaptic alterations after human head injury
To compare the cortical presynaptic deficits detected after head injury to the sensitivity 
of equivalent postsynaptic equivalents, MAP-2 immunoreactivity was detected in the 
cingulate gyrus of the same group of controls and head-injured patients. MAP-2 has been 
routinely used in immunostaining and immunoblotting techniques as An early and 
sensitive marker to examine the cytoarchitecture of postsynaptic structures after brain 
injury (Kitagawa et al., 1989; Kudo et al., 1990; Yanagihara et al., 1990). MAP-2 is 
confined to neurons, its concentration higher in dendrites than in perikarya (Bernhardt 
and Marcus, 1984; De Camilli et al., 1984) and within dendrites it is present both in 
dendritic shaft and spine synapses (Caceres et al., 1984). MAP-2 consists of a high 
molecular weight doublet (280kDa) and a low molecular mass protein (70kDa) which is 
much more abundant in neurons of the developing brain rather than in adult tissue 
(Garner and Matus, 1988). Assembly and stability of neurofilaments and microtubules is 
thought to be regulated by MAP-2 (Bernhardt and Matus, 1984).
In controls, MAP-2 immunoreactivity was localised to dendrites, appearing as long, 
branching processes. However in the cingulate gyrus from head-injured patients who 
survived 72h and 96h respectively, this continuous MAP-2 staining pattern was replaced 
by dendritic swelling and fragmentation, and accumulation in perikarya. Postmantur et 
al., 1996, identified fragmented dendrites in layers of the cerebral cortex after cortical 
impact in rats. Moreover, the same group speculated that the MAP-2 immunostaining 
pattern suggested shearing of dendrites as a consequence of TBI. Whether head injury in 
humans results in shearing of dendrites (i.e. in a similar manner to axons, Graham and 
Gennarelli, 1997) could not be determined in the current study. Nevertheless, this study 
provides direct evidence of dendritic damage in the cortex after human head injury. 
Further characterisation of the distribution and timescale of postsynaptic changes, 
compared with presynaptic alterations, as a consequence of acute brain injury are 
described in section 4.2.4.
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4.1.4. Free radical-mediated damage: Nitrotyrosine formation
Deficits in presynaptic proteins and therefore presynaptic terminals after human head 
injury have been established in this thesis. However, mechanisms of damage contributing 
to these changes in the human brain are not known. Neuronal damage by oxidative stress 
has been hypothesised as a critical mechanism of cellular damage in ageing (Berlett and 
Stadtman, 1997) and neurodegenerative diseases (Good et al., 1996). Although most 
studies have traditionally focused on the contribution of ROS, recent reports have 
described neuronal tissue damage mediated by excessive production of thfe nitric oxide 
radical (*NO) (Mesenge et al., 1996; Spinnewyn et al., 1999). *NO is synthesised from L- 
arginine and molecular oxygen (Palmer et al., 1999) by the action of a number nitric 
oxide synthase (NOS) isoforms: namely neuronal NOS (nNOS), inducible NOS (iNOS) 
and endothelial NOS (eNOS). Constitutive nNOS is postulated to produce relatively 
small quantities of *NO under basal conditions (Garthwaite, 1991; Faraci and Brian, 
1994). However, iNOS identified in neuronal astrocytes and microglia in the brain (Bredt 
et al., 1990) is responsible for the synthesis of large amounts of *NO in response to 
stimuli (Kirk et al., 1990). Transient cerebral ischaemia in the rat has been consistently 
shown to induce augmented tissue levels of *NO (Kader et al., 1993; Sato et al., 1993) 
and total NOS activity (Hamada et al., 1995). A number of groups have speculated that 
upregulation of iNOS activity is predominantly responsible for increased ’NO in global 
(Forman et al. 1998) and focal (Hirabayashi et al., 1999) models of transient cerebral 
ischaemia in the rat. Moreover, administration of NOS inhibitors has been shown to 
attenuate *NO production (Forman et al., 1998) and afford considerable neuroprotection 
(Spinnewyn et al., 1999). Transgenic mice deficient in a NOS gene possessed less 
neurological damage resulting from cerebral ischaemia and reperfusion (Ferriero et al. 
1996).
In contrast to other free radicals, *NO is relatively stable with a lifetime of several 
seconds (Koppal et al., 1995). However, when produced in an oxidising environment it 
reacts with oxygen radicals (particularly superoxide) at a diffusion-controlled rate leading 
to the formation of more reactive nitrogen oxides: the peroxynitrite anion, *N02 and 
N2O3 (Beckman and Koppenol, 1996). Peroxynitrite is not a radical, nevertheless, it is a 
far more potent oxidant than its radical precursors (Beckman et al., 1990), with a half-
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life of less than 1 second (Pryor and Squadrito, 1995). The association between 
peroxynitrite and some neurodegenerative disorders has been inferred from increased 
levels of 3-nitrotyrosine in pathologic tissue (Beal et al., 1997; Ara et al., 1998) 
Immunohistochemical and dot-blotting techniques have been used to measure 
peroxynitrite production, via nitrotyrosine formation, following TBI in mice (Mesenge et 
al., 1996) and focal ischaemia in rats (Takizawa et al., 1999). In the present study, 
immunoblotting techniques were used to assess whether there was evidence of 
peroxynitrite-mediated damage in the cortex after human head injury.
Nitrotyrosine immunoreactivity identified by western blotting detected a number of 
proteins of various molecular weights in control and head-injured patients. This is in 
agreement with Di Stasi et al., 1999, who reported substrates of a range of molecular 
masses nitrated by peroxynitrite in synaptosomes after peroxynitrite treatment. This is 
equivalent to nitration of tyrosine residues on proteins of varying mass. Although the 
mean nitrotyrosine immunoreactivity was no different between the controls and head- 
injured patients, the vast majority of head-injured cases had a nitrotyrosine 
immunoreactivity above that of the controls. The dot-blot analysis provides, for the first 
time, a suggestion that peroxynitrite-mediated damage may have a role in human head 
injury.
Peroxynitrite-mediated nitration of proteins has been shown to occur in tyrosine, 
tryptophan, methionine and alanine residues (Ischiropoulos et al., 1992; Beckman, 1996). 
To date several proteins have been found to be preferential targets of peroxynitrite- 
mediated nitration: these include manganese superoxide dismutase (MacMillan-Crow et 
al., 1998), low molecular weight subunit of neurofilament triplet (Crow et al., 1997), 
tyrosine hydroxylase (Ara et al., 1998) and prostacyclin synthase (Zou et al., 1998). With 
regard to synaptic proteins as potential targets, Di Stasi and co-workers, 1999, identified 
synaptophysin as a major protein target modified by peroxynitrite. In view of the 
reduction in synaptophysin and trend towards an increase in nitrotyrosine 
immunoreactivities, it seems possible that peroxynitrite-mediated damage may have 
contributed to the presynaptic deficit existing after head injury. Given the abundance of 
synaptophysin, approximately 7% of vesicle protein, it is not unforseeable that this is a 
major target for peroxynitrite, although other abundant synaptic proteins such as
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synapsin I and synaptotagmin have been reported not to be nitrated (Di Stasi et al.,
1999). In agreement with this, in this thesis there was no evidence of loss of either 
synaptotagmin or synapsin I after head injury. A possible explanation is the presence of 
10 copies of the tyrosine rich pentapeptide repeat in the cytoplasmic carboxyl terminus of 
synaptophysin (Sudhof et al., 1987), providing a rich environment for potential 
peroxynitrite-mediated nitration. Phosphorylation of key tyrosine residues plays a crucial 
role in signal transduction. Nitration of these tyrosine residues is believed to 
downregulate tyrosine-dependent signaling (Kong et al., 1996; Mallozi et al., 1997). In 
agreement, Di Stasi et al., 1999, identified ppbO8"1 kinase as one of the major protein 
targets modified by peroxynitrite.
Additional evidence of synaptic dysfunction and degeneration induced by oxidative 
insults has been demonstrated by the use of synaptosomes. Synaptosomes prepared after 
cortical contusion in the rat demonstrated a biphasic increase in lipid peroxidation in the 
ipsilateral cortex and hippocampus (Sullivan et al., 1998). A number of previous studies 
have shown that the aldehyde product of membrane lipid peroxidation, 4- 
hydroxynonenal, can disrupt synaptic homeostasis in vitro (Keller et al., 1997; 
Subramaniam et al., 1997) and in vivo (Azbill et al., 1997). Moreover, increased protein- 
protein interactions and increased lipid fluidity observed in physical state synaptosomal 
membranes at lh reperfusion following a lOmin period of ischaemia was prevented with 
the spin-trap agent TV-tert-butyl-a-phenylnitrone (Hall et al., 1995).
The loss of synaptic proteins along with a trend towards an increase in nitrotyrosine 
levels in the cortex of head-injured patients compared with controls is consistent with the 
possibility of peroxynitrite causing oxidative stress-induced conformational and structural 
changes. These observations suggest that head injury promotes the release of *NO, and 
that inhibition of NOS activity and synthesis of *NO may contribute to prevent 
presynaptic pathology after human head injury.
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4.1.5 nbM pathology after head injury
Deficits in cortical ChAT activity present in human postmortem brain after a head injury 
(Dewar and Graham, 1996; Murdoch et al., 1997; 1998) may reflect damage to 
presynaptic terminals or alternatively damage to Ch4 neurons in the nbM. In the present 
study, histological and immunohistochemica! analyses provided evidence of ischaemic 
damage to Ch4 neurons in the nbM of two-thirds of the head-injured patients. The 
cause/s of this damage after head injury are not known; however, macroscopic and 
microscopic analyses identified a number of mechanisms that may be involved. In several 
head-injured cases (n=5), there was neuropathological evidence of midline shift of brain 
tissue and internal herniation as a consequence of raised ICP (Graham et al., 1987). This 
mechanical distortion of the brain may account for the features consistent with plastic 
creep (Langfitt et al., 1964), first described in monkeys by experimental obstruction of 
the tentorial incisura using a saline injection into an inflatable balloon, resulting in 
transformation of neuronal perikarya from a round to elongated shape. Ischaemic 
damage to nbM neurons was also observed in some of the head-injured patients. 
Ischaemia within the nbM may have arisen as a consequence of anterior choroidal artery 
occlusion. This in turn may have been a consequence of raised intracranial pressure. It is 
interesting to note that in a previous study, patients who had a SDH had lower levels of 
cortical ChAT activity than those patients without this secondary insult (Murdoch et al., 
1998). In that study we speculated that since SDH is associated with raised ICP and shift 
of midline structures, neurons within the nbM may be damaged.
Damage to Ch4 neurons in the nbM of head-injured patients is in agreement with results 
obtained using the fluid percussion model in rats (Schmidt and Grady, 1995; Sinson et 
al., 1997), where midline injury produced an average 41% bilateral loss of Ch4 neurons 
(Schmidt and Grady, 1995). Loss of nbM neurons after experimental TBI in rats was 
attenuated by intracerebral infusion of NGF (Sinson et al., 1997). Similarly, NGF 
treatment has been reported to reverse the loss of cholinergic septal neurons after TBI in 
rats (Fischer et al., 1987; Hagg et al., 1988). Aldbeck and co-workers, 1999, reported 
that acute application of NGF increased the firing rate of aged rat basal forebrain 
neurons. In view of the cytoprotective effect of NGF on cholinergic cells and its ability to 
elevate ChAT activity in vitro and in vivo (Whittlemore and Sieger, 1987), it is possible 
that shrinkage of nbM neurons after human head injury might be a consequence of
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compromised retrograde transport of NGF due to disruption or degeneration of 
cholinergic axons projecting to target zones in the cerebral cortex (Vogels et al., 1989). 
In the present study, ChAT immunoreactivity was reduced in Ch4 neurons in the nbM of 
head-injured patients. Although there was a concominant loss of ChAT and NGF 
receptor immunoreactive cells in the rat basal forebrain after fluid percussion injury 
(Leonard et al., 1994), it is not known whether NGF receptor immunohistochemistry is 
reduced in Ch4 neurons after human head injury. This pathological process may play a 
key role given the importance and frequency of diffuse axonal injury after human head 
injury (Graham and Gennarelli, 1997).
Morphological abnormalities observed in nbM neurons in head-injured patients differed 
from those previously reported in AD. Several kinds of cell degeneration in the nbM 
have been observed in AD, including swelling (Arendt et al., 1985) and increased nuclear 
size (Iraizoz et al., 1999), the latter regarded as a plastic response due to elevated 
cellular activity (Buschmann and Lavelle, 1983; Donselaar et al., 1986). The 
neuropathological differences in nbM neurons in AD compared with head injury may be a 
reflection of the underlying mechanisms involved in chronic neurodegenerative versus 
acute brain injury. In the majority of studies of nbM neurons in AD, investigators have 
relied on the large size and hyperchromatic staining pattern seen with classic histological 
techniques for identification of Ch4 neurons in the nbM. Mapping studies have 
demonstrated these large, hyperchromatic neurons to be putative cholinergic neurons 
(Mesulam et al., 1983a; McGeer et al., 1984). In the present study, detection of ChAT 
immunostaining in Ch4 neurons in the nbM verified that the neurons with histological 
evidence of damage or death were cholinergic in origin. In contrast, using stereological 
analyses of immunostaining for the cholinergic specific markers ChAT and VAChT in the 
nbM of AD patients, Gilmor and colleagues, 1999, reported a non-significant 15% 
reduction in the number of cholinergic neurons compared with aged-matched controls. 
This is in agreement with other human postmortem studies (Pearson etal., 1983; Vogels 
et al., 1989), suggesting that cholinergic neurons in the nbM shrink during the 
pathophysiological processes of AD. The alteration in the pattern of ChAT 
immunostaining in the nbM of head-injured patients suggests that the shrunken neurons 
are cholinergic, which we speculate contributes to the reduction of cortical ChAT
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activity previously reported for this same group of head-injured patients (Murdoch et al., 
1998).
4.1.6 Correlation of nbM damage and ChAT activity
Correlation analyses of nbM neuronal damage and cortical ChAT activity in the cingulate 
gyrus, superior parietal cortex and temporal gyrus from head-injured patients (Murdoch 
et al., 1998), revealed a positive association between these two parameters, such that 
lower levels of cortical ChAT activity were associated with greater degrees of neuronal 
damage in the nbM. Likewise, stereotactic lesioning of the nbM in rats produced a loss 
of Ch4 neurons with a concominant reduction in cortical ChAT activity (Wenk et al., 
1980; Bednar et al., 1999). Moreover, electrolytic lesioning of the nbM in the rat 
produced significant reductions in glucose utilisation in 10 of 17 cortical regions 
examined, including the cingulate and parietal cortices (Browne et al., 1998). The 
trajectories of connections between the nbM and cerebral cortex have been traced in 
rodents (Eckenstein et al., 1988), monkeys (Mesulam et al., 1983a; Satoh and Fibiger, 
1985; Everitt et al., 1988) and in man (Selden et al., 1998). Using injections of tritiated 
amino acids into the midportion of the nbM and surrounding structures, Kitt et al., 1987, 
described a medial projection to the cingulate cortex that travelled within the cingulum, a 
lateral projection to the frontoparietal and insular cortices that travelled within the 
external and extreme capsules and a ventral projection to the temporal cortex and 
amygdyla that travelled within the uncinate fasciculus. Although this was performed in 
the rhesus monkey a similar pattern of cholinergic innervation has been described in the 
human brain (Selden et al., 1998). The fact that ChAT activity in each of the cortical 
regions examined correlated strongly with the neuronal damage score in the nbM of 
head-injured patients, suggests that Ch4 nbM neurons contributing to the medial, lateral 
and ventral projections were all damaged as a consequence of head injury. Interestingly, 
association of ChAT deficits in cerebral cortex and extent of disappearence of 
cholinergic soma in the basal forebrain of AD patients produced no correlation (Perry et 
al., 1982; Allen et al., 1990).
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4.1.7 Correlation of nbM damage and levels of presynaptic proteins
No relationship existed upon correlation of the neuronal damage score in the nbM with 
levels of any of the presynaptic proteins detected (by Western blotting) in either the 
cingulate gyrus or the superior parietal cortex. This suggests that although there was 
Western blot and immunohistochemical evidence of presynaptic terminal loss after head 
injury, degeneration of cholinergic terminals is not the primary pathology responsible for 
reductions in cortical ChAT activity after head injury. Alternatively, the presynaptic 
proteins examined are not cholinergic-specific, but are located on all presynaptic 
terminals, for all neurotransmitter systems within the cerebral cortex. Therefore, we 
cannot rule out a presynaptic contribution to loss of cortical ChAT activity after head 
injury, given that there was a striking correlation between ChAT activity in the cingulate 
gyrus and the superior parietal cortex, and the level of synaptophysin immunoreactivity, 
as detected by Western blot analyses.
4.2 Presynaptic pathology in animal models of acute brain injury
Synaptic transmission is regarded the currency of information exchange in the brain 
(Sudhof, 1995). Alteration in strength of synaptic transmission, referred to as synaptic 
plasticity, is believed to have both presynaptic and postsynaptic origins. Dissection of the 
subtle molecular alterations of the synapses and of plasticity might yield clues as to the 
mechanism/s of cognitive and mnemonic deficits existing after head injury. The existence 
of CNS plasticity after head injury is a controversial issue (Cotman and Nieto-Sampedro, 
1982), however, alterations in the levels of a number of presynaptic proteins in the 
neocortex of head-injured patients reported earlier in this thesis provides an indication 
that alterations in synaptic strength does exist after head injury. The aim of the present 
study was to further characterise the integrity of presynaptic terminals, by analysing the 
levels of the three proteins significantly reduced in the cingulate gyrus of head-injured 
patients, in a number of models (permanent and transient) of cerebral ischaemia.
4.2.1 Presynaptic pathology in permanent models of cerebral ischaemia
Two models of 24h permanent MCAo were used, namely the intraluminal thread model 
(Zea Longa et al., 1989) and the diathermy model (Tamura et al., 1981). Using the 
intraluminal thread model and Western blot analyses, no change in the levels of
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synaptophysin, SNAP-25 or syntaxin immunoreactivities were observed in the ipsilateral 
MCA territory compared with the contralateral hemisphere. The cingulate gyrus receives 
its blood supply from the anterior cerebral artery, explaining why optical densities in the 
ipsilateral cingulate gyrus are unchanged compared with the contralateral hemisphere. 
This implies that although the H/E staining indicates an area of neuronal damage in the 
ipsilateral hemisphere, presynaptic terminals are preserved 24h after permanent MCAo 
using this model. This was comparable with the immunohistochemical findings obtained 
for the diathermy model of 24h permanent MCAo. Despite widespread neuronal damage 
in the ipsilateral cortex and caudate, immunostaining for synaptophysin, SNAP-25 and 
syntaxin was preserved. In agreement with Korematsu et al., 1993, immunostaining for 
the presynaptic proteins in the ipsilateral cortex and caudate had a more coarse staining 
pattern compared with the contralateral hemisphere. The accumulation of SNAP-25 and 
syntaxin in the axonal fibre tracts of the ipsilateral caudate is presumably a consequence 
of these proteins being fast anterogradely transported as part of pleiotrophic organelles 
from the cell body to their appropriate targets (Li et al., 1996). Whether these 
accumulations reflect axotomy of axons, or increased demand for these synaptic proteins 
as a consequence of neuronal remodelling and plasticity is not known. In view of the 
extent of oedema and resultant disintegration of tissue it was not possible to measure the 
relative optical densities of the immunostaining for these presynaptic proteins in this 
model of cerebral ischaemia. The permanent models of focal cerebral ischaemia used did 
not support a presynaptic deficit after this type of insult per se. A murine model of 
transient forebrain ischaemia was therefore employed to investigate whether temporal 
alterations in presynaptic inputs existed over longer timepoints, and if transient ischaemia 
with reperfusion rather than permanent ischaemia could be involved.
4.2.2 Neuronal damage after transient forebrain ischaemia
One of the major pathophysiological mechanisms involved in human head injury is 
ischaemic damage. Transient global ischaemia in rodents is known to injure discrete 
populations of neurons. Specifically, neurons in the caudate nucleus (Yang et al., 1997; 
Horsburgh et al., 1999) and the hippocampus (Petito et al., 1987) are among the most 
vulnerable in the CNS to an ischaemic insult. Within the hippocampus, the CA1 
pyramidal neurons have been shown to be the most susceptible to ischaemic damage 
following transient forebrain ischaemia (Kirino, 1982; Pulsinelli et al., 1982; Onodera et
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al., 1986) in rodents. In the present study, neuronal damage was evident in the caudate at 
lday, and widespread 3 and 10 days after 17min transient forebrain ischaemia. Within the 
hippocampal formation, the CA1 and CA2 sectors and the hilar region proved most 
susceptible to ischaemic damage at each of the survival periods. CA3 pyramidal cells and 
dentate gyrus neurons possessed less extensive damage at each of the timepoints 
examined. Previous studies have suggested that CA3 pyramidal cells and dentate gyrus 
neurons are relatively resistant to ischaemic damage following transient forebrain 
ischaemia in gerbils (Marti et al., 1998) and rats (Francis and Pulsinelli, 1982). This study 
has provided evidence of selective neuronal depletion caused by transient forebrain 
ischaemia.
4.2.3 Presynaptic pathology in transient forebrain ischaemia
Synaptic plasticity in the brain after injury has been studied in a number of species and 
experimental models. Consequently, a diverse collection of results exists adding 
controversy to the existence of CNS plasticity after injury. The aim of the present study 
was to investigate the temporal profile of presynaptic pathology in the caudate and 
various presynaptic inputs of the hippocampus after transient forebrain ischaemia in the 
mouse. Immunostaining and relative optical density measurements were used to ascertain 
the level of the three synaptic proteins that were reduced in the cingulate gyrus in head- 
injured patients. Immunostaining for synaptophysin and SNAP-25 was preserved in the 
neuropil of the caudate in mice allowed to survive each of the timepoints after global 
ischaemia. In addition, relative optical density measurements confirmed both 
synaptophysin and SNAP-25 immunostaining were preserved in the caudate of ischaemic 
compared with sham animals. A similar pattern of results were obtained in the various 
hippocampal layers examined. There was minimal change in the relative optical density of 
synaptophysin immunostaining in all of the hippocampal layers measured. Similarly, 
relative optical densities of SNAP-25 and syntaxin immunostaining were relatively 
unaltered in all hippocampal layers at each timepoint after global ischaemia, although 
there was a trend towards a decrease in the outer, middle and inner molecular layers of 
the dentate gyrus with prolonged survival time after global ischaemia. Synaptophysin and 
SNAP-25 immunostaining in the cortical neuropil was preserved in ischaemic brains 
compared with sham animals. Therefore, despite extensive neuronal damage in the
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caudate, cortex and each of the hippocampal sectors, presynaptic proteins appeared to be 
preserved, implying that presynaptic terminals remain intact after cerebral ischaemia.
A number of groups have investigated the integrity of presynaptic terminals in animal 
models of cerebral ischaemia, producing a divergent set of results. Synaptophysin has 
been reported to be increased in the neocortex between 14-60 days after permanent 
MCAo (Stroemer et al., 1995). In this thesis, synaptophysin levels were no different in 
ischaemic compared with sham animals. The difference in results presumably reflects the 
timepoints considered, since Stroemer and colleagues, 1995, found no change in 
synaptophysin immunoreactivity 3 or 7 days after the ischaemic episode. Similarly 
synaptophysin immunoreactivity has been shown to be increased in the caudate 
(Korematsu et al., 1993) and the stratum lacunosum molecular layer and stratum oriens 
of the CA1 sector of the hippocampus after transient forebrain ischaemia in rats. A 
decline in the immunoreactivities for syntaxin and SNAP-25 (Marti et al., 1998), and 
synapsin I and synaptophysin (Marti et al., 1999) have been detected in the inner 
molecular layer of the dentate gyrus after global ischaemia in gerbils. The variability in 
the changes observed is likely to be a consequence of variations in severity of ischaemia, 
recovery times, species and the experimental models of acute brain injury employed.
Despite these reports of presynaptic pathology after acute brain injury, the overwhelming 
consensus is that presynaptic terminals are relatively resistant to ischaemic damage. 
Synaptophysin immunoreactivity has been reported to be preserved in the hippocampal 
CA1 sector 7 days after transient forebrain ischaemia in the rat (Rischke et al., 1990). 
Moreover, immunoblots of SVP-3 8, another synaptic vesicle-specific protein, did not 
show significant changes in extracts from the CA1 sector after traumatic forebrain 
ischaemia in the gerbil (Arai et al., 1991). This is in agreement with results obtained in 
this thesis, since immunoreactivity for each of the presynaptic proteins examined in the 
stratum oriens and stratum lacunosum was unchanged up to 10 days after transient 
forebrain ischaemia. Kitagawa et al., 1992, reported synapsin I immunoreactivity was 
unchanged after 2 months in the degenerated CA1 layer. In addition, electron 
microscopy studies revealed intact presynaptic terminals, rich in synaptic vesicles, twelve 
months after an ischaemic insult (Bonnekoh et al., 1990; Kirino et al., 1990).
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The results obtained using both permanent and transient models of cerebral ischaemia are 
in agreement with the majority of studies, in that presynaptic terminals appear to be 
relatively resistant to ischaemic damage. Moreover, in studies where presynaptic deficits 
have been reported, the loss was always smaller than that of the postsynaptic elements 
and confined to areas of overt infarction (Kitagawa et al., 1992). The preservation of 
immunoreactivity for each of the synaptic proteins might represent preservation of the 
specific epitopes rather than preservation of the synaptic proteins themselves. However, 
Kitagawa and colleagues, 1992, have previously reported loss of not only antigenicity 
but also breakdown of presynaptic proteins after cerebral ischaemia. It is unknown how 
and why presynaptic terminals were persistently preserved. A possible explanation is that 
reactive astrocytes present in the ischaemic territory (Hatakeyama et al., 1989; Kirino et 
al., 1990) may contribute to the maintenance of presynaptic terminals by supplying 
neurotrophic factors required for the survival of detached terminals and their original 
neurons (Kromer, 1996). Alternatively, postsynaptic remnants have been hypothesised as 
having a role in chronic maintenance of presynaptic terminals (Kirino et al., 1990).
4.2.4 Postsynaptic alterations after transient forebrain ischaemia
Presynaptic terminals appeared to be preserved in the cortex, caudate and various 
hippocampal layers after transient forebrain ischaemia in the mouse. To contrast this with 
the status of equivalent postsynaptic structures, the pattern of MAP-2 immunostaining 
was assessed in the same tissue. The low power magnification images indicate the early 
and anatomically-specific loss of MAP-2 after global ischaemia, the most extensive 
depletion of MAP-2 being present in the hippocampus and caudate. High power 
magnification images highlighted the extent and rapidity of loss of MAP-2 from the 
neuronal perikarya and dendrites after transient forebrain ischaemia, particularly in the 
caudate, and the CA1 and CA2 sectors of the hippocampus.
MAP-2 has been used as a reliable and sensitive postsynaptic marker in a number of 
models of cerebral ischaemia (Kitagawa et al., 1989; Inuzuka et al., 1990; Yoshimi et al., 
1991) and TBI (Taft et al., 1992; Kudo et al., 1993; Folkerts et al., 1998). In the present 
study, MAP-2 immunostaining was disrupted in the caudate, cortex and the hippocampus 
after transient forebrain ischaemia. Similarly, previous studies have detected early 
changes in MAP-2 expression in each of these anatomical brain regions. For example,
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MAP-2 immunostaining was reduced in the CA1 sector neonatal (Malinak and Silvestein,
1996) and mature rodents (Matesic and Lin, 1994) after cerebral ischaemia. 
Ultrastructural investigation of the stratum oriens and stratum lacunosum molecular layer 
of the CA1 sector, identified early swelling of dendritic structures as early as 5min after 
transient forebrain ischaemic in the gerbil (Yamamoto et al., 1990). Kitagawa et al., 
1992, reported extensive disruption of MAP-2 immunostaining in the caudate of gerbils 
after global ischaemia. Loss of cortical MAP-2 immunostaining has been reported as 
early as 3h after direct cortical impact injury (Postmantur et al., 1996) and fluid 
percussion injury (Taft et al., 1992) in the rat.
Evidence of early loss of postsynaptic elements, by way of disruption of MAP-2 
immunostaining has been consistently demonstrated in the cortex of head-injured patients 
and in several anatomical brain regions after global ischaemia. Although individual 
deficits in a number of presynaptic proteins was detected in the cortex after head injury, 
this observation was not replicated after transient forebrain ischaemia in the mouse. 
Nevertheless, in agreement with the majority of previous studies, the dissociation of 
MAP-2 and presynaptic protein immunoreactivities suggest that presynaptic terminals are 
relatively resistant to acute brain injury compared with the postsynaptic sites.
4.3 GGF-2 after human head injury
A number of growth factor systems have been proposed to influence outcome after 
ischaemic and traumatic brain injury. One major growth factor signaling system is that 
involving the neuregulin family of peptides. The aim of the present study was to elucidate 
whether GGF-2, a member of the neuregulin family, existed in the adult human brain and 
to determine the level of GGF-2 in the cerebral cortex of patients who sustained a fatal 
head injury.
The present study provides the first demonstration that GGF-2 exists in the human brain. 
Moreover, Western blotting and immunohistochemical analyses indicated that GGF-2 
immunoreactivity was significantly increased in the cingulate gyrus, but not the superior 
parietal cortex of head-injured patients compared with controls. Although there was no 
evidence of elevation of GGF-2 in the superior parietal cortex of the head-injured
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patients, when the group mean values were considered only one control case in the 
group exceeded the mean level of GGF-2 immunoreactivity in the head-injured group. 
Therefore, an anatomically widespread elevation of GGF-2 in the cerebral cortex of 
some head-injured patients cannot be excluded. Anatomical and inter-patient 
heterogeneity in the elevation of GGF-2 in the head-injured patients examined may be a 
reflection of the multiple types and severity of neuropathological features after head 
injury. Association of GGF-2 immunoreactivity with presence of a left SDH in head- 
injured patients, indicated increased GGF-2 immunoreactivity in patients who survived 
24-96h after head injury. Ischaemic brain damage is one of the most common 
neuropathological features after a head injury (Graham et al., 1987). However, the 
presence or absence of ischaemic brain damage after human head injury, determined by 
histological assessment in blocks adjacent to those used for Western blotting, in the 
present study did not identify those patients with the greatest increase in GGF-2 levels. 
Thus, while ischaemia may be one, it is not the sole stimulus for the increase in GGF-2 
after head injury. Eilam and co-workers, 1998, have shown that neuregulins along with 
the receptor ErbB4, is induced by three stimuli in the rat brain: activation of excitatory 
amino acid receptors, increased locomotor activity and tetanic stimulation of the 
perforant path. Activation of excitatory amino acid receptors has been proposed to be an 
important pathophysiological mechanism after head injury (Bullock, 1994; Zauner et al., 
1996). Similarly, Ozaki and colleagues, 1997, reported that a neuregulin isoform induced 
expression of NMDA receptor subunits in the cerebellum. The heterogeneity of the 
GGF-2 response in the cingulate gyrus and the superior parietal cortex may be a 
consequence of variable levels of receptor activation in the cortex of head-injured 
patients. Increased expression of additional growth factors have been described acutely 
after global ischaemia (Takeda et al., 1993; Masamura et al., 1996), middle cerebral 
artery occlusion (Lin et al., 1998; Plate et al., 1999) and TBI (Logan and Berry, 1993; 
Hicks et al., 1997). Administration of peptide growth factors have been reported to 
improve functional outcome (Wen et al., 1995; Saatman et al., 1997) and/or reduced 
morphological damage (Hayashi et al., 1998; Justicia and Planas, 1999) in models of 
acute brain injury. It remains to be determined whether GGF-2 has therapeutic efficacy in 
animal models of ischaemia.
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4.3.1 GGF-2 in white matter and in Alzheimer's disease
The GGF-2 response in the human brain was characterised in subcortical white matter 
from the same group of head-injured patients and controls and in the cingulate gyrus of 
AD patients and aged-matched controls. The observation that GGF-2 immunoreactivity 
was not increased in the corpus callosum of head-injured patients may support a 
primarily neuronal rather that a glial response. Indirect effects of neuronally expressed 
GGF-2 may be to regulate glial cell number, which in turn may provide trophic support 
for neurons. Several lines of evidence support the concept that GGF-2 acts as an indirect 
neurotrophin via induction of neurotrophin synthesis and secretion. For example, 
neurotrophin-3 was upregulated 40-fold in glial cells treated with GGF-2 and this 
response was blocked by antibodies to GGF-2 (Verdi et al., 1996). In retinal ganglion 
cells derived from rats at various stages of embryonic and postnatal development, GGF-2 
acted directly to promote neuronal survival and neurite outgrowth (Bermingham- 
McDonogh et al., 1996). Anton and co-workers, 1997, demonstrated that GGF-2 
signaling is involved in interactions between migrating neurons and glial cells in the 
developing cerebral cortex.
The role of growth factors in chronic neurodegeneration has been the subject of 
extensive investigation. The levels of NGF has been found to be increased in AD brains 
(Crutcher et al., 1993; Scott et al., 1995). In contrast, both BDNF and NT-3 are reduced 
in the cerebral cortex of AD patients compared with aged-matched controls (Narisawa- 
Saito et al., 1996). The present study provides no support for a role of GGF-2 in the 
pathophysiology of AD. Thus, the elevation of GGF-2 levels after head injury in non­
acute brain injury may be a feature of the pathophysiological processes associated with 
acute brain injury, rather that the chronic degeneration of AD in elderly patients.
4.3.2 GGF-2 in animal models of acute brain injury
Potent therapeutic effects for NGF (Holtzman et al., 1996), bFGF (Koketsu et al., 1994), 
BDNF (Kiprianova et al., 1999), CNTF (Wen et al., 1995), HGF (Miyazawa et al., 
1998), IGF-1 (Saatman et al., 1997) and TGF-a (Justicia and Planas, 1999) have been 
described in animal models of acute brain injury. The observation that GGF-2 was 
increased in both neurons and glial cells after permanent and transient MCAo in rats
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(Soriano et al., 1998) is indicative of a possible role for GGF-2 in acute brain injury. 
Similarly in the present study, Western blotting analyses suggested that GGF-2 was 
increased in the ipsilateral and contralateral cortices after 4h SDH, and in the ipsilateral 
caudate and cortex after 24h permanent MCAo in the rat. The findings in both human 
head injury and animal models of cerebral ischaemia suggest that the GGF-2 response 
may contribute to a plastic response after acute brain injury, potentially providing an 
environment for neuronal survival and repair. While peptide growth factors stimulate 
different signal transduction mechanisms, their actions are likely to converge on common 
effector proteins. Stoop and Poo, 1996, speculated that these targets are protein kinases, 
downstream of proteins involved in trafficking, docking and exocytosis of synaptic 
vesicles. In agreement, some neurotrophic factors have been shown to have the capacity 
to enhance the efficacy of synaptic transmission (Kim et al., 1994; Kang and Schuman, 
1995). Moreover, using rat cortical neurons (Takei et al., 1997) and xenopus 
neuromuscular cultures (Wang et al., 1995), some neurotrophic factors have been 
demonstrated to upregulate the expression of a number of presynaptic proteins. Whether 
GGF-2 has the capacity to upregulate synaptic proteins and contribute to presynaptic 
pathology after acute brain injury was beyond the scope of the present study.
In conclusion, the results from this thesis demonstrate that cortical presynaptic terminals 
are abnormal after head injury, in that subtle individual presynaptic protein alterations 
were identified. The fact that some presynaptic proteins remained unaltered may be a 
consequence of the function or quantity of individual proteins. Cortical cholinergic 
deficits existing after head injury are primarily due to damage to Ch4 neurons in the 
nbM, although loss of a proportion of cortical presynaptic terminals cannot be excluded. 
In contrast to the preservation of presynaptic terminals in animal models of acute brain 
injury, early and neuroanatomicaly widespread disruption of MAP-2 illustrates the 
vulnerability of postsynaptic elements compared with the presynaptic equivalents. A 
number of peptide growth factors are thought to have a presynaptic action. Whether 
GGF-2 acts at the presynaptic locus to protect presynaptic terminals from damage 
remains to be determined. However, the expression of neuronal nAChR channels during 
synaptogenesis in response to GGF-2 (Yang et al., 1998), suggests a role for GGF-2 at 
the presynaptic cholinergic terminal. Whether this is operational in the mammalian CNS 
in response to brain injury is not known.
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4.4 Future work
This thesis has largely characterised presynaptic pathology after acute brain injury. 
Although, some evidence was presented providing an insight into a possible role of free 
radical-mediated damage in presynaptic terminal dysfunction, additional studies would be 
needed to explore this further. A likely approach would be preparation of cortical 
synaptosomes from human head injury material and exposing these to free radical 
generators, to establish whether free radical-mediated damage contributes to presynaptic 
protein loss after head injury. Exposure of cortical synaptosomes to peroxynitrite, 
followed by immunoprecipitation studies would identify molecular masses of synaptic 
proteins that are potential targets for peroxynitrite-mediated nitrosylation. Deficits in the 
cortical cholinergic system have been frequently reported after head injury and 
experimentally-induced brain damage. However, the presynaptic proteins examined are 
not restricted to the cholinergic terminals, but are homologous throughout all 
neurotransmitter systems. Autoradiographic analysis of [3H]-citalopram binding in the 
cerebral cortex from controls and head-injured patients would provide another index of 
presynaptic terminal integrity, via measuring the levels of presynaptic serotonin uptake 
sites after head injury.
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Appendix 1: Histological assessment of neuronal damage
Haematoxylin and Eosin
Sections were dewaxed in histoclear for lOmin and rehydrated in 99% and 95% alcohol 
for 3 and 2min respectively. After rinsing with water, nuclei were stained with 
haematoxylin for lOmin. The haematoxylin stain was then blued in Scott’s Tap Water 
Substitute for a few seconds followed by washing in water. Staining was examined 
microscopically and if necessary differentiated in acid alcohol, followed by a few dips 
in Scotts Tap Water Substitutes. Once adequate differentiation was achieved, sections 
were washed in water and stained with eosin for a maximum of 5min. Thereafter, 
sections were washed with water, followed by dehydration of sections in alcohol and 
cleared in histoclear prior to mounting with DPX.
Luxol Fast Blue / Cresyl Violet
Sections were dewaxed in histoclear, rehydrated in 95% alcohol and stained in 0.1% 
luxol fast blue for 2h in an oven at 60°C. Remove excess staining with 95% alcohol and 
rinse sections in water. Staining was differentiated in 0.05% aqueous lithium carbonate 
and differentiation continued in numerous changes of 70% alcohol until grey matter 
could be distinguished from white matter. After washing, differentiated sections were 
stained with cresyl violet for 5min and rinsed in running water. Staining was 
differentiated in 95% alcohol containing a few drops of acetic acid, prior to dehydration, 
clearing and mounting with DPX.
Appendix 2: Focal Cerebral Ischaemia in the Rat: Permanent Middle Cerebral
Artery Occlusion - Intraluminal Thread Model
Four male Sprague-Dawley rats (270g-330g) were anaesthetised using 4% halothane in a 
mixture of 70% nitrous oxide and 30% oxygen. Animals were orally intubated and 
mechanically ventilated with halothane concentration reduced 1.5%-2%. The femoral 
arteries were cannulated to enable monitoring of arterial blood pressure and sampling for 
blood gas analysis. Body temperature was maintained at 37°C by means of a rectal 
temperature probe and heating lamp.
Middle cerebral artery occlusion was performed using a modification of the method used 
by Zea Longa et al., (1989). Briefly, after coagulation by diathermy of the maxillary, 
lingual, occipital branches of the carotid arteries, the pterygopalantine was tied off with 
6-0 suture and microvascular clips applied at the bifurcation of both the common and 
internal carotid arteries and the internal and pterygopalantine. A 3-0 silk suture (with 
rounded tip) was inserted into the external carotid, tied loosely in place, and advanced 
into the internal carotid until (removing clips as required) until resistance was achieved 
(approximately 22mm). The filament was tied off and diathermied to secure it in place 
and the animal was allowed to recover.
Appendix 3: Global Cerebral Ischaemia in the Mouse: Bilateral Common Carotid
Artery Occlusion
In thirteen C57BL/6 mice, surgical anaesthesia was induced with 3% and maintained 
with 1.5% halothane delivered in 70% nitrous oxide / 30% oxygen via a face mask. A 
rectal probe was inserted and core body temperature was maintained at 37°C using a 
heating lamp. Bilateral common carotid artery occlusion was achieved using the 
technique of Barone et al., (1993). A ventral midline incision was made and the common 
carotid arteries were isolated by clearance of muscle and connective tissue. The carotids 
were elevated and occluded bilaterally for 17min with microaneurysm clips. The duration 
of ischaemia was based on previous observations made in a study of neuronal damage 
following different durations of global ischaemia in C57BL/6 mice. Following occlusion, 
the clips were removed and the incision was sutured closed using a 6-0 silk suture. The 
procedure for the SHAM animals (n=5) was identical, with the exception of applying the 
clips.
Animals were placed in an incubator for 2h and allowed to recover for 1 (n=3), 3 (n=4) 
and 10 days (n=l) and observed daily. At each end point, mice were reanaesthetised and 
transcardially perfused via the left ventricle with heparinised 0.9% NaCl followed by 4% 
paraformaldehyde in phosphate buffer. The brain was then postfixed in the skull in 4% 
paraformaldehyde for a further 24h. Following this, the brain was removed from the skull 
and washed in phosphate buffer for 2h.
Appendix 4: Subdural Haematoma in the Rat
Nine adult male Sprague-Dawley rats (weight 350-450g) were anaesthetised using 4% 
halothane in a mixture of 70% nitrous oxide and 30% oxygen. A tracheotomy was 
performed and the animals were mechanically ventilated, with halothane reduced to 1%. 
Both femoral arteries were cannulated to monitor arterial blood pressure and sampling 
for blood gases analysis. Venous cannulae were placed to allow autologous blood to be 
drawn. Core body temperature was maintained at 37°C by means of a homothermic 
blanket controlled by a rectal thermometer.
A subdural haematoma was induced using a method described previously (Horsburgh et 
al., 1997). Briefly, the animals were placed in a stereotaxic frame, the skull exposed and 
a burr hole was drilled 2mm to the left and 1mm posterior of Bregma. The dura was 
incised and a blunt J-shaped needle was inserted into the subdural space. The subdural 
haematoma was produced by slowly injecting 0.4ml of non-heparinised freshly drawn 
autologous venous blood into the subdural space over a period of 7min. SHAM-operated 
animals (n=5) underwent the same surgical procedures, without production of a 
haematoma.
Appendix 5: Focal Cerebral Ischaemia in the Rat: Middle Cerebral Artery
Occlusion - Diathermy Model
Four adult male Fisher 344 rats were allowed food and water ad libitum and maintained 
under standard conditions. Rats were anaesthetised with 5% halothane in a mixture of 
nitrous oxide/oxygen (70:30). After non-surgical oral intubation, animals were 
mechanically ventilated and the halothane concentration was reduced to 1.5%. The 
femoral artery was cannulated to enable monitoring of blood pressure and measurements 
of blood pH, pC02, p02. During surgery, body temperature was maintained at 37°C 
using a rectal thermometer and heating lamp.
The MCA was permanently occluded using the method of Tamura et al., 1981. Briefly, 
the left temporalis muscle was dissected and a craniectomy was performed at the level 
where the middle cerebral artery crosses the lateral olfactory tract. The MCA was 
occluded with micropolar forceps on a low power setting using continuous saline 
irrigation (n=2). In an identical surgical procedure, SHAM-operated animals (n=2) had 
the MCA exposed but not occluded. The wound was sutured and the rats were allowed 
to recover for 24h after surgery. Rats were then deeply anaesthetised with 5% halothane 
and decapitated.
